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Parathyroid Localization
Nis Schmidt, MD, MSc, FRCSC
Member, Editorial Board, Canadian Journal o f Surgery. Clinical Professor, Department o f
Surgery, University o f British Columbia, St. P aul’s Hospital, Vancouver, BC

success in the surgical
Increased
management of primary hyper

parathyroidism results not from ad
vances in localization, but from cer
tainty of the diagnosis. After that
the experience of the operator is
the best guarantee for success in
locating and removing overactive
parathyroid tissue, bringing the
clinical problem under control. In
spite of great biochemical, isotopic
and technical advances, the best
preoperative localization techniques
for discovering a parathyroid adeno
ma are optimistically not better
than 80% accurate in pointing to
the offending parathyroid gland, or
glands, when that organ is incrimi
nated as the cause of the patient’s
hypercalcemia.1 If all available in
The Canadian Journal of Surgery
1867 Alta Vista Dr.
Ottawa, Ont. K1G 3Y6

vestigative tools for locating an
enlarged parathyroid or detecting
increased parathormone concentra
tion were brought to bear on every
patient suspected of having primary
hyperparathyroidism, the inconve
nience, morbidity and cost factors
would be unreasonable and the in
creased sensitivity and specificity
would still fall short of 100%.
Much has been written on the
subject of preoperative parathyroid
localization. Of historical interest
only is the once-used barium swal
low to locate a retroesophageal or
retropharyngeal parathyroid tu
mour. Selenium-methionine scan
ning, thallium-technetium subtrac
tion scanning, computed tomogra
phy and and magnetic resonance
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Fax: (613) 523-0937
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imaging have a specificity at best of
80% and a sensitivity of 80%, in
creasing as the gland diameter in
creases over 1 cm.2 Arteriography
and venous parathormone sampling
are individually no more sensitive
than the above investigative proce
dures, but are much more invasive
and therefore risky. Currently the
least invasive and most widely avail
able preoperative investigative tool
used to locate a parathyroid tumour
is real-time ultrasonography.
Wexler and associates in this
issue of the Journal (pages 175 to
180) give a thoughtful prospective
evaluation of preoperative parathy
roid ultrasonography versus para
thyroid nuclear scanning. Their
findings in a small series of 27
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patients treated at the Royal Victo
ria Hospital in Montreal, an institu
tion with experienced and skilled
radiologists and surgeons, are bet
ter than the literature would sup
port — 78% sensitivity and 100%
specificity to locate a parathyroid
adenoma preoperatively to one side
or other of the neck.
Once the hypercalcemic patient is
considered to have primary hyper
parathyroidism of significant mag
nitude to justify surgical treatment,
the failure to cure that patient
through surgery depends on four
factors: the size, location and num
ber of the glands, and the experi
ence of the operating surgeon.
Glands smaller than 1 cm in
diameter (about 30% in our experi
ence), unless they are located at the
inferior poles of the thyroid lobes,
are poorly seen by ultrasonography,
and they are rarely seen if located
deep to the thyroid lobes, adjacent
or under the tracheoesophageal
groove, or behind the superior thy
roid poles. Glands in the thymic
extension into the neck and those
located deep to the clavicular heads
and along the common carotid ves
sels are rarely visualized. Large
glands are easier to find at all
locations in the neck. Glands great
er than 2.5 cm in diameter are rare.
Double adenomas are infrequently
found by localization techniques be
cause they are seldom of equal size,
whereas hyperplasia of all the
glands, especially in tertiary hyper
parathyroidism of renal disease, is
often well visualized. Parenthetical
ly, the glands most easily visualized
preoperatively by ultrasonography
are usually easily found on explora
tion of the neck. False-positive ul
trasonographic findings for the
most part are thyroid nodules or
occasionally large lymph nodes.
The bottom line of parathyroid sur
gery is that in 85% of situations the
parathyroid adenoma or hyperplasia
is easily found by any surgeon
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comfortable with operating in the
neck. Careful bloodless dissection is
the friend of success. It’s the 15%
of cases that present difficulty, forc
ing the parathyroid surgeon to stay
longer, search deeper and use all
the tricks known through experi
ence to find the elusive tumour.
The failure rate of parathyroid ex
ploration should not exceed 5%.
Unilateral exploration cannot be
advocated generally because preop
erative localization does not yet
give us that level of confidence.
Admittedly once a parathyroid ade
noma is located, the possible pres
ence of a second adenoma is about
2% on either side of the neck in our
experience. If both parathyroid
glands on one side are enlarged and
diseased, there is a high chance
that hyperplasia exists, and the sec
ond side has to be explored. In spite
of the preoperative ultrasonograph
ic findings, if the suspected tumour
is not found during neck explora
tion the other side of the neck must
be explored.1 If one satisfactory
parathyroid tumour is located, it is
not necessary to do a biopsy on all
parathyroid tissue since the chance
for ectopic parathyroid tumours or
mediastinal tumours occurs in only
1% to 2% of cases (personal unpub
lished data).
For the most part, when a para
thyroid exploration is being con
templated, ultrasonography, in spite
of its mediocre value in preoperative
investigation, should be done. Even
with a positive report from an expe
rienced and confident radiologist, a
bilateral neck exploration is still the
best plan. If the radiologist is not
confident, a marginal report can be
disadvantageous to the surgeon
with infrequent parathyroid experi
ence. One must explore that patient
with caution since a failed parathy
roid exploration greatly increases
the morbidity, risk and difficulties
for the subsequent control of hyper
calcemia of parathyroid disease.

Since the advent of accurate,
widely available, multichannel bio
chemical analysis, hypercalcemia is
becoming uncovered within the
general population quite often. This
means that parathyroid exploration
will be performed increasingly fre
quently. It also means that with
infrequent experience, the failed ex
ploration rate will climb unless sur
geons confronted with the clinical
problem seek some advice and expe
rience in finding the often hidden
parathyroid adenoma. Until a better
localization method is available,
probably a tagged monoclonal anti
body, practical help is available.
Intraoperative localization using
methylene blue is of practical value,
although few experienced parathy
roid surgeons find it necessary; 500
ml of dextrose and normal saline
containing 5 m g/kg of methylene
blue, infused rapidly over 30 min
utes just after the induction of
anesthesia, will in almost all cases
stain the parathyroid adenoma a
deep purple. The thyroid gland will
stain a grey-blue, and normal para
thyroid tissue rarely changes its tan
brown hue. It amazes me how often
a deep colour change speeds up the
exploration and localization of para
thyroid adenomas in the primary
and in the repeat neck exploration
and adds to the surgeon’s confi
dence that abnormal parathyroid
tissue has indeed been adequately
removed.3
In my experience with parathy
roid surgery, which has grown ex
tensively in the past few years, a
solid history and physical examina
tion to rule out causes of hypercal
cemia other than primary hyper
parathyroidism, an accurate repeat
ed determination showing an elevat
ed calcium level, ionized calcium
and parathormone measurements
that are elevated or of high-normal
values are sufficient to recommend
parathyroid exploration by an expe
rienced surgeon. Localization help

QUILL ON SCALPEL

in addition to ultrasonography,
through the use of intravenous
methylene blue during surgery,
should give even the occasional
parathyroid surgeon confidence to
explore and find most abnormal
glands, and give them the satisfac
tion which comes through treating

this interesting clinical problem
successfully.
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Microvascular Reconstruction
of the Hand
Ralph T. Manktelow, MD, FRCSC
Head. Division o f Plastic Surgery. Department o f Surgery, Toronto General Hospital. Toronto,
Ont.
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hen I see a patient in the
emergency department who
has a serious hand injury or a
finger or hand amputation I am
often unsure of what is the best
approach to treatment. From the
technical standpoint there are usu
ally several options available, from
simple amputation closure to the
most complex procedure — replan
tation. It is technically feasible to
repair, with varying degrees of
functional success, tendons, bones,
nerves, vessels, joints and skin.
However, just because a technique
of repair or reconstruction is avail
able does not necessarily mean that
it should be carried out.
The surgeon dealing with a badly
mangled hand must look at what
can be accomplished in terms of
regaining the two main hand func
tions — pinch and grip. Whether to
repair and reconstruct depends on
both biologic and psychosocial fac
tors. The degree of damage to the
various tissues and structures deter
mines the extent of recovery. Can
bones that are fixed or replaced
unite, can tendons be repaired or
replaced and develop good gliding,
can nerves be repaired and have

useful sensibility and motor func
tion, and will joints move again?
Will skin coverage be adequate to
handle the functional needs of the
patient and provide not only dura
ble, sensate coverage but adequate
cosmesis? There are many variables
that make functional recovery un
predictable. However, the biology
cannot be viewed in isolation from
the patient and the patient’s unique
psychosocial factors. The hand
therapist who spends many hours
with the patient postoperatively will
find each one unique in the way
that they pursue their therapy pro
gram and cope with disability.
These two factors — rehabilitation
compliance and coping — are criti
cal to the outcome of hand recon
struction. Some patients pursue the
tedious repetitions required in the
therapy program with diligence and
perseverance. Others do not have
the motivation, endurance and abili
ty to tolerate discomfort that are
needed for successful therapy. In
some situations the patient who is
unable to pursue the therapy pro
gram manually may be assisted with
dynamic splints.
When sensory nerve injuries are

present even the best of repairs will
never allow recovery of normal sen
sibility. It is always difficult for the
therapist and the surgeon to under
stand why a patient who has poor
sensibility will use the extremity
well, but others who have minimal
measurable loss of sensibility find
this enough of a handicap to pre
vent them from using the finger or
hand. When the surgeon sees a
patient in the emergency depart
ment with a severe hand injury or
amputation, how that person is
going to cope and how vigorously
they are going to pursue their exer
cise programs are unknown factors.
However, in the initial discussion
with the patient, the surgeon may
be able to make a tentative assess
ment.
The patient with a hand amputa
tion described in this issue by Ewart
and Zuker (pages 239 to 242) illus
trates the decision-making problem
faced by the surgeon in the emer
gency setting: The hand is almost
completely severed with division of
all structures except for extensor
tendons. The wrist is destroyed ne
cessitating shortening of the ex
tremity and fusion of the metacarCJS, VOL. 33, NO. 3. JUNE 1990
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pals to the distal radius. Will the
loss of the wrist and loss of the
normal mobility of the base of the
thumb be of such functional disad
vantages that the patient is better
off with a prosthesis? There is no
sure answer to this question be
cause the biologic and psychologi
cal factors, which determine the
value of the surgery, are largely
hidden from the surgeon at the time
of the preoperative emergency con
sultation.
The final factor that affects deci
sion-making is the patient’s func
tional requirements for the hand.
These requirements include selfcare, hobbies, sports and vocation.
A man who uses his hand in the
northern bush to cut trees needs a
hand which is strong and pain free,
with good sensibility and one that
can tolerate cold weather. A seam
stress who uses her hand for meti
culous activities needs good sensi
bility in the fingers but may not
need a lot of strength. Cold sensi
tivity will not be a problem. The
watchmaker who works with jewel
ler’s forceps needs extreme sensibil
ity but does not need a lot of
movement. The mechanic or tool
and die maker needs a strong grasp
for tools such as a wrench or a
screwdriver and needs full wrist
movements so that the hand can be
placed in awkward positions about
machinery. For some persons, play
ing squash, skiing or bicycling are
very important activities in bringing
satisfaction to their lives. For oth
ers the requirements are more ba
sic. What do they need to be able to
eat, wash and clothe themselves?
For all patients function will be
adversely affected by pain.
The effect of a hand injury on
body image is usually considered
relatively unimportant compared
with its effect on pinch or grip.
Obviously the appearance of a per
son’s face is important to them in
their ability to relate to people
170
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socially. However, the appearance
of the hand has long been underap
preciated in terms of its psychoso
cial effect on the patient. Many
patients will not use an ugly hand
which has good pinch or grip capa
bility because they do not want the
hand to be seen, believing that it
makes them look deformed. The
effect of this factor varies with
psychosocial background; for exam
ple, a patient from a Third World
country who has had an amputation
may not allow the extremity to be
seen because in that country an
amputation would indicate the pres
ence of a socially unacceptable con
dition. Occasionally, the psychoso
cial effect of an amputation will be
so severe that a replantation may be
beneficial even if the hand is of little
functional use. Conversely, a man
who works in a shipyard or other
occupation where many people have
lost fingers may find an amputation
a “badge of respect” among his
fellow workers.
The advent of microvascular sur
gery has given us the technical
feasibility to reattach amputated
parts. The decision to reattach de
pends upon the functional contribu
tion of the amputated part in terms
of grip and pinch capability and of
psychosocial value. The latter is
extremely difficult to evaluate in the
emergency situation. Generally, sur
geons believe that a single finger
should not be reattached because it
will not have a normal range of
motion or normal sensibility and
will tend to be bypassed in favour of
the rest of the hand for many
functional activities. Furthermore, a
finger which is stiff tends to get in
the way and limits the overall use
fulness of the hand. Therefore, for
a labourer a single digit replanta
tion may be more of a liability than
an asset. Replantations which are
distal to the proximal interphalangeal joint are usually better than
more proximal replantations, be

cause the joint is functioning and
composite finger motion is good.
When two to four fingers have been
amputated the usefulness of replan
tation becomes much greater, be
cause the possibility that total hand
function will be improved by replan
tation increases with the number of
fingers that have been injured.
When the thumb has been amputat
ed replantation is almost always
worthwhile, because the thumb is
so important for both pinch and
grip. The carpometacarpal joint is
almost always preserved, allowing
the thumb to be positioned for most
of these activities. Amputations
proximal to the palm are often
associated with severe tissue injury
which greatly limits the functional
result.
Surgeons doing replantation
must have a good understanding of
the sophistication of prosthetic
limbs. Dynamic hooks, myoelectric
hands and “functional” cosmetic
prostheses have improved greatly in
recent years. Proximal level ampu
tations through the palm, wrist and
distal forearm are often useful lev
els for replantation. Amputations in
the proximal forearm usually do not
lend themselves well to replantation
because the fine motor nerves and
vessels to the forearm musculature
often cannot be repaired. Amputa
tions of the upper arm are some
times useful between the elbow and
middle part of the humerus. More
proximally there is usually unrepai
rable injury to motor nerves to the
upper arm musculature, poor rein
nervation of forearm and hand mus
culature and poor return of hand
sensibility. Nevertheless, there are
no fixed rules for replantation. The
decision on each patient must be
made on the basis of the injury, the
patient’s personality and the func
tional requirements of the hand.
For this, the benefits of an experi
enced team approach are invalua
ble. ■
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Atypical Tuberculosis
Discovered in a Breast
Nodule
To the editors. Atypical mycobac
teria have been given increased at
tention recently because of the fre
quent development of infections due
to Mycobacterium avium-intracellulare in patients with acquired im
mune deficiency syndrome. Other
nontuberculous myycobacteria
have, however, been associated with
human infections. In Ontario Myco
bacterium xenopi is the second
most commonly isolated such myco
bacterium.1'2 These organisms may
be resistant to first-line antimycobacterial antibiotics.3 Al
though usually a commensal in pa
tients who have chronic obstructive
lung disease, M. xenopi can pro
duce cavitary pulmonary disease
and has been isolated from bone,
the urinary tract, epididymis, lymph
nodes and a prosthetic joint.3

Case Report
An asymptomatic 25-year-old im
migrant woman from Iran was
found to have a breast nodule dur
ing routine physical examination.
Chest radiographs appeared normal.
The 3-cm nodule, which was tender
and mobile, was removed. Histolog
ic examination of the nodule
showed benign fibrocystic disease.
The breast tissue sent for culture
yielded M. xenopi. No acid-fast ba
cilli were seen in the histologic
specimens. The patient has re

Contributions to the Correspondence section
are welcome. They should be typewritten
and double spaced.

mained well and has not needed
chemotherapy.

Human Umbilical Vein
Grafts

Comment

To the editors. I find it necessary to
respond to the conclusion reached
by Batt and colleagues in their
reported experience with 52 human
umbilical vein grafts placed in 48
patients over a span of 9 years (Can
J Surg 1990; 33: 61-65) to discon
tinue use of this graft material as
an arterial substitute.
My 16-year experience with over
1000 implants reported in part in
the Journal o f Vascular Surgery
(1988; 7: 336-346) indicates the
efficacy of the material as an arteri
al conduit in properly selected cases
and when attention is paid to specif
ic technical details. We have not
found it necessary, for example, to
use a distal autologous venous in
terposition, which may contribute
to failure by adding composite anas
tomosis. More importantly, Batt
and colleagues stated that prior
failure of lower limb bypasses had
occurred in 22 of their cases (42%),
but they did not emphasize the
salvage role of the umbilical vein in
these cases and in those with poor
runoff, as suggested by the “ rel
atively large numbers of patients
with far-advanced ischemia” . For
the authors to cast blame on the
umbilical vein graft in the form of
their conclusion to discontinue its
use is not warranted by the data.
Failure of revascularization is a
complex phenomenon, probably
multifactorial and frequently misun
derstood. It is simplistic to blame a
graft when the capacitance of the

Mycobacterium xenopi was first
isolated by Schwabacher in 19594
from a cutaneous lesion of a South
African toad. It has been associated
with disease in humans, the most
common of which is pulmonary
infection. This case report is
thought to be the first in which M.
xenopi was cultured from breast
tissue.
P. Murat, MD
P. Thomas, MB, FRCP(Lond),
FRCPC, FCCP
Department o f Medicine,
Division o f Respirology,
St. M ichael’s Hospital,
University o f Toronto,
Toronto, Ont.
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system may be limited, the resist
ance significantly elevated, rheolog
ic components not appreciated, pro
coagulant factors not analysed and
other factors that could have been
investigated or considered were not.
Finally, the authors would have
given their paper a better balance if
they had referenced articles with
contrary views.1-7 There must be
something else amiss (other than
the graft material) when different
groups obtain conflicting results
using the same material.
Herbert Dardik, MD, FACS
Chief, Department o f Surgery.
Englewood Hospital.
Englewood. NJ

Using the same human umbilical
vein graft with a different sample of
patients would be expected to lead
to a different experience. Such is
the nature of clinical studies. No
one study on its own can provide
definitive conclusions. However,
when sufficient weight of evidence
points from a variety of different
sources to the wisdom of discontin
uing use of the human umbilical
vein graft, we believe it is our
responsibility as clinicians and re
search scientists to report our con
clusions.
Dr. Dardik is correct in challeng
ing us to ensure a sound balance of
references describing conflicting ex
periences in each of our reports. We
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Preliminary results. B r J Surg 1983; 70:
85-88
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patients with severe lower limb ischemia:
a report of 121 consecutive cases. Sur
gery 1985; 97: 294-298
3. H irsch SA, Jarrett F: The use of stabi
lized hum an umbilical vein for femoropopliteal bypass. Ann Surg 1984; 200:

147-152
4. K arkow WS, Cranley JJ, Cranley RD, et
al: Extended study of aneurysm formation
in umbilical vein grafts. J Vase Surg
1986; 4: 486-492
5. P arker HJ, F ell G, Devine TJ, et al:
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To the editors. We appreciate Dr.
Dardik’s interest in our article, but
we respectfully suggest that there is
nothing “amiss” with our study.
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R. Guidoin, PhD
Laboratory o f Experimental Surgery,
Pavilion de Services,
Universite Laval,
Quebec, PQ

SESAP VI Question
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believe we have followed his exam
ple in this regard.
It is perhaps worth noting that,
regardless of the clinical experience
of any one hospital or clinical cen
tre, the highly respected, successful
corporation and former manufac
turer of the chemically processed
human umbilical vein graft, Meadox
Medicals Inc., would not have aban
doned this bioprosthesis recently
had it foreseen a strong, expanding
market.

Item 121
A 19-year-old man is taken to the operating room urgently after an
automobile accident. At celiotomy, he has a subcapsular hematoma of
the liver that appears to be expanding, a pulverized spleen, and a jagged
5- to 7-cm laceration of the left colon at the peritoneal reflection with
moderate fecal contamination.
Treatment of the liver injury would best be accomplished by
(A) incising the capsule and directly ligating the bleeding vessels
(B) packing the liver and returning to the operating room in 48 to
72 hours
(C) leaving the hematoma intact and draining the area thoroughly
(D) extending the incision into the chest and inserting an inferior
vena cava shunt via the right atrium
(E) hepatic artery ligation
For the incomplete statement above select the best of the five
completions.
For the critique of Item 121 see page 228.
(Reproduced by permission from SESAP VI Syllabus; Surgical Educa
tion and Self-Assessment Program No. 6. For enrolment in the Surgical
Education and Self-Assessment No. 6, please apply to the American
College of Surgeons, 55 East Erie St., Chicago, IL 60611.)
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Preoperative Parathyroid Localization:
a Prospective Evaluation
of Ultrasonography
and Thallium-Technetium Scintigraphy
in Hyperparathyroidism
Barry L. Stein, MD, CM; Marvin J. Wexler, MD, CM, MSc, FRCSC, FACS
To assess the ability of ultrasonography (US) and dual tracer thallium-technetium
subtraction scanning (NS) to localize abnormal parathyroid glands, these two
investigations were carried out preoperatively in 27 consecutive patients who
underwent surgery for hyperparathyroidism. Nineteen patients had adenomas and 8
hyperplasia. Of 23 US procedures 2 were inadequate, and of 26 NS procedures 1
was inadequate.
Ultrasonography was found to be superior to NS for preoperative localization of
abnormal parathyroid glands (sensitivity per gland 53% versus 36%); detection rates
for hyperplasia were poor for both techniques (sensitivity per gland 36% and 25%).
However, when positive, both techniques were extremely accurate (positive
predictive value of 100% for both). There was no correlation between the weight of
the gland or degree of physiological hyperfunction (parathyroid hormone level) and
detection rates for the two techniques. False-positive results were rare for both, so a
positive result was highly predictive of an abnormality at that location.
Ultrasonography had sufficient accuracy to suggest its routine use when adenoma
is suspected, particularly to detect the side of the lesion (sensitivity 78% and
positive predictive value 100%). The addition of subtraction scintigraphy does not
appear to be warranted.
Dans le but d’evaluer la capacite de l’echographie (EG) et celie de la scintigraphie a
double definition par soustraction au thallium-technetium (SG) pour localiser les
parathyroides anormales, ces deux examens ont ete pratiques avant la chirurgie
chez 27 patients consecutifs qui ont ete operes pour hyperparathyroidie. Dix-neuf
patients etaient porteurs d’adenomes, alors que 8 souffraient d’hyperplasie. Sur 23
EG pratiquees, 2 ont ete insatisfaisantes comparativement a 1 sur 26 pour les SG.
L’echographie s’est montree superieure a la SG pour la localisation preoperatoire
des parathyroides anormales (taux de sensibilite par glande de 53% par rapport a
36%); le taux de detection des hyperplasies a ete mauvais pour les deux techniques
(sensibilite par glande de 36% et de 25%). Toutefois, lorsqu’elles etaient positives,
les deux techniques etaient extremement precises (pouvoir predictif positif de 100%
pour les deux). On n’a observe aucune correlation entre le poids de la glande ou le
degre d’hyperfonctionnement physiologique (le niveau d’hormone parathyroidienne)
et les taux de detection des deux techniques. Les faux positifs ont ete rares avec les
deux techniques. En consequence, un resultat positif etait fortement predictif d’une
anomalie au foyer localise.
L’echographie possedait une precision suffisante pour suggerer son emploi
systematique quand un adenome est soupfonne, particulierement lorsqu’il s’agit de
localiser la lesion (sensibilite de 78% et pouvoir predictif de 100%). L’ajout de la
scintigraphie de soustraction ne parait pas justifie.

P rimary
can be

hyperparathyroidism
effectively treated in
90% to 95% of cases at first opera
tion by an experienced parathyroid
surgeon by excision of the diseased
glands.1 In the other 5%, a missed
abnormal parathyroid gland is the
most common cause of failure.2 The
operation is often difficult. Unusual
and ectopic locations are common,
and supranumerary glands occur in
5% to 8% of patients. Extensive
dissection with exposure and biopsy
of all glands has been advocated3
but carries a risk of complications.
For the occasional neck surgeon,
location of the four parathyroid
glands can be tedious, and failures
of primary exploration are not un
common.
To facilitate exploration, reduce
operating time and increase the
From the Department o f Surgery, Royal
Victoria Hospital, McGill University, Montre
al, PQ
Presented at the 11th annual meeting o f the
Canadian Association o f General Surgeons,
held in conjunction with the 57th annual
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success rate for the occasional sur
geon, numerous techniques for pre
operative localization of abnormal
parathyroid glands have been tried.
They include thermography, galli
um and selenium nuclear scanning,
cine-esophagography, lymphogra
phy and various intraoperative
staining techniques. None has been
consistently successful. We report
ed an unsatisfactory experience
with high-resolution computed to
mography.4 Selective angiography
and venography with venous hor
mone assay are time-consuming,
technically difficult and risky,5 and
are usually reserved for reoperation.
Thallium-technetium subtraction
scanning (NS) and ultrasonography
(US) are newer, readily available,
noninvasive localization techniques,
and recent reports of their use have
been encouraging.6' 8 In this paper,
we report the results of a prospec
tive study using these two investi
gations in 27 patients who under
went surgery for hyperparathyroi
dism.

Patients and Methods
Between January 1986 and July
1988, 27 consecutive patients (19
women, 8 men), ranging in age
from 16 to 70 years (mean 51
years) and scheduled to undergo
surgery for hyperparathyroidism,
had preoperative localization
studies; 25 had both US and NS
and 2 had NS only. Preoperative
parathyroid hormone levels were
measured for all patients using a
C-terminal assay.9 The results of
the localization studies were known
to the surgeon preoperatively. All
patients underwent neck explora
tion by the same surgeon. All para
thyroid glands were identified at
surgery and detailed records were
kept of the location, size and
weight of the abnormal glands. The
operative findings were compared
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with the preoperative US and NS
findings, and the studies were then
collectively reinterpreted by a single
nuclear radiologist or ultrasonographer to assess their reproducibility.
Ultrasonography was performed
using a real-time scanner (Diasonic
DRF 400; Diasonics Inc., Milpitas,
Calif.) with a 10 MHz small-parts
probe. The patients were examined,
in transverse and longitudinal
planes, supine with the neck slight
ly hyperextended. Acoustic gel was
used as a couplant.
Nuclear scanning of the neck,
including a portion of the superior
mediastinum, was done with the
patient supine and the head and
neck extended and immobilized.
Thallium-201 (2 mCi) was injected.
Five frames of 5 minutes each were
taken immediately after the injec
tion with a low-energy all-purpose
collimator in magnification mode.
Technetium pertechnetate (1 mCi)
was then injected. A single frame of
5 minutes was taken after a
5-minute waiting period. At the
termination of scanning, the neck
was palpated and the presence or
absence of any nodularity was not
ed. Subtraction of the technetium
from the thallium image was then
carried out by computer.
Operative findings were the stan
dard against which the localization
studies were compared. A true-posi
tive result correctly predicted an
abnormality found at surgery. A
false-negative one implied a failure
of the technique to detect disease
confirmed operatively. The results
of the studies were tabulated in
three ways: (a) the ability of the
technique to predict correctly
whether each parathyroid gland was
normal or abnormal; (b) its ability to
detect correctly the side of the neck
on which each abnormal gland was
located; and (c) its ability to make
the correct predictions overall, con
sidering all four parathyroid glands
as one unit.

Statistical Analysis
This was carried out using the
following standard definitions: sen
sitivity = true positives/true posi
tives + false negatives; specificity =
true negatives/true negatives +
false positives; positive predictive
value = true positives/true posi
tives + false positives; negative pre
dictive value = true negatives/true
negatives + false negatives. Stu
dent’s t-test was used to analyse the
differences.

Results
From the operative and histologic
findings, 19 patients were found to
have solitary adenomas and 8 hy
perplasia (6 tertiary, 2 secondary).
Of the 25 US procedures, 2 were
technically inadequate, and of the
27 NS procedures, 1 was inade
quate. The operative location of the
abnormal glands and results of the
localization tests are shown in
Table I, together with the weight of
the abnormal glands for adenoma
and hyperplasia.
Ultrasonography
Ultrasonography (Table II) cor
rectly predicted 18 glands as being
abnormal and 56 as normal; howev
er, 16 abnormal glands were missed
and there were 2 false-positive pre
dictions. Sensitivity and specificity
were 53% and 97% respectively per
gland. These values increased to
61% and 100% when only the side
of the neck was considered (Table
III). When the data were reanalysed,
separating the adenomas from hy
perplasia, the sensitivity per gland
was 67% and 36% respectively (Ta
ble IV). Considering only the side of
the neck, these values were 78% for
adenomas and 30% for hyperplasia.
The positive predictive value was
100% for both adenoma and hyper-
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erroneously predicted as normal
(i.e., no parathyroid seen after sub
traction scanning). The sensitivity
per gland, which was 36%, in
creased only slightly to 38% when
only the side of the neck was
considered (Table VI). Specificity
and positive predictive value were
both 100%. When considered ac
cording to pathologic type (Table
VII), the sensitivity per gland was
47% for adenoma and 25% for hy
perplasia, and the specificity and
positive predictive value were 100%
for both.
Gland weight was used as an
indirect, reproducible measure of
the size of the gland. When US
correctly identified an abnormal
parathyroid, weights ranged from
0.2 g to 10.47 g (mean 1.67 g)
(Table VIII). The technique failed to
identify abnormal glands that
ranged in weight from 0.2 g to 3.08
g (mean 0.98 g). There was no
correlation between the weight of
the abnormal gland and the ability
of US to detect it correctly (p >
0.05). As was the case with US no
correlation was found between
gland weight and detection rate for
NS (mean = 2.06 g versus 1.00 g).
In 25 of the patients the serum
parathyroid hormone level was de
termined before the localizing pro
cedures were performed (Table IX).
Of the patients who had an elevated
level (> 30 pg/ml), 8 were correct
ly identified by US as having abnor
mal glands and 9 had false-negative
results. Nuclear scanning gave 10
true-positive results and 9 false
negative ones. Again, no correlation
could be found between detection
rate and parathyroid hormone level
for either US or NS [x = 0.15 for
US and 0.37 for NS, kappa index of
concordance10).
Six patients were identified on
palpation as having multinodular
goitre. Two tests of US were non
diagnostic, three gave true-positive
results and one a false-negative reCJS, VOL. 33. NO. 3. JUNE 1990
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suit. On NS, three tests gave false
negative results and three true-posi
tive.

Discussion
Since all patients with hyperpara
thyroidism have at least four para
thyroid glands with one or more
abnormal glands, a true test of a
localizing technique is not only its
ability to detect an abnormal gland
but to predict the status of each
parathyroid gland. Normal glands
usually cannot be detected either by
US or subtraction scanning; there
fore, neither technique should have
detected an abnormal focus in the
location of a normal gland. If an
abnormal gland is present, it should
be detected and correctly localized.
If an abnormality is predicted in the
upper neck and is found at surgery
to be in the lower neck, then the
technique is in error. However, for
the surgeon, the side of the abnor
mality is perhaps of greater impor
tance. We chose, therefore, to ana
lyse our data in three ways: accura
cy per gland (assuming four
glands), accuracy per side of the
neck and accuracy per patient as a
whole (all four glands taken togeth
er as one unit).
For both techniques, false-posi
tive results were rare; there were
none for NS, only two for US and
none per side of the neck for either
technique. Thus, the specificity was
almost 100% in all instances. The
failures were the result of the tech
nique not finding the abnormality
that existed.
Ultrasonography had a sensitivity
of 53%. This increased to 61%
when only the side of the neck was
considered. Nuclear scanning’s sen
sitivity was inferior to US in all
categories.
The histologic type of the abnor
mality is thought to play an impor
tant role in the localization abilities
178
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of both US and NS. The sensitivity
of US for adenomas was far greater
than that for hyperplasia (67% ver
sus 36%) even though our patients
were an unusually select group with
secondary and tertiary hyperplasia,
often with very large glands. Simi
larly, NS was almost twice as effec

tive in detecting adenomas as hy
perplasia (47% versus 25%). This
trend has been observed for both
techniques by others11-14 and re
mains unexplained. It is not neces
sarily related to the size of the
abnormal glands. In our series,
weight as an indirect measure of

Table III. Ultrasonography: Sensitivity and Specificity According to the Three Categories
Per patient, %

Per side of neck, %

Per gland, %

57
-*
86
-*

61
100
100
62

53
97
90
78

Sensitivity
Specificity
Positive predictive value
Negative predictive value

'Since all patients had diseased glands, true-negative results are not possible when considering
the patient as a whole, and specificity and negative predictive values do not apply. However, this
is not so when a single gland or side of the neck is considered.

Table IV. Ultrasonography: Sensitivity and Specificity According to Pathologic Type of
Abnormality
Per patient, %

Sensitivity
Specificity
Positive predictive value
Negative predictive value

Per side of neck, 0/o

A

H

A

75

0

78
100
100
82

-

-

86

0

-

-

Per gland, %

H

A

H

30

67
96
86
90

36
100
100
29

-

100
-

A = adenoma, H = hyperplasia.

Table V. Nuclear Scanning: Results According to Three Categories

Pathologic type
of abnormality
Adenoma
Hyperplasia
Totals

Per patient,
n = 26
TP

Per side of neck,
n = 52

Per gland,
n = 104

FP

FN

TP

TN

FP

FN

TP

TN

FP

FN

9
1

0
0

10
6

9
3

19
1

0
0

10
10

9
5

57
8

0
0

10
15

10

0

16

12

20

0

20

14

65

0

25

Table VI. Nuclear Scanning: Sensitivity and Specificity According to the Three Categories
Per patient, °/o

Per side of neck, %

Per gland, %

38

38
100
100
50

36
100
100
72

Sensitivity
Specificity
Positive predictive value
Negative predictive value

-

100

Table VII. Nuclear Scanning: Sensitivity and Specificity According to Pathologic Type of
Abnormality
Per patient, %
Sensitivity
Specificity
Positive predictive value
Negative predictive value

Per side of neck, %

Per gland, %

A

H

A

H

A

H

47

14

-

-

47
100
100
66

23
100
100
9

47
100
100
85

25
100
100
35

100
-

100
-

PREOPERATIVE PARATHYROID LOCALIZATION

size did not correlate with detection
ability for either US and NS or
adenoma and hyperplasia. This is
contrary to the findings of some.
For example, Gimlette and col
leagues15 found that 25 of 26 para
thyroid glands having a mass great
er than 1 g were correctly located;
none of 10 glands having a mass
less than 0.3 g was correctly locat
ed by scanning. Thallium-201 up
take (%/g) did not differ between
hyperplastic and adenomatous
glands. Kim and associates16 per
formed subtraction scintigraphy on
33 patients; 22 of 29 adenomas
were correctly localized, but only 1
of 4 patients who had multigland
enlargement had all the enlarged
glands localized. However, 50% of
the lesions weighing less than 0.3 g
were successfully identified.
Parathyroid hormone levels did

not correlate with detection rates
for either technique. For US this
finding may reasonably be expected,
since the technique detects struc
ture and not function. Nuclear
scanning, however, may be func
tionally dependent. The thallous ion
is an analogue of the potassium ion
and, like potassium, is extracted by
cells upon perfusion. The high cellularity and vascularity in function
ing lesions may be a factor in its
uptake17 and perhaps more likely to
increase with increased production
and secretion of parathyroid hor
mone. The facts that such secretion
is periodic and serum levels were
not measured concurrently with
NS, may explain the lack of correla
tion noted.
Dual tracer scintigraphy with
thallium and technetium is reported
by some1112 to have a localization

T a b le V III. C o rre la tio n o f W e ig h t (g ) o f A b n o rm a l G la n d s and D e te c tio n A b ility
U ltras o n o g rap h y

N u c le a r scan n in g

TP

FN

TP

FN

0 .2 8
0 .4 9
0 .5 3
0 .6 0
0 .6 4
0 .7 0
0 .7 6
1.02
1.03
1.10
1.38
2 .1 3
2 .2 5
1 0 .4 7

0 .2 0
0 .2 4
0 .4 4
0 .4 6
0 .6 7
0 .7 0
1 .3 8
1.6 8
1.9 0
2 .2 9
3 .0 8

0 .2 8
0 .5 3
0 .6 4
0 .7 0
0 .7 0
1 .3 8
1 .6 8
2 .1 3
1 0 .4 7

0.30
0.35
0.44
0.46
0.49
0.49
0.57
0.67
0.76
1.02
1.10
1.18
1.90
2.25
3.08

M e a n 1.6 7

0 .9 8

2 .0 6

1.00

In ca s e s o f 4 -g la n d h y p e rp la s ia , th e w e ig h t o f an in c o m p le te ly e xc is e d o r p a rtia lly tra n s p la n te d
fo u rth g la n d is n o t in c lu d e d in th is ta b u la tio n .

T a b le IX . C o rre la tio n o f P a ra th y ro id H o rm o n e L e ve l and D e te c tio n A b ility
U ltra s o n o g ra p h y

N u c le a r scanning

P a ra th y ro id horm one
le v e l, p g /m l

TP

FN

TP

FN

0 - 3 0 (n o rm a l)
3 0 -6 0
60 - 1 0 0
>100

4
2
3
3

2
1
5
3

0
3
4
3

7
1
4
4

12

11

10

14

T o ta ls

sensitivity as high as 70% to 90%.
Our lower rate may be due to the
dose of 1 mCi of technetium we
used, which is lower than that
recommended by others.16 Thallium
accumulates in both parathyroid
and thyroid tissue, technetium only
in the thyroid. The subtraction of
the two scans shows the location of
abnormal parathyroid tissue. With a
lower dose of technetium, the thy
roid is not as “ hot” , so the poten
tial difference on digital subtraction
is minimized, resulting in a lower
sensitivity. However, our results are
almost identical to those of Attie
and colleagues14 who used a 5 mCi
dose in 62 adenomas, ranging in
size from 1 to 4 cm in diameter, and
had only 59% sensitivity.
Many thyroid nodules do not ac
cumulate technetium but do accu
mulate thallium. Thus, when the
technetium scan is subtracted from
the thallium scan, a thyroid nodule
might give a false-positive result.18
This can be avoided by palpating
the neck and thyroid to detect such
nodules for consideration when in
terpreting the scan. This was not a
problem in our study, because we
had no false-positive results in our
six patients with multinodular
goitre. Likewise, nodules or cysts
within the thyroid gland may be
erroneously interpreted by US as an
abnormal parathyroid or conversely
create difficulties in detecting a con
tiguous enlarged parathyroid. Three
of four adenomas missed by US in
the series of Dwarakanathan and
colleagues13 are explained thus.
Again, this was not the case in our
experience.
Our results compare favourably
with those of early studies indicat
ing the accuracy of US for preoper
ative localization of adenomas and
its superiority over NS. No modality
is ideal, each gives some false-nega
tive results, but we have found few,
if any, false-positive results when
the findings in patients with nodCJS, VOL. 33. NO. 3. JUNE 1990
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ules in the thyroid are interpreted
with care. Although greater accura
cy may be obtained by combining
two or three modalities, this does
not appear to be cost effective. In
our hands, the contribution of sub
traction scintigraphy in addition to
US was minimal. Both studies, car
ried out in 18 patients with adeno
mas, correctly localized the lesion
in 7 patients; in 3 neither study was
effective. In eight patients, only one
modality was positive and in six of
these it was US that detected the
lesion. Similar findings have been
reported by Attie and colleagues.14
Of 32 patients in their series who
underwent three imaging studies
(including magnetic resonance im
aging), the adenoma in 13 cases
was accurately imaged by two mo
dalities but not by the third. In 12
of the 13 the test that failed was
subtraction scintigraphy.
Ultrasonography for parathyroid
glands requires a radiologist skilled
in this application. In such a set
ting, it provides an effective, safe,
noninvasive and inexpensive localiz
ing procedure for parathyroid ade
nomas. At present, our data sug
gest that US is useful in directing
the surgeon to the appropriate side
of the neck in the case of adenomas
(sensitivity 78%, specificity 100%).
We believe, as do Mattar and associ
ates17 and Attie and colleagues,14
that this will decrease operating
time by limiting the extent of dis
section. It can allow the surgeon to
plan the dissection preoperatively
and direct attention to the affected
side of the neck. Previously, we
have strongly advocated that all
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parathyroid glands should be ex
plored and biopsied.3 It may now be
reasonable to reconsider the conser
vative approach of unilateral neck
exploration. If US (with or without
NS) localizes an abnormality to only
one side and if, at surgery, an
abnormal gland is found on that
side, together with a normal gland,
then perhaps the opposite side of
the neck need not be explored. The
reported incidence of hypocalcemia
varies depending upon the extent of
parathyroid dissection and biopsy.19
Arguments favouring a conservative
approach are strengthened if preop
erative US also demonstrates no
abnormality on the contralateral
side. It follows that preoperative
localization of an adenoma could
reduce the extent of dissection and
the morbidity without significantly
increasing the risk of persistent
hypercalcemia.
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Feeding Jejunostomy:
a Safe Adjunct to Laparotomy
Mohammad Al-Shehri, MD; Pawel Makarewicz, MD; Joel B. Freeman, MD, FRCSC
It is well established that a feeding jejunostomy is an invaluable adjuvant for use in
critically ill and malnourished patients. What is not well known are the
complications of inserting these tubes. Some surgeons are reluctant to insert
feeding tubes unless the indications are very clear. From their experience with the
insertion of 133 feeding jejunostomy tubes during a 3-year period, the authors
conclude that the complications associated with the insertion of such tubes are few
and that the procedure is justified even if the tube is never used.

II est bien etabli que la jejunostomie d’alimentation constitue un adjuvant
incomparable pour le patient gravement malade souffrant de denutrition. Ce qu’on
connait moins bien, ce sont les complications relatives a l’insertion de ces tubes.
Certains chirurgiens hesitent a poser des tubes d’alimentation a moins que les
indications en soient tres claires. Apres avoir inserer 133 tubes d’alimentation au
cours d’une periode de 3 ans, les auteurs concluent que les complications reliees a la
pose de ces tubes sont peu nombreuses et que l’intervention est justifiee, meme si le
tube n’est jamais utilise.

here has been a resurgence of
interest recently in jejunosto
my feeding to provide nutritional
support.1-3 This has been precipitat
ed, in part, by the expenses and
potential complications associated
with parenteral nutrition.4 Current
opinions favour the administration
of nutrients through the gut, a
route that is more physiological and
efficient.5 There have also been
great improvements in the formula
tion and techniques of enteral feed
ing. Nasogastric tube feeding is
clearly the safest and least compli
cated method of delivering enteral
nutrients. Yet there are a number of

T

clinical situations in which surgical
ly inserted feeding tubes have cer
tain advantages. In this paper we
review the experience at the Ottawa
General Hospital with feeding jeju
nostomy.

Patients and Methods
We reviewed the records of all
patients in whom a feeding jejunos
tomy tube was inserted at the Otta
wa General Hospital between 1981
and 1984. There were 133 patients
(56 men 77 women).
The indications for the procedure

are shown in Table I: 93 patients
underwent major upper gastrointes
tinal procedures and a feeding jeju
nostomy was inserted at the same
time to ensure adequate nutritional
support distal to the operative site;
33 patients had a feeding jejunosto
my inserted in anticipation of a long
or potentially complicated postoper
ative recovery period; 7 patients had
neurologic disorders.
The feeding jejunostomy was ins
erted in conjunction with other ab
dominal surgical procedures in 110
cases, but in 23 cases the jejunosto
my was inserted as a separate oper
ative procedure; 10 of the 23 were
done under local anesthesia because
of the poor general condition of the
patient.6 Approximately 75 of the
133 tubes were inserted by one
surgeon (J.B.F.).
We inserted jejunostomy tubes in
13 patients with frank intra-abdomi
nal sepsis, including perforated viscus, anastomotic dehiscence or dis
placed, leaking gastrostomy tubes.
The standard Witzel technique
was used in all patients.7 A 3 mm
cautery incision was made through
the serosa and muscularis on the
antimesenteric border. The bowel
wall was grasped firmly between
thumb and forefinger to make the
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mucosa pout outward. The mucosa
was touched with the cautery and
the bowel swabbed with povidoneiodine solution. The catheter was
inserted through this enterotomy
and secured with a 3-0 Vicryl purse
string suture. A 5 cm serosal tunnel
was constructed with 3-0 Vicryl or
silk. The catheter was brought
through the abdominal wall away
from the primary incision, with the
proximal end of the bowel located
superiorly. It is useful to record this
technical information in case rein
sertion of the catheter is ever neces
sary. Care was taken to fix the
entire 5 cm tunnel to the abdominal
wall to prevent kinking, bowel her
niation and dislodgement of the
tube. The average time for the
procedure, when done in conjunc
tion with other operations was 10
minutes.
Three types of catheter were used
— red rubber (in 78 cases), Silastic
(in 35) and Foley (in 20). Their
sizes ranged from 8 to 16 French
but a no. 10 French red rubber
catheter was used in the majority of
patients.

techniques in all but two patients in
whom percutaneous tube replace
ment was necessary. The tube was
accidentally pulled out in 18 pa
tients. It was replaced percutaneously in 10 of these. Whenever
percutaneous repositioning was re
quired, the tube’s position was con
firmed radiologically using soluble
contrast material. In one patient
this radiologic examination con
firmed that the tube was outside the
bowel. The tube was removed be
fore feeding was started. Wound
infection at the tube exit site oc
curred in 10 patients (8%). All the
infections were minor and respond
ed to simple wound care.
Intolerance to the feeding for
mula (diarrhea, cramping, abdomi
nal distension, nausea and vomit
ing) occurred in 45 (33%) patients.
This was managed by reducing the
flow rate and gradually reinstituting
the enteral feeding according to a
written protocol. The liberal use of
antidiarrheal agents and constant
infusion pumps were also helpful in
controlling the diarrhea. In six pa
tients, the symptoms were so severe
that the enteral feeding had to be
stopped.

Results
The catheter was used for nutri
tional support in 120 of the 133
patients (90%); enteral feeding was
considered unnecessary in 13 pa
tients.
The average length of use was 38
days (range from 1 to 285 days).
More than half the patients contin
ued to use the feeding jejunostomy
at home. There were no operative
deaths or morbidity related to inser
tion of the tube. After removal of
the tube the fistula closed spontane
ously in all patients. Two patients
had aspiration pneumonia. Tube
blockage was a frequent problem,
particularly when the smaller Silast
ic catheter was used. This problem
was easily rectified by irrigation
182
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Discussion
Although the feeding tube was
often placed for prophylaxis, it was
actually used in 120 of the 133
patients for an average of 38 days.
The technique is rapid, safe and
simple. Very few deleterious side
effects were reported even when the
tube was not used for feeding. The
time required and the paucity of
complications suggests that feeding
jejunostomy can be an integral
component of many major abdomi
nal procedures even in the absence
of definite indications that enteral
feeding will be required.
Feeding jejunostomies avoid the
expense and potential hazards of

parenteral nutrition if feeding can
be carried out distal to the site of
the diseased area and as long as the
gastrointestinal tract is functioning.
An additional benefit of feeding je
junostomy is the possibility of out
patient feeding, which was carried
out in more than half of the 133
patients in this series. This had an
obvious salutary effect upon the
length of hospital stay.
One surgeon inserted most of
these catheters. Conceivably, the
relative paucity of complications
was attributable to his individual
experience. We reviewed the surgi
cal literature related to complica
tions associated with feeding cathe
ters (Table II2'38' 12). It seems clear
that feeding jejunostomy is a safe
procedure in the hands of abdomi
nal surgeons. Decision-making re
garding its use is analogous to the
consideration often given to inci
dental appendectomy during other
operations. The surgeon should be
concerned about adding a proce
dure which is marginally indicated.
When such operations go awry, the
surgeon may find it difficult to
justify his decision. However, our
experience and that in the literature
supports the tenet that the risks are
minimal but the potential benefits
are great.
Our major catheter-related com
plications included diarrhea and
skin infections around the tube.
The latter occurred in 10 (8%) of
our patients, but these skin infec
tions were superficial and easily
managed. All jejunostomy fistulas
closed after tube removal. The inci
dence of tube dislodgement into the
peritoneal cavity ranges from 1% to
4% in the literature.3-81012 This
complication occurred in only one
patient in our series and fortunately
was discovered before feeding be
gan. The use of fluoroscopy and
dye injection to confirm catheter
position after any manipulation of
the tube is recommended to prevent

FEEDING JEJUNOSTOMY

this potentially dangerous complica
tion. This problem can also occur
when dislodged tubes are reinserted
percutaneously. After reinsertion
and before feeding is reinstituted, it
is mandatory to confirm, using
contrast material, that the tube is in
the bowel lumen.
Recently several patients of ours
whose gastrostomy tubes became
dislodged complained of diarrhea at
low infusion rates. This symptom
combined with mild abdominal pain
led to a diagnostic contrast study.
All had few, if any, abdominal
symptoms. This may be an impor
tant clinical spectrum to remember
when caring for such patients.
Formula intolerance was the
major problem encountered in our
series. This reflects the known in
ability of the small bowel to control
osmolarity, in contrast to the stom
ach. Formula intolerance has been
the most common problem in most
of the papers we reviewed. It seems
to occur in direct proportion to the
severity of the patient’s illness.
Hence, critically ill patients in the
intensive care unit, particularly
those on respirators and receiving
muscle relaxants, are the most diffi
cult to feed enterally. These data
emphasize the importance of using
the stomach whenever possible and
of taking great care to eliminate the
risks of aspiration. The recent de
velopment and refinements of per
cutaneous endoscopic gastrostomy
will probably outdate feeding jeju-

nostomy as a separate procedure.
As well, during laparotomy, one can
consider insertion of both a gastros
tomy and jejunostomy.
Diarrhea occurred in 28 (21%)
patients, bloating and cramping in
10 (8%), and nausea and vomiting
in 7 (5%). These were managed by
first reducing or discontinuing en
teral feeding, which was gradually
reinstituted according to a written
nursing protocol. The use of antidiarrheal agents and constant in
fusion pumps were helpful in con
trolling the diarrhea. These prob
lems were severe enough to discon
tinue the feeding in only 6 (4%).
Aspiration occurred in two pa
tients. Just as formula intolerance is
more common with jejunal versus
gastric feeding, a relative advantage
of jejunal feeding is a presumed
reduced rate of aspiration. The cur
rent study and previous experience
in our institution confirms that,
while uncommon, aspiration can
occur even when feeding distal to
the pylorus. Presumably, the je ju 
nal feeding stimulates gastric secre
tion and dilatation. This may cause
aspiration particularly in elderly, de
bilitated or critically ill patients.
Of note were the jejunostomy
tubes inserted in the presence of
abdominal sepsis without leaks or
fistula formation. In this series je ju 
nostomy tubes were inserted in 18
patients who suffered from sepsis or
who had dislodged percutaneous or
surgical gastrostomies. Each had a

perforated viscus with fluid collec
tions and peritoneal fibrin forma
tion. An area of stomach or jeju 
num, or both, was prepared by
removing as much fibrin as possible
and rubbing the serosa with a dry
gauze. The enterotomy and tunnel
were constructed as described
above. No leakage occurred.

Conclusions
Feeding jejunostomy is a simple,
safe procedure which adds less than
10 minutes of operating time. It
permits nutritional access without
the expense and potential complica
tions of parenteral nutrition, and is
easily adapted to home use. Tube
insertion has a low complication
rate and can be performed in the
presence of intra-abdominal sepsis.
The tubes can be reinserted or
removed easily and without signifi
cant morbidity. The risk of aspira
tion pneumonia is much lower than
with gastric feeding although diar
rhea is more common. Feeding jeju 
nostomy can be performed under
local anesthesia in selected highrisk patients or when percutaneous
endoscopic gastrostomy is contrain
dicated.6
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ommend it as a reference text for
medical school libraries and tertiary
care hospitals.

ness is a lack of discussion on the role
of duplex scanning; this undoubtedly
will become the method of choice for
assessing venous disease. Nevertheless,
the book presents objective and concise
information and would be a valuable
addition for any surgeon interested in
venous disorders.
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COMPLICATIONS IN SURGERY
AND TRAUMA. 2nd ed. Edited by
Lazar J. Greenfield. 981 pp. Illust. J.B.
Lippincott Co., Philadelphia. 1989.
$95 (US). ISBN 0-397-50904-9

This well-written book covers a wide
range of specialties within the broad
field of surgery. Each specialty section
is written by recognized experts in their
field.
The book comprises 10 sections:
wound healing, plastic surgery, thoracic
surgery, cardiovascular surgery, alimen
tary tract surgery, endocrine system
surgery, nervous system surgery, geni
tourinary surgery, musculoskeletal sur
gery and, finally, a synopsis of surgical
complications. The sections emphasize
the problems most likely to be encoun
tered by the surgical resident or practis
ing surgeon.
The chapters on my area of special
interest and expertise, hepatobiliary and
pancreatic surgery, were written by
well-known, experienced surgeons and
cover the major areas in a concise yet
comprehensive manner.
This book should be useful for resi
dents and surgeons in any field of
surgery, but particularly those in the
fields of trauma, thoracic and cardiovas
cular surgery, orthopedics and neuro
surgery. It is also a useful reference
text for surgical libraries. 1 highly rec
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Sherif S. Hanna, MD, FRCSC, FACS
Department o f Surgery,
Sunnybrook Medical Centre,
2075 Bayview Ave.,
Toronto, Ont.

York Hsiang, MD, FRCSC

CONTROVERSIES IN THE MAN
AGEMENT OF VENOUS DISOR
DERS. Edited by Bo Eklof, Jan Erik
Gjores, Olav Thulesius and David
Bergqvist. 327 pp. Illust. Butterworth
& Co. (Publishers) Ltd., London. 1989.
$185 (US). ISBN 0-407-01566-3
This book, the fifth publication by the
Societas Phlebologica Scandinavica, will
be of particular interest to vascular
physicians, surgeons and radiologists.
The text is aptly entitled “Controver
sies”. Each chapter is written by wellknown Scandinavian authors, followed
by discussions written by equally re
nowned world experts. This arrange
ment makes for interesting reading as it
presents varying opinions from both
sides of the Atlantic.
The anatomy, physiology, diagnosis
and treatment of systemic venous disor
ders are covered. The only major weak

Assistant Professor,
Department o f Surgery,
Faculty o f Medicine,
University Hospital, UBC Site,
2211 Wesbrook Mali,
Vancouver, BC

VASCULAR DISORDERS OF THE
UPPER EXTREMITY. 2nd ed. Edited
by Herbert I. Machleder. 409 pp. Futura Publishing Company, Inc., Mount
Kisco, NY. 1989. $55 (US). ISBN 087993-347-X
Vascular disorders of the upper extrem
ity pale in comparison with conditions
affecting the lower limbs. However, for
the discerning clinician there is a wealth
of interesting innovation in the diagno
sis, assessement and management of
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General Surgical Procedures After Heart
Transplantation
John Yee, MD; Dimitri Petsikas, MD; Michael A. Ricci, MD;* Albert Guerraty, MD, FRCSCf
Seventy-eight cardiac transplantations were performed between July 1982 and
March 1989. The perioperative death rate was 10%. Overall survival was 86%.
Among the long-term survivors, 14 patients underwent 16 noncardiac surgical
procedures. Seven of them required emergency laparotomy, four for biliary tract
disease, one for ruptured abdominal aortic aneurysm, one for suspected abdominal
sepsis and one for enterocolitis. Elective surgical interventions included repair of
symptomatic abdominal wall hernia, treatment of hemorrhoids or perianal
condylomas, total hip arthroplasty, maxillary sinus drainage and resection of a
duodenal villous adenoma.
Preoperatively, all patients received cyclosporine orally. Ten of the 14 patients
were on triple-drug immunosuppression (cyclosporine, azathioprine and low-dose
prednisone [less than 0.20 m g/kg daily]). The remaining four patients took
cyclosporine with either azathioprine or prednisone.
There were no deaths. Complications were limited to residual choledocholithiasis
treated by percutaneous removal, two cases of wound infection and an incisional
hernia. The authors’ experience indicates that noncardiac surgical procedures may
be safely performed in patients who have received a heart transplant.

he past decade has witnessed a
marked increase in heart trans
plantation accompanied by a steady
improvement in survival rates.
There is a large population of pa
tients who have undergone trans
plantation and who therefore re
quire comprehensive medical care.1
It is inevitable that some o f them
will need emergency or elective sur
gery for noncardiac problems. To
determine the risk for noncardiac
surgery in this patient group, we
reviewed our experience with 78
cardiac transplant recipients.

T

Patients and Methods
Soixante-dix-huit transplantations cardiaques ont ete effectuees entre juillet 1982 et
mars 1989. La mortalite perioperatoire a ete de 10% et la survie globale de 86%.
Parmi les survivants de longue date, 14 patients ont subi 16 interventions
chirurgicales pour des causes non cardiaques. Sept d’entre-eux ont necessity une
laparotomie d’urgence, quatre pour des affections biliaires, un pour rupture d’un
anevrisme de l’aorte abdominale, un pour suspicion de sepsie abdominale et un pour
une enterocolite. Les interventions chirurgicales non urgentes comprenaient la
reparation d’une hernie symptomatique de la paroi abdominale, le traitement
d’hemorroldes ou de condylomes perianaux, une arthroplastie totale de la hanche, le
drainage d’un sinus maxillaire et la resection d’un adenome villeux du duodenum.
Tous les patients avaient re?u en preoperatoire, de la cyclosporine par voie orale.
Dix des 14 patients recevaient une immunosuppression triple (cyclosporine,
azathioprine et prednisone a faible dose [moins de 0.20 m g/kg par jour]). Les
quatre autres patients recevaient de la cyclosporine avec soit de l’azathioprine, soit
de la prednisone.
II n’y a eu aucun deces. Les complications se sont limitees a une
choledocholithiase traitee par voie percutanee, a deux cas d’infections de plaie et a
une hernie d’incision. L’experience des auteurs indique que les operations non
cardiaques peuvent etre pratiquees sans danger chez les greffes cardiaques.

From the Department o f General Surgery and Department o f Cardiovascular and Thoracic
Surgery, Royal Victoria Hospital, M cG ill University, Montreal, PQ
Presented at the 12th annual meeting o f the Canadian Association o f General Surgeons, held in
conjunction with the 58th Annual Meeting o f the Royal College o f Physicians and Surgeons o f
Canada, Edmonton, Alta., Sept. 22, 1989
*Present address: University o f Vermont College o f Medicine, Vascular Surgery, Burlington, Vt
fPresent address: Medical College o f Virginia, Cardiovascular Surgery. Richmond, Va
Reprint requests to: Dr. J. Yee, Resident in General Surgery, Royal Victoria Hospital, 687 Pine
Ave. W, Montreal, PQ H3A 1A1

We reviewed the medical records
of all patients who underwent or
thotopic cardiac transplantation at
the Royal Victoria Hospital, Mon
treal, between January 1985 and
March 1989. The records of anoth
er seven patients who received
transplants at Hopital Notre-Dame,
Montreal, between July 1982 and
January 1985, were also reviewed
because they were followed up at
the Royal Victoria Transplant Clin
ic. We paid particular attention to
the management and outcome of
noncardiac surgical problems.
Seventy-eight cardiac transplants
had been performed by our group
during the study period. There were
68 men and 10 women. The mean
age of the group was 49 ± 9 years.
The overall survival was 86% with a
mean follow-up of 22 months. Ac
tuarial survival at 1 year was 88%.
The early postoperative death rate,
(up to 30 days) was 10%. No deaths
were attributed to abdominal com 
plications.
Immunosuppressive therapy con
sisted of azathioprine (400 mg) pre-
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operatively and methylprednisolone
(500 mg) and azathioprine (125 mg)
intraoperatively. Maintenance im
munosuppression consisted of anti
thymocyte globulin (10 m g/kg dai
ly) and azathioprine (at doses ad
justed according to the peripheral
blood leukocyte count). Steroids,
prednisone at 0.20 m g/kg or less
daily, were used only in patients
with recurrent rejection. Cyclospo
rine (1 m g/kg daily) was started on
the postoperative day 3, and the
dose was subsequently adjusted to
maintain a serum level of 150 to
300 ng/m l. Antithymocyte globulin
was discontinued as adequate levels
of cyclosporine were achieved.

Results
Fourteen patients (12 men, 2
women) (18% of the total) under
went 16 surgical procedures after
cardiac transplantation.* The mean
age of this group was 50 years
(range from 37 to 62 years) at the
time of the transplantation. The
average time between transplanta
tion and subsequent noncardiac sur
gery was 10 months (range from 1
to 51 months).
Seven patients (9%) had emergen
cy laparotomy, done for biliary tract
disease in four and for a ruptured
abdominal aortic aneurysm in one.
Severe enterocolitis and presumed
appendicitis accounted for the other
two emergency cases. Only one ab
dominal complication had developed
within 30 days of transplantation.
Indications for the seven elective
procedures included symptomatic
inguinal or incisional hernias, peria
nal disease, osteonecrosis of the
hip, recurrent sinusitis and duode
nal villous adenoma.

*Readers wishing to obtain full clinical de
tails o f these patients in table form should
contact Dr. J fee.
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Most patients received isoflurane
for general anesthesia. All patients
received antibiotics prophylactically.
Endomyocardial biopsy after major
abdominal procedures revealed no
significant rejection.
All patients had continued to re
ceive their immunosuppressive med
ication during and after surgery.
When oral medication was contrain
dicated cyclosporine was adminis
tered by intravenous infusion over 4
hours at 25% of the daily oral
dosage. Prednisone was replaced
with an equivalent dose of methyl
prednisolone intravenously. Azathi
oprine was given intravenously at
the same dose as had been given
orally. Hydrocortisone succinate
(100 mg) was administered intraop
eratively, followed by three postop
erative doses at 8-hour intervals to
provide sufficient corticosteroids to
meet the metabolic stresses of intra
abdominal surgery. Antibiotics and
ranitidine were used prophylactical
ly during these procedures.
Before 12 of the 16 surgical
procedures the patients received tri
ple drug immunosuppression (cy
closporine, azathioprine and predni
sone). In three procedures only cy
closporine and prednisone were so
used, and in one the patient re
ceived only cyclosporine and azathi
oprine. Adjustment of immunosup
pression was minimal. Monitoring
for rejection was done by endomyo
cardial biopsy when the patient was
kept in hospital for more than 5
days. Cyclosporine levels were mon
itored daily and maintained in the
therapeutic range.
There were no deaths. Four com
plications occurred in three pa
tients: residual choledocholithiasis,
wound infection (two patients) and
an incisional hernia.

Discussion
The special features of heart-

transplant patients all pose chal
lenges for the general surgeon: the
possibility that there were low-flow
states during and immediately fol
lowing cardiopulmonary perfusion,
the threat of infection and impaired
wound healing, and the effects of
continued immunosuppression.
The results at several centres
suggest that cardiac transplant pa
tients are at high risk for serious
and potentially lethal abdominal
complications. Jones and col
leagues,2 for instance, described a
group of post-transplant patients, in
which the rate of general surgical
complications was 13%. Over half
the patients who suffered abdomi
nal complications did so within 30
days of transplantation, and among
them the death rate was more than
40%. Pancreatitis or peptic ulcer
disease was implicated in all of
these deaths. Furthermore, 70% of
the patients with early complica
tions had pathologic findings relat
ed to perforated ulcer or pancreati
tis. Disesa and colleagues3 reported
a similarly high rate, with 11 of 14
general surgical complications oc
curring within 30 days of transplan
tation. Pancreatitis or perforated
peptic ulcer was the preoperative
diagnosis in 45%.
At the University of Pittsburgh4
12% of cardiac transplant patients
subsequently underwent general
surgical procedures. Nine emergen
cy laparotomies and eight elective
procedures were reported. Patients
with acute abdominal complications
requiring surgery had a death rate
of 33%. No deaths occurred after
elective surgery. Steroid therapy
was not reported as having masked
signs of peritoneal irritation.
Colon and associates5 reported a
34% rate of complications requiring
general surgical consultation. Onethird of these required surgery.
Pancreatitis and gallbladder disease
accounted for two-thirds of the gen
eral surgical consultations. The
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death rate for patients who required
laparotomy for severe pancreatitis
and its complications was 40%.
Elective cholecystectomy was un
complicated.
In the another series6 there were
22 elective and 7 emergency intra
abdominal operations. The death
rate (there were five deaths among
those who underwent emergency
laparotomy) was 17%. Twelve elec
tive cholecystectomies were per
formed without complication. One
laparotomy was performed for pan
creatic disease and four for compli
cations of peptic ulcer disease.
Merrell and associates7 reported a
15% rate of acute abdominal com
plications. Pancreatitis and gas
trointestinal bleeding accounted for
a large proportion of them. No
predisposing factors could be identi
fied, except that recent pulses of
high-dose antirejection steroid ther
apy was associated with 33% of the
abdominal complications. This sug
gested to them that steroid-sparing
immunosuppression might lead to a
lower rate of abdominal complica
tions.
In our series, 9% of post-trans
plant patients underwent emergency
procedures. Cholecystitis was com
monly encountered, but none of the
laparotomies was performed for
peptic ulcer disease or pancreatitis,
described as frequent by other cen
tres. Only one of our patients re
quired operation within the early
post-transplant period. Those who
had elective surgery had an uncom
plicated postoperative course except
for one who had a late wound
infection after herniorrhaphy. En
doscopy was performed without
complication. Like Merrell and col
laborators,7 we detected no cases of
“rebound” graft rejection. Al
though we did not find any associa
tion between abdominal complica
tions and the higher dose steroids
used to treat episodes of rejection,
our death rate and low incidence of

early abdominal complications, es
pecially the absence of pancreatitis
and peptic ulcer, may be related to
the low doses of maintenance cor
ticosteroids we used.
Previous reports8-12 have docu
mented a 0.3% to 1% incidence of
abdominal complications after ex
tracorporeal circulation and routine
cardiac surgery. Gastroduodenal he
morrhage was encountered most
frequently. Pancreatitis, well de
scribed following cardiopulmonary
bypass,1314 has been associated with
the administration of azathioprine
and corticosteroids after cardiac
transplantation.1516 The high ab
dominal morbidity after general car
diac surgery has been attributed to
pre-existing disease in middle-aged
patients with concomitant heart dis
ease, perioperative splanchnic hypo
perfusion often exacerbated with
vasopressors, and difficulties inher
ent in the clinical assessment of
sedated and ventilated patients.
These same factors, combined with
the side-effects of immunosuppres
sive medication and increased sus
ceptibility to sepsis, may contribute
to death among patients in the early
post-transplant period.
The risk of death after cardiac
transplantation is highest immedi
ately after transplantation and de
clines rapidly to a constant level by
the third month.17 Patients are es
pecially vulnerable in this period
and require close surveillance with
aggressive investigation of potential
complications, particularly those re
lated to pancreatitis and peptic ul
ceration. Endoscopy, shown to be
safe after heart transplantation,18
and ultrasonography are particular
ly useful. Late complications,
though less frequent, demand a
similar diagnostic approach. Early
laparotomy should be considered
when careful clinical examination
suggests that abdominal disease is
evolving.
Elective abdominal surgery can

be performed safely. Our data, to
gether with that published by other
groups, show that morbidity is min
imal. Perianal disease, which often
represents a potential source of sep
sis, may be treated by elective sur
gery. Cholelithiasis may reflect bile
metabolism altered by cyclospo
rine.19 Total joint arthroplasty is a
safe and effective means of rehabili
tating transplant patients with ste
roid-induced osteonecrosis.20 Suc
cess with major plastic and recon
structive procedures has also been
described among transplant recipi
ents.21
For optimal care there should be
close communication between the
treating surgeon and the transplant
team. Effective treatment will in
clude a thorough but directed d.^^,
nostic approach with early interven
tion when indicated. Disease in the
pancreaticobiliary system is com
mon and should be actively sought.
The surgeon should not delay treat
ment or deny elective surgery be
cause of previous heart transplanta
tion. Adequate immunosuppression
must be maintained and monitored.
Appropriate antibiotic prophylaxis
and meticulous wound care may
minimize the potential for septic
complications among these pa
tients.
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arterial and venous insufficiency affect
ing the shoulder, arm and hands, even
though these conditions are not fre
quently seen.
The first edition of this monograph
was published in 1983, and in this
edition Machleder has included many
associate authors to cover areas such as
the vascular examination (David Sum
ner), small artery disease (John Porter)
and the thoracic outlet syndrome (David
Roos).
The book begins with an account of
the vascular examination of the upper
limb, which includes a description of
the neglected art of clinical examina
tion. A chapter by Sumner presents the
essentials of noninvasive assessment,
including pressure data with digital
pressure measurements, plethysmogra
phy and venous testing. In the angio
graphic section are outlined various
types of investigations relating to trau
ma, atherosclerosis, Takayasu’s disease,
giant-cell arteritis and vasospastic disor
ders. This section also includes discus
sions on transluminal dilatation and
thrombolytic therapy.
In the section on small artery dis
ease, it is gratifying to see the authors
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state that there is “little justification for
the division of the Raynaud’s syndrome
into disease and phenomenon’’. This is
in keeping with my experience, in
which conditions of “Raynaud’s syn
drome’’ are characterized as either idio
pathic or secondary to other diseases.
Associated systemic diseases, including
clinical evaluation and treatment, are
covered nicely in this section. The dis
cussion of upper extremity sympathec
tomy and its comparison with lumbar
sympathectomy, digital periarterial sym
pathectomy and drug treatment is ex
cellent. Seventy pages are devoted to
the thoracic outlet syndromes, but the
major portion of the last section relates
to arterial and venous disorders. These
comprehensive, easy-to-read chapters
are accompanied by useful diagrams
and photographs.
The final chapter is an extremely
thorough account of upper extremity
manifestations of systemic disorders
and contains over 600 references.
The book has up-to-date references
and will be valuable to both the experi
enced vascular surgeon who wishes to
quote chapter and verse about a dis
ease, and to medical students or resi

dents who wish to obtain complete,
current information about the diagnosis
and management of conditions they see
infrequently. The contributions of inter
nists to this book may even make it
acceptable reading for non-surgeons.
John L. Provan, MS, FRCS, FRCSC,
FACS
Professor of Surgery,
Faculty of Medicine,
University of Toronto,
Toronto, Ont.

CURRENT OPERATIVE UROLOGY.
Edited by E. Douglas Whitehead. 400
pp. Illust. J.B. Lippincott Company,
Philadelphia. 1989. $75.50 (US).
ISBN 0-397-50991-X
An unusual feature of this surgical
textbook is its format. It is divided into
25 topics of interest to urologists in
particular, but also to other surgical
specialists such as gynecologists and
general surgeons.
continued on page 210
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Second Annual W.R. Ghent Lecture on
Trauma. Abdominal Organ Injury:
Diagnosis, Treatment and Education
Charles E. Lucas, MD
In this lecture the author reviews aspects of education in the care of traumatized
patients, with particular attention to abdominal injuries. He notes the lack of
education in this aspect of medical care during the medical school years and the
variable quality of trauma care education during residency training. The author
outlines an organized approach to the teaching of trauma care, focusing on
cognitive, psychomotor and affective education and the establishment of a uniform
core curriculum for residents with the ultimate goal of enhancing patient care.

L’auteur passe en revue dans cette communication, divers aspects de la formation
relative aux soins aux victimes de trautismes, une attention particuliere etant
accordee aux blessures abdominales. II note le manque de formation specifique a ce
type de soins medicaux durant les annees du cours de medecine, ainsi que la qualite
inegale de la formation en traumatologie re?ue durant la residence.
L’auteur decrit les grandes lignes d’une approche structuree pour l’enseignement
des soins aux traumatises, centree sur une formation cognitive, psychomotrice et
affective, ainsi que l’etablissement d’un programme academique uniforme pour les
residents, le tout etant destine a ameliorer les soins aux patients.

t is an honour to receive any
invitation to present scientific
data and personal biases to a distin
guished group of professional
peers. This honour is enhanced
when the presentation is a named
lectureship, in this instance, the
Ghent Lecture. When this honour
revolves around the combination of
abdominal trauma, education and

I

science, my personal pleasure is
unsurpassed. Although I did not
know Dr. Ghent personally, all men
(and women) are known by their
acts, personal interactions and writ
ten word.1-3 Dr. Ghent’s writings
define, for me, a man desirous of
coordinating divergent skills among
many peers into a common goal
which is then nurtured for the
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betterment of the common good, in
this instance, better emergency
medical care for the injured Canadi
an citizen.1 His good name is re
membered by this lectureship; his
good works can only be fulfilled by
the continued efforts of each of you
working together to provide ongo
ing re-evaluation and improved care
to the traumatized patient.3
My objective today is to review
one aspect of this effort, namely,
education in the care of injured
patients with special emphasis on
abdominal injury.

Premedical Education
This education begins long be
fore our experiences in medical
school;4 everyone is exposed to
some aspects of trauma from the
earliest years. When health care
represents 10% of a nation’s gross
national product, many people have
family or relatives involved in some
aspect of the health care industry.
Discussions with these relatives
often centre around the care of
traumatized patients since to the
layman this is the most exciting
aspect of the health care worker’s
daily activity. The dramatic and
exciting aspects of trauma care
have reached the communications
industry4 through such television
heroes as Dr. Kildare and Dr. Ben
Casey. Recent television contribu
tions have highlighted the dynamic
CJS, VOL. 33, NO. 3, JUNE 1990
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activities of the emergency medical
service teams working in the field.
Unfortunately, some recent contri
butions have highlighted the inade
quate physician whose knowledge is
deficient or who is unavailable, a
reflection of the serious problem
faced today by physicians in the
area of professional liability. The
already serious malpractice problem
within the United States is one
which appears to be growing in
Canada. The effects of the malprac
tice crisis within the state of Florida
have ruined a well-established emer
gency medical service system in
Dade County. In the state of Michi
gan, a general surgeon with no
malpractice settlements or suit loss
es currently pays over $40 000 an
nually in order to have $200 000 to
$600 000 coverage.
Editorial comments in the daily
newspapers often attack the effica
cy of the medical profession and,
more specifically, emergency medi
cal services. All of these factors,
which are a part of our premedical
school educational system within
North America have led to a reduc
tion in the number of applicants to
medical schools in the US. Current
ly, over 60% of applicants to medi
cal schools in the US are accepted.
Such a lowering of standards will
ultimately lead to a lower quality of
care. Let us hope that Canada does
not follow the same path. Our re
sponsibility as educators in the area
of trauma necessitates that we re
verse the stance perpetuated by the
above factors and remember the
advice given by Dr. Ghent in 1981
when he stated ’’The public good is
the higher law” .1

Medical School Education
The next phase of education in
care of the traumatized patient
takes place in medical school.56
Unfortunately, the medical school
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curriculum in this area often is
haphazard or absent.78 Part of the
deficiency relates to the faculty con
flict with personal and institutional
needs. Typically, the medical school
faculty is involved in the areas of
research, patient care and educa
tion,69 with education receiving low
priority and being assigned to the
more junior faculty. Following the
ideals of Dr. Ghent, we must insist
that our alma maters provide for
our medical students an organized,
comprehensive curriculum on all
aspects of trauma, the number one
killer of young people in North
America.

Residency Education
Following medical school, educa
tion in the treatment of trauma
takes place in the surgical residency
programs, especially those of gener
al surgery, orthopedic surgery, tho
racic surgery and plastic surgery.
The quality of this education, how
ever, continues to vary between
training institutions.10 Until recent
ly, there was no well-defined mini
mal requirement of exposure to the
care of severely injured patients to
meet the qualifications for sitting
the specialty board examinations.
Furthermore, stimulation for facul
ty to become involved in the teach
ing of trauma care is lacking in our
residency training programs. Junior
faculty members often learn how to
teach while working on the trauma
service, where they are encouraged
to promote clinical investigations
and write clinical reviews in order to
be promoted to other more lucrative
and “less dirty” services.6 How
many full professors of surgery
have the honour of being called to
help treat a seriously injured patient
involved in a motor vehicle accident
at 02:00 hours?11 What reward sys
tems exist within most of our train
ing programs to encourage our best

teachers to continue to be involved
on the trauma service? How many
of the dynamic, creative and effec
tive surgeons maintain a presence
in the emergency department? Dr.
Ghent emphasized, “The most im
portant component of an effective
emergency department is person
nel.”2 By this statement, I am sure
that he meant all personnel —
physicians, nurses, attendants, floor
sweepers and administrators.
The objective of an excellent edu
cational program during the surgi
cal residency years requires that
specific emphasis be placed on all
three of the educational domains —
cognitive, psychomotor and affec
tive.9 The development of a specific
curriculum outlining learning objec
tives enhances successful imple
mentation of these objectives. The
cognitive objectives define the
knowledge base or the decision
making skills required for the care
of traumatized patients; the psycho
motor objectives identify the techni
cal skills which must be learned
while caring for injured patients;
the affective domain delineates the
attitudinal characteristics which
need to be enhanced or developed in
the caring but effective maturing
surgeon.

Cognitive Education
Instruction in the cognitive do
main takes place in many different
settings. Most of the knowledge is
gained during daily rounds.56-910
Bedside teaching allows not only
for recitation of the published con
cepts regarding a particular injury
but permits the elucidation of sub
tle facts which can be brought forth
by the mature surgeon. A drawback
of bedside teaching is the episodic
experience for a particular resident
who is exposed to many interesting
problems but may not be exposed
to other, critical areas.
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Establishment of a Uniform
Core Curriculum
Definition of a core curriculum is
enhanced by some of the packaged
programs which deal with all as
pects of general surgery, including
trauma. The American College of
Surgeons has provided excellent
leadership with their Surgical Edu
cation and Self-Assessment Pro
gram (SESAP). The American Col
lege of Surgeons Committee on
Trauma provides a good cognitive
base with their course on Advanced
Trauma Life Support (ATLS) which
specifically addresses multisystem
injury. The in-training examinations
for residents also address the care
of traumatized patients. These
packaged programs are augmented
by the weekly lecture sessions. It is
to be hoped that every trauma ser
vice throughout North America will
develop such lectures for the trau
ma team and identify specific cogni
tive objectives to be met during a 1
or 2-year cycle. The specific cogni
tive objectives of such lectures are
then reinforced by identifying edu
cational needs during morbidity and
mortality conferences. A journal
club assigned to deal with unusual
cognitive objectives in trauma care
will help fill some educational gaps,
and special assignments to residents
with perceived deficiencies will pre
pare them for later examinations.
Stagnation is the curse of all
established educational programs.
Education in trauma care is no
exception. The maintenance of an
excellent base of knowledge is dy
namic and fluid, constantly slough
ing outdated facts and incorporat
ing new techniques, studies and
procedures as they are introduced.6
Healthy care of this living body of
knowledge requires yearly input
from many trauma experts through
out Canada and the US.
I foresee a time when each region
will be assigned an area of study.

Besides collating and making pre
sentations to a central committee,
the regional centres would be re
sponsible for yearly updates on
what is new and, more importantly,
what new research projects are ap
propriate. No one group is an island
possessing the cognitive skills to
achieve this objective in all areas of
care. Dr. Ghent emphasized this
when he stated, ’’The input by all
specialty groups has been sought
during revisions and the new incor
porates many changes.”2 Although
space does not permit a complete
discussion of all challenging ques
tions within this cognitive base, the
following examples will highlight
the need for a living body of knowl
edge filtering from different regions
of North America into a central
committee.
In 1989, a 37-year-old man was
seen in the emergency department
following a motor vehicle accident.
He had a systolic blood pressure of
50 mm Hg, a pulse rate of 120/min
and inadequate perfusion as indicat
ed by a weak, thready pulse and
cold, clammy skin. His immediate
resuscitation with a balanced elec
trolyte solution led to an increase in
the systolic blood pressure to 90
mm Hg and a fall in the pulse rate
to 105/min within 15 minutes.
Rapid examination revealed a prob
able fracture of the right femur,
bilateral rib fractures, a scalp lacer
ation, abdominal and chest-wall ten
derness and normal breath sounds.
While he was receiving electrolytes,
his systolic blood pressure fell to 80
mm Hg as the pulse rate rose.
Internal bleeding was diagnosed.
Laparotomy was performed immedi
ately, but no injuries were seen.
While the patient was in the operat
ing room, the systolic blood pres
sure fell further to 60 mm Hg. A
left thoracotomy was performed in
an effort to identify a thoracic
source for the continued bleeding
and to provide internal cardiac mas

sage. Minimal bleeding was identi
fied from the left thorax. The main
injury was severe pulmonary contu
sion. The patient died, despite con
tinued intraoperative attempts at
resuscitation.
During the discussion of this case
at the morbidity and mortality con
ference, the surgical resident and
many of the trauma surgeons
praised the decision to perform a
laparotomy. When the role of diag
nostic peritoneal lavage or abdomi
nal computed tomography scanning
was questioned, the surgical resi
dent rightly pointed out that an
unstable patient should never be
taken to the radiology department
for prolonged x-ray studies and that
this patient was too unstable to
undergo diagnostic peritoneal la
vage. When the resident was ques
tioned about diagnostic peritoneal
lavage in the operating room, he
responded that the patient needed
immediate full laparotomy. These
questions led to a long discussion
of the recent studies comparing
diagnostic peritoneal lavage and ab
dominal computed tomography
scanning after blunt trauma. Many
important cognitive points were ad
dressed and the resident team was
well educated regarding a number
of facts which will certainly appear
on their subsequent examinations.
Unfortunately, the role of diagnos
tic paracentesis, which takes ap
proximately 10 seconds to perform,
was ignored. Although this tech
nique has been well documented as
an excellent means for identifying
hemoperitoneum, the advent of new
techniques (diagnostic peritoneal la
vage and abdominal computed to
mography) seems to have blinded
today’s residents to the value of the
technique, which is an important
aspect of recent medical history.
A regional trauma centre as
signed the task of collating data on
early diagnostic evaluation for blunt
abdominal trauma would address
CIS, VOL. 33, NO. 3, JUNE 1990
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both old and new techniques to
provide a compendium of data for a
uniform trauma curriculum.
For our younger surgical col
leagues who missed the era of diag
nostic paracentesis, I recommend
that bihemispheric diagnostic para
centesis be performed just lateral to
the recti muscles.12 Using a
20-gauge needle and a 10 ml sy
ringe, this procedure takes approxi
mately 10 seconds to complete and
can be done during resuscitation.
When any amount of blood is re
trieved in the aspirating needle, one
can predict the findings of diagnos
tic peritoneal lavage, thus preclud
ing its need. When no blood ap
pears on aspiration, the likelihood
of a life-threatening hemoperitoneum approaches zero.
Despite a long discussion outlin
ing the benefits of diagnostic para
centesis in unstable patients, the
lesson was not perceived by all.
More recently, a patient presented
with a gunshot wound to the poste
rior abdomen and posterior chest.
This patient had a low systolic
blood pressure and paralysis below
the level of the eighth thoracic
vertebra. Because of the unstable
vital signs and the potential for a
life-threatening intrathoracic or in
tra-abdominal hemorrhage, the pa
tient was treated immediately with a
balanced electrolyte solution, then
taken to the operating room. The
systolic blood pressure remained
marginal, so a left thoracotomy was
done. It revealed a moderate hemo
thorax as the cause of the hypoten
sion. At laparotomy it was apparent
that the posteriorly located gunshot
wound had not entered the perito
neal cavity. The righteous resident
in this instance defended his deci
sion on the basis that his patient
was unstable and had a potentially
lethal hemorrhage which precluded
delay in operative intervention.
When questioned about the role of
diagnostic paracentesis to rule out
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intra-abdominal hemorrhage, the
resident indicated that the hemorrh
age was thought to arise from the
left thorax and that was the cavity
first explored. He indicated that the
threat for rapid hemorrhage was
too likely to permit left tube thora
costomy, which would take too
long. When questioned about the
role of diagnostic thoracentesis
while the patient was on the operat
ing table, he replied that he had
never considered that possibility
and had not seen it in any of his
readings.
Clearly, the regional team as
signed to deal with the diagnostic
approach to abdominal injury
should also be prepared to revise
standards for approaching patients
with penetrating thoracic wounds.
The resident was further advised
that after he performed a negative
thoracotomy, a diagnostic para
centesis followed by diagnostic peri
toneal lavage would have precluded
the need for opening a second
major body cavity. Hopefully, he
now knows that thoracotomy and
laparotomy are not the ideal treat
ment for paraplegia.
Initial Evaluation and Diagnosis
A regional committee assessing
initial evaluation of patients with
abdominal trauma would collate
data on these tests for both blunt
and penetrating trauma from either
gunshot or stab wounds. There are
subtle differences between the dif
ferent types of penetrating wounds,
and they need a different approach
to diagnosis and treatment. The
regional committee would also iden
tify the exact criteria for a positive
peritoneal lavage in patients with
pelvic fracture in whom there is a
high frequency of false-positive
findings on diagnostic peritoneal
lavage.
Possibly, a new degree of hemoperitoneum should be indicated

for operative intervention in pa
tients with pelvic fracture. Our pedi
atric surgical peers no longer per
form diagnostic peritoneal lavage
for blunt injury because they have
elected to observe, nonoperatively,
patients with known hemoperitoneum. The current guidelines in
many centres suggest that a posi
tive peritoneal lavage will make lap
arotomy mandatory when the pa
tient can be treated by observation.
This reasoning has no logic. A
negative peritoneal lavage reassures
the surgeon that there is no hemoperitoneum and, thus, circum
vents the need for observation in a
special care unit. On the other
hand, a positive peritoneal lavage
could be used as a baseline against
which subsequent diagnostic com
puted tomography scans or a subse
quent peritoneal lavage could be
compared during observation. The
criterion that any patient who has a
positive peritoneal lavage must un
dergo laparotomy must be put to
rest.
Liver Injuries
A review of the recent treatment
of liver injury identifies many para
doxes whereby currently popular
recommendations discount a wealth
of previous experiences and publica
tions. Consequently, the regional
centre assigned the task of setting
the optimal treatment regimens for
liver injury would have a full agen
da. Most surgeons currently recom
mend exploratory laparotomy for
patients with penetrating abdominal
stab wounds thought to have in
jured the liver, regardless of wheth
er the patient’s condition is stable
or hypovolemic shock is present.
Despite these recommendations, we
now see many patients with stab
wounds to the abdomen in whom
peritoneal penetration is neither es
tablished nor ruled out. Presum
ably, many patients with liver inju-
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ries are successfully treated nonoperatively.
What is the current recommen
dation for the treatment of pa
tients with penetrating gunshot
wounds to the right upper quad
rant? Many of these patients have
stable vital signs but the trajectory
of the bullet clearly transgresses
the liver. When there are no perito
neal signs, should the patient be
observed rather than explored?
Many such patients who undergo
exploration have nonbleeding,
through-and-through gunshot
wounds which are not even drained.
Should not the same policy of care
ful observation applied to patients
with right upper quadrant stab
wounds also be applied to patients
with similar gunshot wounds?
When patients present with blunt
abdominal trauma following a
motor vehicle accident, a positive
diagnostic paracentesis or diagnos
tic peritoneal lavage leads to opera
tive intervention. Some centres ob
tain abdominal computed tomogra
phy scans but omit paracentesis and
peritoneal lavage. When the source
of bleeding is from a probable liver
injury, stable patients are observed
nonoperatively.
Hemoperitoneum and Liver Injuries

What are the current guidelines
for successful observation of pa
tients with hemoperitoneum and
liver injury confirmed by computed
tomography? Hepatic artery ligation
was once considered to be a techni
cal mishap associated with inevita
ble death. During the 1960s, hepat
ic dearterialization became an ac
ceptable treatment for refractory
bleeding from the injured liver. Dur
ing the 1970s, hepatic dearterializa
tion was used as prophylaxis
against postoperative bleeding in
patients with large liver wounds not
bleeding at laparotomy. Our own
experience has shown that in a

small but significant number of pa
tients hepatic necrosis develops fol
lowing hepatic dearterialization for
trauma. What are the current
guidelines for hepatic dearterializa
tion and should this procedure be
used in conjunction with liver su
tures, intrahepatic packing or in
patients with associated peritonitis
from hollow viscus injury?13 In
trahepatic and parahepatic packing
for liver injury, once considered the
technique of an inadequate sur
geon, has matured and is now a
respectable procedure in certain cir
cumstances.13 The questions that
need to be answered regarding liver
packing include the timing intraoperatively, the technique (intrahepat
ic or parahepatic), the value of a
rubber dam between the liver and
pack, and the timing of pack re
moval.14
Hepatorrhaphy, the technique I
prefer for the closure of most liver
injuries, has been proposed by
many as the cause of the hepatic
necrosis. Does this so-called hepatic
necrosis following hepatorrhaphy
reflect inappropriate technique or
unusually tight tieing of the hepa
torrhaphy sutures? The type of
drainage following treatment of
liver injury continues to be contro
versial. Many years ago, T-tube
choledochostomy was the recom
mended treatment for the most se
vere liver injuries to decompress the
extrahepatic and, therefore, the in
trahepatic biliary system.13 Our
studies showed that not only does
T-tube choledochostomy not pre
vent complications following the
treatment of liver injury but it is
associated with an increased risk of
new complications related to biliary
tract sepsis. Currently, the contro
versy regarding drainage centres
around the need to use closed
drainage as opposed to none at all,
with the result that some young
surgeons provide no drainage for
very severe liver injuries which need

to be drained to the outside in order
to prevent the infrequent but fatal
complications such as bile peritoni
tis. The regional centre studying
liver injury would address these
questions and even design prospec
tive randomized projects to identi
fy the best modalities for treatment.
Splenic Injury

The optimal treatment of splenic
injury is forever changing. The asplenic state was known to be associ
ated with infection in rodents in
1920.15 The modern techniques for
successful splenorrhaphy were well
described in adults by 1930.15 The
increased incidence of post-splenec
tomy sepsis in children was known
in the 1950s.15 Despite this knowl
edge, the standard in the 1970s was
splenectomy for all injured spleens.
This policy was so ridiculous that
surgical residents would “hide” tiny
avulsions from their attending staff
to prevent unnecessary splenecto
my. The popularization of splenorr
haphy was a big step forward but
was severely criticized when applied
to adult patients.
Fortunately, the surgical world
has accepted splenorrhaphy and has
even moved a step further toward
nonoperative treatment of splenic
injury observed by abdominal com
puted tomography. Although the
current surgical literature suggests
that splenic disruption observed by
abdominal computed tomography
should be treated by operative inter
vention in order to avoid missing
associated hollow viscus injury, I
am confident that this lack of wis
dom will be corrected during the
next decade. I look forward to a
time when the criteria for nonopera
tive treatment of splenic disruption
confirmed by computed tomography
are well defined and followed by
most North American surgeons.
Clearly, the regional centre as
signed to evaluate splenic injury
CJS, VOL. 33. NO. 3, JUNE 1990

193

LUCAS

would have an exciting agenda re
solving these issues. Additional is
sues that the centre must resolve
relate to the wound breakingstrength in patients with splenorr
haphy and those treated nonoperatively for splenic injury.15

plain film? This centre would also
need to address the current guide
lines for treatment of duodenal he
matoma in adults. Should these
patients be observed for 3 weeks as
is currently popular with children?
The Regional Centres

Pancreatic and Duodenal
Injuries

Pancreatic and duodenal injuries
continue to be a challenge.16 The
regional trauma centre designated
to update treatment of pancreatic
injury could address the role of
serial serum amylase determinations
and abdominal computed tomogra
phy scans in patients with a nega
tive diagnostic peritoneal lavage.
Recently, we reported that patients
with negative peritoneal lavage and
a positive abdominal computed to
mography scan showing probable
pancreatic disruption are candidates
for endoscopic retrograde cholangi
opancreatography (ERCP) to identi
fy the degree, if any, of pancreatic
disruption.17 We have observed a
patient with blunt abdominal injury,
a rising serum amylase, and “tran
section” of the body of the pancre
as on abdominal computed tomog
raphy scan when the ERCP showed
integrity of the primary, secondary
and tertiary pancreatic ducts.17 The
centre assigned to updating the
criteria for surgery of pancreatic
injury would need to encourage
prospective studies designed to
identify the value of ERCP in this
setting.
The centre working with the
guidelines for treatment of duode
nal injury will need to identify the
current status of abdominal com
puted tomography with contrast
after a negative diagnostic peritone
al lavage. Is this test better than
simply looking for scoliosis and
decreased visualization of the right
psoas shadow on an abdominal
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Each specialty area within the
field of trauma could be reviewed by
a regional centre annually to define
the objective criteria for surgical
intervention and to develop ques
tions which will test the cognitive
domain of surgical residents caring
for such patients. The guidelines
for treatment and the questions
designed to test these guidelines
would be sent to a central commit
tee from which they would be dis
tributed to other regional commit
tees for constructive criticism and
revision.6 The materials would then
come back to the central committee
for collation and return to the re
gion of origin. Since this approach
requires a consensus, one would
have to discount those questions
for which no consensus could be
reached. Whenever the questions
are too controversial to produce a
consensus, further research and
further prospective studies would
be necessary to identify the best
approach. This type of involvement
of multiple centres annually would
create a sense of excitement in all
participants and lead to a living
body of knowledge which would be
revitalized each year. Maintenance
of this living body of knowledge
would require the frequent replace
ment of experienced surgeons with
new surgeons responsible for the
yearly maintenance of the data
bank. Since the American College
of Surgeons Committee on Trauma
is already organized in a regional
framework, one could logically rec
ommend that this be the central
committee to which each region
would forward data annually.6

Psychomotor and Affective
Education
The psychomotor domain is criti
cal to the successful care of injured
patients. Surgeons are physiologic
mechanics, working on the human
chassis. A skilled hand is as impor
tant as experience with that particu
lar injury. A proper residency pro
gram needs to define which experi
ences are appropriate at the differ
ent levels of surgical training.
There are many procedures which
are minor and should be included
into the mandatory core curriculum
of junior residents, whereas the
more major surgical procedures
would fit into the core curriculum
of the more mature residents.818
Although each resident would not
get to do each major procedure in
injured patients, an absolute mini
mum of major procedures which
each resident needs to perform dur
ing his surgical training must be
identified. This curriculum for the
psychomotor domain should be co
ordinated and be in concert with the
guidelines established by the boards
testing surgical proficiency.
The evolution of new surgical
procedures mandates that the prac
tising surgeon have some mecha
nism whereby a refresher course
would provide the new cognitive
materials and psychomotor skills
required to remain up to date with
the treatment of various injuries.
Successful care of the injured pa
tient requires that the surgeon
show leadership, courage and deci
siveness.19 These affective traits
need to be encouraged as part of
our core curriculum so that the
mature surgeon has the ability to
make life and death decisions even
though the database is inadequate.
The surgeon needs to be taught
that sins of omission are much
worse than sins of commission. The
importance of teamwork in the care
of the injured patient cannot be
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Examinations
over stressed. The maturing resi
dent must learn to avoid peer pres
sure while carrying out the proper
order of priorities. Avoidance of turf
battles between the surgical special
ties requires the presence of a team
captain who is responsible for up
dating and maintaining the appro
priate emergency medical services
and schedules, and resolving dis
putes between different surgical
specialties. This team captain would
really function as the chairman
(chairwoman) of a large trauma
committee designed for the optimal
care of injured patients. Nobody
can say it better than Dr. Ghent,
”As chairman of the committee, I
know from bitter experience that
the buck stops here, with me.” 1

Conclusions
The actual care of an injured
patient cannot be separated from
education. The proposed guidelines,
briefly outlined herein, for the de
velopment of an organized ap
proach to a uniform core curricu
lum for residents and practising
physicians alike reflects this union
of patient care with education.
Clearly, multiple disciplines must be
involved in the input, which should
be constructively criticized by all
parties in order to enhance the
quality of the yearly revisions. The
ultimate goal of this intricate sys
tem of living education would be
enhanced patient care. The chal
lenge is there. We surgeons must
accept the task lest others of less
skill and less idealism pick up the
gauntlet.

References
1. Ghent WR: MDs should consider “the

public good is the higher law” when
determining fitness to drive. Can Med

Assoc / 1981; 124: 1518-1521
2. G hent WR. Dacnone LE: A numerical
method of evaluating and categorizing
hospital emergency departments. Can
Med Assoc J 1 9 7 115: 149-152
3. G hent WR, Good BE, M cCrank MN, et
al: Investigation of automotive mishaps
in Frontenac County (Ontario). Can J
Surg 1970; 13: 236-242
4. L ucas CE: Presidential address: com
mercialism, consumerism, capitalism,
and care of the acutely ill surgical
patient. Am Surg 1977; 43: 366-371
5. L ucas CE, L edcerwood AM, W alt AJ:
A scientific basis for medical student
education in trauma. J Trauma 1973;
13: 520-528
6. L ucas CE. L edcerwood AM, Gursel E,
et al: The surgical clerkship and medical
student education in trauma. J Trauma
1986;26:1024-1030
7. Imbembo A: Presidential address: per
spectives in medical education. Surgery
1984; 96: 88-91
8. Matory WW: Trauma Curriculum in
Medical Schools, American College of
Surgeons, Report to Education Subcom
mittee, Committee on Trauma, 1987:
43-44
9. R osenberg IK, L ucas CE, P itts CC:
Surgery: an integral part of core curric
ulum. J Surg Res 1972; 12: 220-227
10. T runkey DD: Presidential address: on
the nature of things that go bang in the
night. Surgery 1982; 92: 123-132
11. L edcerwood AM: Presidential address:
care of the injured, who will do it? Am
Surg 1984; 50: 293-296
12. L ucas CE: The role of peritoneal lavage
for penetrating abdominal wounds. J
Trauma 1977; 71: 649-650
13. L ucas CE, L edcerwood AM: Factors
influencing morbidity and mortality after
liver injury. Am Surg 1978; 44: 406412
14. L ucas CE: Liver injury: a modern day
surgical challenge. S Afr J Surg 1976;
14: 163-174
15. D ulchavsky SA, Lucas CE, Ledcerwood
AM, et al: Wound healing of the injured
spleen with and without splenorrhaphy.
J Trauma 1987; 27: 1155-1160
16. L ucas CE: Diagnosis and treatm ent of
pancreatic and duodenal injury. Surg
Clin North Am 1977; 57: 4 9 -6 5
17. Hayward SR, L ucas CE, S ugawa C, et
al: Emergent endoscopic retrograde cho
langiopancreatography. A highly specif
ic test for acute pancreatic trauma. Arch
Surg 1989: 124: 745-746
18. L ucas CE, Denis R, L edcerwood AM:
Societal impact on surgical education in
trauma. J Trauma 1985; 25: 154-155
19. L ucas CE, L edcerwood AM: Mandatory
incarceration for convicted armed felons:
a trauma prophylaxis. J Trauma 1978;
18: 291-292

The examinations of the Royal College
are held in September of each year.
Candidates wishing to sit for the ex
aminations should note the following:
1. Every candidate for admission to
the examinations must submit an
application for assessment of
training.
2.

3.

4.

5.

Candidates in training in Canada
should apply for preliminary
assessment of training at least
one year before the date on which
they expect to sit for the examina
tions, that is to say not later than
September 1 of the preceding
year. Candidates who have had
training outside of Canada should
submit their initial application for
assessment at least 18 months
before they expect to sit for the
examinations, that is by March 1
of the preceding year. Only can
didates whose assessment of
credentials is complete will be ac
cepted to sit for the examinations.
Candidates who desire to sit for
an examination, having complied
with the above requirement of
preliminary assessment of train
ing, must notify the Royal College
in writing of their intent before
February 1 of the year of the ex
amination. Upon receipt of this
notice of intent, the evaluation of
the candidate’s performance dur
ing training will be added to the
previously completed assessment
of credentials. Each candidate will
then receive notification as to
eligibility together with an applica
tion form for admission to the ex
amination to be completed and
returned.
The following documents may be
obtained from the Royal College
office:
(a) Application forms for assess
ment of training;
(b) General information booklet
on training requirements and
examinations;
(c) Specific requirements for
training
and
re g u la tio n s
relating to the examinations of
each specialty.
R equ ests
should indicate the specialty
or specialties of interest to the
applicant;
(d) Listing of specialty training
programs in Canada
ac
credited by the Royal College.
Address all enquiries to:

Dr. J.P. DesGroseilliers, Director,
Office of Training and Evaluation,
The Royal College of Physicians
and Surgeons of Canada,
74 Stanley,
Ottawa, Canada
K1M 1P4.
(613) 746-8177.

CJS, VOL. 33, NO. 3, JUNE 1990

195

cost effective
prophylactic
alternative
cefotaxime

sodium

in contaminated
or potentially
contaminated
gastro-intestinal
surgery
Claforan "... was superior
in preventing infectious
morbidity and side effects
and reduced hospital
drug costs com pared
directly with multidose
regimens of cefazolin
or cefoxitin (p value not
statistically significant) ”.
Dr. R.N. Jones

ROUSSEL
ROUSSEL CANADA INC.
MONTREAL, QUEBEC
©Registered Trademark of Roussel Uclaf, Paris

oran

CANADIAN SOCIETY FOR VASCULAR SURGERY

Inflammatory Aneurysms of the
Abdominal Aorta
Gregory Luna, MD, MPH, FACS; C.Wm. Cole, MD, FRCSC; Jacob Choi, MD, FRCSC;
Neil McPhail, MD, FRCSC; Graeme Barber, MD, FRCSC
The treatment of inflammatory aneurysms of the abdominal aorta presents a
formidable challenge to the surgeon. The retroperitoneal inflammatory reaction
obliterates normal tissue planes, limiting access to the infrarenal aorta. During a
70-month period 25 (6%) of 439 patients operated on for abdominal aortic
aneurysms were found to have the inflammatory type. These patients were more
likely to be symptomatic than patients with noninflammatory aneurysms and they
were more likely to be male. Although surgical repair of the aneurysms required
longer aortic occlusion time and more blood replacement, the outcome was similar to
that for patients treated for noninflammatory aneurysms.

from the inflammatory process ap
pears to allow for safe surgery with
results that are comparable to those
for noninflammatory aneurysms.

Methods

From the Division o f Vascular Surgery, Ottawa Civic Hospital, Ottawa, Ont.

A prospectively collected vascular
database was used to identify all
patients operated on for an abdomi
nal aortic aneurysm during the 70
months from March 1981 to De
cember 1986. Aneurysms were clas
sified as inflammatory or noninflam
matory by their gross appearance at
surgery as recorded in the operative
notes. In addition to patient demo
graphics, the following variables
were compared with respect to in
flammatory and noninflammatory
aneurysms: aneurysm size, manner
of presentation, symptoms, type of
reconstruction, hospital course and
outcome. The hospital records of
patients with inflammatory aneu
rysms were further reviewed for
details regarding radiologic investi
gations. Long-term patient outcome
was determined from clinic records
and direct patient and family con
tact.
Statistical analysis between the
groups was carried out using x 2
and Student’s f-tests as appropriate.

Presented at the 11th annual meeting o f the Canadian Society fo r Vascular Surgery, held in
conjunction with the 58th annual meeting o f the Royal College o f Physicians and Surgeons o f
Canada. Edmonton, Alta., Sept. 24, 1989

Findings

Le traitement des anevrismes inflammatoires de l’aorte abdominale represente un
formidable defi pour le chirurgien. La reaction inflammatoire retroperitoneale efface
les plans normaux des tissus, limitant de la sorte faeces a l’aorte sous-renale. Au
cours d’une periode de 70 mois, 25 (6%) des 439 patients operes pour un anevrisme
de l’aorte abdominale avaient un anevrisme de type inflammatoire. Ces patients
etaient plus sujets a etre symptomatiques que les patients souffrant d’anevrismes
non inflammatoires et il y avait plus de chance que ce soit des hommes. Meme si la
reparation chirurgicale necessita une occlusion aortique plus prolongee et davantage de transfusions sanguines, Tissue fut comparable a celle des patients traites pour
un anevrisme non inflammatoire.

nflammatory aneurysm, a proc
ess that involves the aortic wall
and surrounding retroperitoneal
structures, is a well-recognized vari
ant in the spectrum of aneurysmal
disease. The cause is poorly under
stood. Because of the pathologic
differences between these aneu
rysms and the noninflammatory va
riety there may be a different pat
tern of symptoms, and the involve
ment of adjacent structures in the

I

inflammatory process presents tech
nical problems for the vascular sur
geon. The technical difficulty and
associated complications, which
may include enterotomy or major
venous or ureteral injury, have
prompted some to recommend no
noperative treatment for inflamma
tory aneurysms. Understanding the
potential operative hazards and
adopting a modified technique to
control the aorta in an area free

Accepted fo r publication Nov. 1, 1989
Reprint requests to: Dr. Gregory Luna, Division o f Vascular Surgery, CPC Ste. 637, Ottawa
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During the review period 439
patients were operated upon for
abdominal aortic aneurysm; 25 (6%)

■*- For prescribing information see page 206
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of these were classified by the oper
ative findings as having inflammato
ry aneurysms. Patient demograph
ics, manner of presentation and
operative results are outlined in
Table I.
The majority of patients with
inflammatory aneurysms were
symptomatic, most commonly suf
fering from back or abdominal pain.
Twelve of the 25 patients under
went excretory urography before
operation; ureteral obstruction was
demonstrated in 4 of them. Ureterolysis was carried out in one and
the obstructive uropathy resolved
spontaneously in the remainder.
Tube grafts were used in 20% of
patients with noninflammatory an
eurysms and in 3 of the 25 with
inflammatory aneurysms. Nine of
the patients with inflammatory an
eurysms required placement of at
least one limb of the bifurcation
graft in the femoral position. The
difference in the distribution of dis
tal graft position between the two
groups was not statistically signifi
cant.
One ureteral injury occurred dur
ing repair of an inflammatory aneu
rysm. It was recognized and imme
diately repaired and there were no
long-term sequelae. There were no
duodenal injuries.
The death rate for repair of intact
aneurysms was 4% in both groups.
There were two deaths in the in
flammatory group during the fol
low-up period, at 13 and 23
months, which suggests a long
term outcome comparable to that of
patients with noninflammatory an
eurysms.

Discussion
Inflammatory aneurysm of the
abdominal aorta is a distinctive
pathologic variant that is now well
recognized and is within the experi
ence of most vascular surgeons;
198
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repair remains a challenge for even
the most experienced. The first clin
ical series describing inflamatory
aneurysms was published by Walk
er and associates in 1972.1 Subse
quent case reports and clinical se
ries have characterized the problem
and documented a higher incidence
of complications associated with re
pair. Of all abdominal aortic aneu
rysms 5% to 10% are reported to be
of the inflammatory variety, which
is more common in men than wom
en, a feature that has not been
emphasized in the literature. In the
present series men outnumbered
women 24 to 1, a rate consistent
with that of the few other series
that have noted the difference in
sex distribution. Overall, women
make up 15% to 20% of all patients
with aneurysmal dilatation of the
abdominal aorta. Among patients
with inflammatory aneurysms,
women have been reported to ac
count for less than 4%,2-4 which is
consistent with the present series.
Unlike the noninflammatory variety,
the majority of patients with inflam
matory aneurysms have symptoms
clearly referable to the aneurysm.
The 52% frequency of symptoms in
our series is consistent with rates
reported previously. Abdominal and
back pain and a recent history of
substantial weight loss are the most
constant features. The severity of
symptoms often leads to the diag
nosis of an expanding or ruptured
aneurysm. Rupture among these
patients, however, appears to be

less frequent than among patients
with noninflammatory aneurysms.
Symptoms of ureteral obstruction
are found in 25% of patients with
inflammatory aneurysms and were
often the presenting symptom in
the sporadic case reports prior to
Walker’s description.5
Despite the increased awareness
of this entity and availability of
accurate imaging techniques for
structures in the retroperitoneum,
the diagnosis of inflammatory aneu
rysm is usually made intraoperatively. Computed tomography (CT) is
currently the most accurate test for
identifying an inflammatory aneu
rysm and has a reported sensitivity
of 70% to 80%.4-6-8 Our experience
with CT in diagnosing inflammatory
aneurysms is similar to that report
ed from other centres where the
radiologic diagnosis was frequently
made only in retrospect. Careful
inspection of the transmural thick
ness on the computed tomogram
should improve the ability to make
the correct diagnosis preoperatively. Excretory urography and ul
trasonography may assist in the
preoperative diagnosis although the
sensitivity of these tests is less than
that of CT.
An elevated erythrocyte sedimen
tation rate has often been described
as a reliable marker for inflammato
ry aortic aneurysm. Pennell and
colleagues4 found such an elevation
in nearly three-quarters of patients
with inflammatory aneurysms, but
also in one-third of patients with

T a b le 1. C o m p a ris o n o f P a tie n ts W ith In fla m m a to ry and N o n in fla m m a to ry A b d o m in a l A o rtic
A n e u ry s m s

M ea n age, y r
M a le /fe m a le
P resence o f s y m p to m s
R upture
C la m p tim e , m in
B lo o d re p la c e m e n t, m l
O perative d e a th s
R uptured
In ta ct

In fla m m a to ry
(n = 2 5 )

N o n in fla m m a to ry
(n = 4 1 4 )

66
2 4 /1
1 3 (5 2 % )
1 (4 % )
97
3965
2 (8 % )
1
1

68
3 4 4 /7 0
9 5 (1 7 % )
7 5 (1 8 % )
85
3004
3 6 (9 % )
23
13

p valu e
NS
0 .0 6 7
< 0 .0 1
0 .0 7
NS
< 0 .0 2
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the noninflammatory type. The pos
itive predictive value of this test
would then appear to be less than
10% and therefore of no value in
the diagnosis. The pathognomonic
features of inflammatory aneurysms
are easily recognized when the retroperitoneum is exposed at surgery
or autopsy. Figure 1 illustrates the
classic porcelain appearance with
the anterior wall of the aneurysm
covered by a shiny, white, pearly
tissue. The surrounding viscera,
particularly the duodenum, are ede
matous and densely adherent. The
normal anatomical planes of loose
areolar tissue that usually allow
separation of the periaortic struc
tures are obliterated, and the mes
entery of the small bowel around
the aneurysm is often thickened
and shortened. In addition to the
duodenum, the ureters, vena cava,
renal vein and sigmoid colon are
often fixed to the inflammatory
process surrounding the aneurysm.
The desmoplastic reaction about
the aneurysm involves only the an
terior and lateral walls. The wall of
the aneurysm in these areas is usu
ally three to four times its normal
thickness and may have a transmu
ral diameter as great as 4 cm.4’7 The

posterior wall is thinned and is the
point of disruption when rupture is
encountered. Histologic examina
tion reveals that the majority of the
aneurysm wall is a thickened adven
titia characterized by a chronic in
flammatory process with lympho
cyte and plasma cell infiltration.
There is an associated endarteritis
of the adventitial vessels and neuro
nal entrapment.
The gross and microscopic fea
tures of inflammatory aneurysms
have generated various theories
about the etiology of this process.
The belief that the periaortic fibro
sis is a reaction to chronic extrava
sation of blood has been discounted
principally because it is rare to find
evidence of hemorrhage or hemo
siderin-laden macrophages in the
surrounding fibrotic reaction.34 The
possibility that this process is a
variant of Takayashu’s disease also
appears unlikely. Takayashu’s dis
ease affects young or middle-aged
women and usually involves the
branches of the aortic arch, while
inflammatory aneurysms are seen
almost exclusively in elderly men
whose disease is usually concentrat
ed in the abdominal aorta and prox
imal iliac arteries. Inflammatory an

FIG. 1. Inflammatory aneurysm showing typical shiny white appearance and
inflammatory reaction involving periaortic structures (duodenum — single arrow
head, megacolon — double arrowheads).

eurysms have been grouped in the
pathology literature with idiopathic
retroperitoneal fibrosis and chronic
periarteritis under the heading of
chronic periaortitis.9 Although
there are similarities among these
disease processes, there are distinct
differences. Inflammatory aneu
rysms exhibit a true aneurysmal
dilatation of the aorta associated
with a marked thickening of the
anterior and lateral aortic wall and
desmoplastic reaction of the pe
riaortic retroperitoneum. Patients
with idiopathic retroperitoneal fi
brosis do not usually have an aneu
rysmal aorta and the fibrotic reac
tion completely encases the aorta
and vena cava without sparing the
posterior aortic wall. Tissue planes
between the inflammatory process
and the great vessels, preserved in
idiopathic fibrosis, are obliterated in
patients with inflammatory aneu
rysms, and this accounts for the
great technical difficulty encoun
tered during repair, borne out in
this and other series by prolonged
aortic clamp times and greater oper
ative blood loss. The basic princi
ples of safe repair of inflammatory
aneurysms are described in the re
cent vascular surgical litera
ture. 1’2-4-5’8 The crucial component
of safe repair is the prevention of
injury to adherent structures by
avoiding the duodenum entirely and
achieving control of the aorta above
the involved area. Special tech
niques for obtaining proximal and
distal aortic control such as sub- or
supradiaphramatic cross-clamping
and distal occlusion using a balloon
catheter have also been described.
These techniques are usually not
necessary but may be of help when
the inflammatory process extends
beyond the infrarenal aorta. If the
diagnosis is made preoperatively,
ureteral catheterization is suggest
ed, particularly if there is evidence
of obstruction. The value of this
approach is confirmed by the reCJS, VOL. 33, NO. 3, JUNE 1990
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duced morbidity and mortality of
recent reports and in the present
series. Our results indicate that
there was no increased morbidity or
mortality for patients with inflam
matory compared with noninflam
matory abdominal aortic aneurysm.
It has been suggested that rup
ture of inflammatory aneurysms is
an infrequent event and that the
indications for elective repair may
be modified in such patients with
out serious consequences. The
point is controversial, however, and
there are several reports that show
no significant difference in rupture
rates between the two types.61011
Steroid therapy has been suggested
to reduce the inflammatory compo
nent, and perhaps reduce the poten
tial hazard of surgical repair, but
this too, remains controversial.12 It
appears that a modified surgical
technique to deal with the inflam
matory aneurysm results in no
greater hazard to the patient than
occurs during repair of a noninflam
matory aneurysm. It seems appro
priate, therefore, to recommend
surgical repair of aneurysms with
out regard for the presence of an
inflammatory type.

Summary
Inflammatory aneurysms are an
important form of abdominal aortic
aneurysms that demand respect and
a modified surgical approach if re
pair is to be effected without major
complication. Patients with this
process are more often symptomatic
than are patients with the nonin
flammatory counterpart, and they
occur almost exclusively in males.
Although the presentation may
mimic rupture, disruption of the
aortic wall occurs less commonly
than among patients with nonin
flammatory aneurysms. The wide
spread use of CT scans for diagno
sis may lead to increased recogni
200
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tion of the variation preoperatively.
Surgical repair is alone difficult but
can proceed with the same morbidi
ty and mortality as that associated
with repair of noninflammatory an
eurysms.

T h is Publication
is available in
M icroform .
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Factors Affecting Survival After Rupture
of Abdominal Aortic Aneurysm: Effect of
Size on Management and Outcome
John Lawlor Murphy, MD, FRCSC;* George Graeme Barber, MD, FRCSC;f
Neil Virden McPhail, MD, FRCSC;$ Thomas Keith Scobie, MD, FRCSC§
Between 1970 and 1 9 85 ,1 72 consecutive patients (146 men, 26 women) underwent
repair o f ruptured abdominal aortic aneurysms. The mean age was 69.8 years. The
overall death rate was 49.4%. The most significant predictors of death were an
intraoperative urine output under 100 ml, systolic blood pressure less than 90 mm
Hg on admission or in the operating room, cardiac arrest and a history of collapse.
Discriminant analysis correctly classified 90% o f the survivors and 84% of the
nonsurvivors.
Aneurysm size was documented in 133 cases; the average diameter was 8.78 cm,
and 13 (10%) of the aneurysms were smaller than 6.0 cm. A correct diagnosis was
made preoperatively in 46% o f these 13 cases compared with 77% overall (p < 0.05),
and the time from arrival to transfer to the operating room was 6.71 versus 2.37
hours (p < 0.05). The death rate for patients who had the small aneurysms was 77%
versus 45% for those with larger aneurysms (p < 0.06).
This study confirms the continuing poor results after repair of ruptured
abdominal aortic aneurysms. A subset of patients having small aneurysms (less than
6.0 cm) require an aggressive approach to diagnosis and treatment.

De 1970 a 1985, 172 patients consecutifs (146 hommes et 26 femmes) ont subi la
reparation d’une rupture d’un anevrisme de I’aorte abdominale. Leur age moyen
etait de 69.8 annees. La mortality globale a ete de 49.4%. Les facteurs previsionnels
de deces les plus importants furent: un debit urinaire peroperatoire inferieur a 100
ml, une hypotension (a moins de 90 mm Hg) lors de l’admission ou dans le bloc
operatoire, un arret cardiaque ou des antecedents de collapsus. Une analyse
discriminante a permis de classifier correctement 90% des survivants et 84% des non
survivants.
La taille de l’anevrisme a ete determine dans 133 cas; 13(10% ) etaient inferieurs a
6.0 cm et la taille moyenne etait de 8.78 cm. Les 13 petits anevrismes ont ete
correctement diagnostiques dans 46% des cas comparativement a 77% pour
l’ensemble (p < 0.05), alors que le delai entre l’admission et l’operation a ete de
6.71 heures comparativement a 2.37 heures (p < 0.05). La mortality chez les
patients porteurs de petits anevrisme a ete de 77%, alors qu’elle etait de 45% pour
ceux qui avaient de gros anevrismes (p < 0.06).
Cette etude confirme que les resultats de la reparation des ruptures d’anevrismes
de l’aorte abdominale sont encore mauvais. II existe un sous-groupe de patients
porteurs de petits anevrismes qui necessite que Ton approche le diagnostic et le
traitement de fa?on agressive.

upture of abdominal aortic an
eurysms accounts for less than
1% o f deaths annually.1 The inci
dence increases with age, to
1 .3 6 /1 0 0 0 for those older than 90
years.1 Reported death rates for
patients reaching hospital range be
tween 15% and 68%,23 averaging
50%. Overall death rates are likely
higher, because a considerable pro
portion o f patients may die at home,
as suggested by Ingoldby and col
leagues.4
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The in-hospital death rate has
not changed significantly in the
past decade. The principal determi
nants of outcome reflect general
health and degree of shock. We
attempted to prognosticate in such
a group of patients in the hope of
developing formulas that would reli
ably predict outcome and therefore
be useful in selected cases to guide
intervention.
Aneurysm size, measured by ul
trasonography or computed tomog
raphy, is a major determinant of
therapy for asymptomatic abdomi
nal aortic aneurysms. The effect of
size documented intraoperatively on
management and outcome was as
sessed.

Patients and Observations
An abdominal aortic aneurysm
was considered ruptured when
blood was present outside the aortic
adventitia in the retroperitoneum or
peritoneal cavity. All patients with
ruptured aneurysms were taken to
the operating room promptly for
surgical exploration. Investigations
were usually limited to a complete
blood count, determination of the
prothrombin and partial thrombo
plastin times, the platelet count and
the electrolyte levels, cross-match
ing of the blood and electrocardiog
raphy. Further investigations were
seldom required, as this was a clini
cal diagnosis. Therapeutic measures
included establishment of adequate
intravenous access, administration
of fluids and antibiotics intrave
nously and insertion of a urinary
catheter. The patient was prepared
for surgery while the team
scrubbed, then anesthesia was in
duced and prompt laparotomy with
aortic control carried out. Monitor
ing devices such as an arterial line
and a Swan-Ganz catheter were
usually then inserted. During the
study period the surgery was car
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ried out by one of three full-time
vascular surgeons practising in a
vascular surgery unit.
Between 1970 and 1985, 172
consecutive patients (146 men
[85%] and 26 women [15%]) under
went an operation for a ruptured
abdominal aortic aneurysm. The av
erage age was 69.8 years. The pain
had persisted an average of 16.6
hours, and the principal location
was the abdomen in 43%, the back
in 31%, the lower quadrants of the
abdomen in 20% and other areas in
6%. There was a history of fainting
or collapse in 98 (57%). Cardiac
arrest had occurred preoperatively
(including at a referring hospital
before transfer) in 34 (20%). Associ
ated diseases, according to informa
tion available at the time of arrival
in the emergency department, in
cluded coronary artery disease (in
38%), hypertension (in 21%), chron
ic obstructive pulmonary disease (in
15%) and diabetes mellitus (in 6%).
In all but five patients the vascular
consultant had noted a pulsatile
mass that had not necessarily been
detected by the triage examination.
The systolic blood pressure at the
time of arrival averaged 88.4 mm
Hg.
The correct diagnosis by the
emergency department physician
was considered to have been made
when the patient was promptly re
ferred to a vascular surgeon as the
first consultant; this occurred in
77% of cases. The patients were
transferred to the operating room
an average of 2.37 hours after
arrival, 65 (40%) of them in less
than 30 minutes. The average sys
tolic blood pressure at the time of
induction of anesthesia was 97.8
mm Hg.
In 47 cases (27%) free intraperitoneal blood was found; the
quantity did not necessarily reflect
frank anterior rupture of the aorta.
The diameter of the aneurysm, doc
umented in all but 39 cases, aver

aged 8.78 cm. The most common
associated vascular abnormalities
were common iliac aneurysms (pres
ent in 63 [37%] of the 172 cases).
In three cases transthoracic control
of the aorta was obtained. Although
the operative procedure was most
commonly bi-iliac grafting, the fre
quency of tube grafting has in
creased in recent years; aortic bifur
cation grafting was done in 134
cases, aortic tube grafting in 14,
axillobifemoral grafting in 5 and
other procedures in 4. In 15 cases
only laparotomy was performed; su
prarenal aneurysms were present in
8 of these cases. On average 6.0 L
of blood was lost, 8.4 L of fluid
replaced, 11.3 units of blood re
placed and 636.9 ml of urine
passed.
The complication rate was sub
stantial. Of the 59 patients with
cardiac complications 38 had myo
cardial infarction and 19 had ar
rhythm ias requiring therapy.
Among the 53 patients with acute
renal insufficiency and the 2 with
nephrotic syndrome 21 underwent
hemodialysis; 5 survived. The 53
patients with pulmonary complica
tions had, by definition, at least one
of atelectasis, pneumonia, effusions
and prolonged intubation. The 15
patients with coagulopathies had
undergone massive transfusion;
only 2 survived. The 11 patients
with sepsis had multiple organ fail
ure.

Outcome
The rate of survival to hospital
discharge was 51%. Of the 85
deaths 20 occurred in the operating
room and 8 more than 30 days after
surgery.
The mortality data were analysed
for prognostic significance of the
independent variables with use of
the x2 test and Yates’ correction.
The results are shown in Table I in

RUPTURED ABDOMINAL AORTIC ANEURYSM

would survive in 69% of the cases,
the false-positive and false-negative
rates were high; 25% of the patients
predicted not to survive did survive
and 38% of the patients predicted to
survive actually died. The second
formula, with additional variables
obtained intraoperatively, was cor
rect in 87% of its predictions; how
ever, its false-positive rate (10%)
and false-negative rate (16%) ren

descending order of statistical sig
nificance.
With the use of Wilkes’ A and
the F statistic, variables were select
ed for use in canonial discriminant
function to construct formulas for
prognostication (Table II). The first
formula was based on information
available in the emergency depart
ment. Although it was correct in
predicting whether the patient
T a b le 1.

Independent Variables for Patients With Ruptured Abdominal Aortic Aneurysms in
Descending Order of Prognostic Significance

V a ria b le

Intraop urine
output, < 100 ml
Intraop systolic blood pressure,
mm Hg
Highest < 100
Lowest < 60
Preop cardiac arrest
Postop renal failure
Preop collapse
Previous diagnosis;
surgery not done
Systolic blood pressure
< 90 mm Hg on arrival
Age, yr
< 65
6 5 -7 5
> 75
> 20 units blood replaced
Blood loss < 8 L

No. of s u r
vivors (n = 8 7 )

N o. of non su r
vivors (n = 8 5 )

4

32

p v a lu e *
<

0
24
7
15
38
4

18
50
27
38
60
21

< 0.0001
< 0.0001
< 0.0002
< 0.0002
< 0.0005
< 0.0005

38

57

<

0.005

34
32
21
2
8

14
42
29
14
20

<

0.005

<0.01
<0.05

Correlation Coefficients in Descending Order of Contribution to Discriminant Analysis
Formulas*
F o rm u la 2: fo rm u la 1 +
o p e ra tiv e d a ta

F o rm u la 1: e m e rg e n c y
d e p a rtm e n t data

Cardiac arrest
Collapse
Pulse rate
Age
Systolic blood pressure
In emergency dept
Difference between emergency
dept and operating room

(0.76)
(0.70)
(0.54)
(0.50)
(0.48)
(0.28)

Cardiac arrest
Acute renal failure
Lowest systolic blood pressure in
operating room
Pulse rate
Urine output in operating room
Collapse
Systolic blood pressure in
emergency dept
Highest systolic blood pressure in
operating room
Free intraperitoneal blood
Age
Systolic blood pressure at
induction of anesthesia
Units blood transfused
Correct diagnosis
Blood loss
Vascular abnormalities

'Variables were selected with the use of Wilkes' X and the F statistic.

Discussion

0.0001

*ln x z testing with Yates’ correction.

T a b le II.

dered it quite imprecise for clinical
application.
Of the 133 aneurysms whose size
was documented 13 were less than
6.0 cm in diameter. The 13 patients
were more likely to die and less
likely to receive a correct diagnosis;
consequently, their time between
arrival in the emergency department
and transfer to the operating room
was longer, and more of them had a
low urine output in the operating
room (Table III).

(0.45)
(0.42)
-(0 .3 6 )
(0.34)
-(0 .3 4 )
(0.34)
-(0 .3 4 )
-(0 .3 3 )
(0.29)
(0.24)
-(0 .2 4 )
(0.16)
(0.12)
(0.11)
(0.04)

The factors influencing outcome
after rupture of an abdominal aortic
aneurysm have been evaluated ex
tensively and can be grouped into
three categories: physiologic status
(e.g., age and associated diseases)
before rupture, degree of hypovo
lemic shock (e.g., fainting or col
lapse, systolic blood pressure in the
emergency department and urine
output in the operating room), and
promptness of diagnosis and treat
ment. A study like ours, based on
emergency department histories,
lacks the sophisticated preoperative
data available to other vascular sur
geons predicting outcome.5
Although we found age to be
independently significant the issue
is contentious in the literature. Au
thors such as Mannick and associ
ates6 have suggested that age is not
a major factor; others2-7 have dis
agreed. Selection may also be in
volved: Ingoldby and colleagues4
noted that only 5 of 70 patients
older than 75 years survived to
reach hospital. The influence of age
in our discriminant analysis for
mulas was limited. Therefore, age
alone should not be a deterrent to
surgery.
The prevalence of associated dis
eases is likely understated for our
group of patients as compared with
similar groups.7' 10 A history of corCJS, VOL. 33. NO. 3, JUNE 1990
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onary artery disease, hypertension,
chronic obstructive pulmonary dis
ease or diabetes mellitus did not
affect the likelihood of survival
among our patients. Variables dem
onstrating the degree of shock,
however, were highly significant
predictors and were the major con
tributors to the prognostic for
mulas. Similar observations have
been made by Donaldson and as
sociates7 and by Wakefield and col
laborators.11
The correct diagnosis was made
promptly by 77% of the emergency
department physicians, an improve
ment from the 68% documented
earlier.8 Although misdiagnosis has
been found by others to affect out
come adversely12 it was not a statis
tically significant factor in our
group of patients. The average time
from arrival to transfer to the oper
ating room, 2.37 hours, compares
well with figures in other reports711
and was also not a significant fac
tor.
Although the type of operation
was not significant the finding of
free intraperitoneal blood was a

major contributor to the prognostic
formulas. The importance of exces
sive blood loss and degree of blood
and crystalloid resuscitation has
previously been noted.3811 Howev
er, 28% of the patients in our study
who lost more than 8 L of blood
survived, and the contribution of
the degree of blood loss to the
prognostic formulas was limited.
Donaldson and colleagues7 found
an accuracy of 70% in predicting
outcome on the basis of age, hema
tocrit and blood pressure at the
time of admission. They also noted
that the outcome was very poor if
the systolic blood pressure fell
below 100 mm Hg.
Shackleton and colleagues13 con
structed a formula from the data for
106 unselected patients using step
wise logistic regression and were
able retrospectively to classify the
patients into one of four risk
groups. The most significant varia
bles were level of consciousness
before transfer to the operating
room, history of congestive heart
failure and unmeasured anion gap.
The death rates for the four groups

T a b le III. E ffe c ts o f A n e u ry s m S ize o n P re se n ta tio n and O u tc o m e
A n e u rys m d ia m e te r, cm *
V a r ia b le

< 6 .0 (n = 13)

> 6 .0 (n = 1 2 0 )

p v a lu e t

Age > 7 5 yr
A s s o c ia te d co ro n a ry a rte ry d is e a s e
C o lla p s e
P re o p c a rd ia c arrest
S y s to lic b lo o d p re ss u re < 9 0 m m Hg in
e m e r g e n c y dept
D e te c ta b le m ass
S y s to lic b lo o d p re ss u re < 9 0 m m Hg in
o p e ra tin g room
F re e in tra p e rito n e a l b lo o d
B lo o d lo s s > 7 L
A s s o c ia te d va scu la r a b n o rm a litie s
T u b e g ra ftin g
U rin e o u tp u t < 1 0 0 m l in o p e ra tin g
ro o m
C o r r e c t dia g n o sis
D e a th ra te

3 0 .8
3 0 .8
7 6 .9
1 5 .4
6 1 .5

2 6 .7
4 1 .9
5 7 .3
1 9 .0
5 4 .2

NS
NS
NS
NS
NS

9 2 .3
3 8 .5

9 7 .3
4 0 .0

NS
NS

23.1
2 5 .0
23.1
23 .1
3 8 .5

3 1 .4
2 7 .6
5 1 .4
5 .9
1 8 .4

NS
NS
< 0 .1 2
< 0 .1 5
< 0 .0 5

4 6 .2
7 6 .9

7 6 .7
4 5 .0

< 0 .0 5
< 0 .0 6

M a le /fe m a le ratio
T im e b e tw e e n a rriv a l in e m e rg e n c y d e p t
a n d tra n s fe r to o p e ra tin g ro o m , h

1 0 /3
6.71

1 0 4 /1 6
2 .3 4

NS
< 0 .0 5

* % o f p a tie n ts.
t In x 2 te stin g w ith Y a te s ’ c o rre c tio n ; NS = n o t s ig n ific a n t.
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were 100%, 75%, 28% and 12%;
with the two high-risk and the two
low-risk groups combined the rates
were 78% and 20%. The authors
cautioned against clinical applica
tion of this information. For the
group at highest risk the death rate
of 100% suggests that intervention
is futile; however, only 5 of the 106
patients were so classified.
With discriminant analysis we
constructed two predictive for
mulas. Medical information avail
able in the emergency department,
such as a history of congestive
heart failure, was unhelpful in the
statistical analysis. Since their false
positive rates proved to be very
high, the formulas have limited
practicality and would likely per
form less well prospectively.
The classification developed by
Fitzgerald, Stillman and Powers3
could not be applied retrospectively.
Thus, we cannot predict outcome
reliably and can only advocate ag
gressive management, namely
transfer to the operating room.
The average diameter of the 133
abdominal aortic aneurysms in our
series for which the size was docu
mented was 8.78 cm, similar to the
average in previous reports.27911
The 13 aneurysms less than 6.0 cm
in diameter represented 10% of the
total, a figure similar to that in the
autopsy study by Darling.14 The
death rate was 77% for our 13
patients and 75% for the 12 pa
tients studied by Cronenwett and
associates15 who had small aneu
rysms that became acutely tender or
ruptured during conventional fol
low-up. Emond and associates16
suggested that there is an average
of 8.2 mm of undersizing in 66% of
preoperative ultrasonograms and
computed tomograms compared
with intraoperative measurements.
The only factors that we identified
as contributing to the high death
rate in the patients with small ab
dominal aortic aneurysms were in-

RUPTURED ABDOMINAL AORTIC ANEURYSM

correct diagnosis and consequent
delay in transfer to the operating
room and low intraoperative urine
output. Hiatt and collaborators12
noted that misdiagnosis and delay
adversely affected outcome in their
29 patients with small abdominal
aortic aneurysms, 9 of whom died.

Conclusions
Abdominal aortic aneurysms con
tinue to carry a high death rate
after rupture; in our series the
figure was 51%. The major contrib
uting factors remain the degree of
shock and subsequent renal insuffi
ciency. Our ability to predict out
come is very limited, and aggressive
surgical treatment remains the pre
ferred approach.
Small abdominal aortic aneu
rysms do rupture and seem to carry
a high death rate that is related to
delays in diagnosis and treatment.
This small subset may benefit from
an ultrasonographic diagnostic
screening program.
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Claforan
P R E S C R IB IN G IN F O R M A T IO N
Action
In vitro studies indicate that the bacterial action of Claforan (cefotaxime sodium) a semi synthetic cephalosporin
antibiotic, results from inhibition of cell wall synthesis.
Indications and Clinical Uses
T reatm ent: Claforan (cefotaxime sodium) may be indicated for the treatment of infections caused by susceptible
strains of the designated micro organisms in the diseases listed below.
Lower respiratory tract infections : pneumonia and lung abscess caused by Streptococcus pneumoniae
(formerly Diplococcus pneumoniae), other streptococci (excluding enterocci, eg. S. faecalis), Straphylococcus
aureus (penicillinase and non penicillinase producing), Escherichia coli, Hemophilus influenzae, (including
ampicillin resistant strains) and unspecified Klebsiella species.
U rinary tract in fe c tio n s: caused by Escherichia coli, unspecified Klebsiella species (including K. pneumoniae),
Proteus mirabilis, indole positive Proteus, Serratia marcescens and Staphylococcus epidermidis. Also, uncomplicated
gonorrhea caused by N. gonorrhoeae including penicillin resistant strains.
B acte re m ia /S e p tice m ia : caused by Escherichia coli, unspecified Klebsiella strains and Serratia marcescens
Skin in fe c tio n s : caused by Staphylococcus aureus (penicillinase and non penicillinase producing, S. epidermidis,
Group A streptococci, Escherichia coli, Proteus mirabilis and indole positive Proteus.
Intra-abdom inal infections: caused by Escherichia coli, and unspecified Klebsiella species.
Gynecological infe c tio n s: including pelvic inflammatory disease, endometritis and pelvic cellulitis caused by
E. coli, Group A streptococci and Staphylococcus epidermidis; anaerobic bacteria including unspecified Peptococcus
and Peptostreptococcus strains and some strains of Bacteroides fragilis. In several cases, although clinical cures
were achieved, bacteriological follow-up was not available.
Central nervous system in fe c tio n s: meningitis and ventriculitis caused by Haemophilus influenzae, Neisseria
meningitidis, Streptococcus pneumoniae, Klebsiella pneumoniae and Escherichia coli. Claforan is not active
against Listeria monocytogenes.
Clinical experience with Claforan in anaerobic infections is limited. Claforan has been used with some success in
wound and intra-abdominal infections against some strains of unidentified Bacteroides and anaerobic cocci.
Claforan has been shown to be active against some strains of Pseudomonas.
In the treatment of infections encountered in immunosuppressed and granulocytopenic patients, results of therapy
with Claforan have not been impressive.
Claforan should not be considered in the treatment of enterococcal infections, i.e. Streptococcus laecalis.
Specimens for bacteriologic culture should be obtained prior to therapy in order to isolate and identify the causative
organisms and to determine their susceptibilities to Claforan. Therapy may be instituted before results of susceptibility
studies are known; antibiotic treatment should be re evaluated once these results become available.
Prophylactic U s e : The administration of Claforan perioperatively (preoperatively, intraoperatively and postoperatively)
may reduce the incidence of certain infections in patients undergoing elective surgical procedures (e g. abdominal
or vaginal hysterectomy, gastrointestinal and genitourinary tract surgery) that may be classified as contaminated or
potentially contaminated.
In patients undergoing caesarian section who are considered to be at increased risk of infection, intraoperative
(after clamping the umbilical cord) and postoperative use of Claforan may also reduce the incidence of certain
postoperative infections.
Effective use for elective surgery depends on the time of administration (see Dosage and Administration).
For patients undergoing gastrointestinal surgery, preoperative bowel preparation by mechanical cleansing as well as
with a non-absorbable antibiotic (e.g. neomycin) is recommended.
If there are signs of infection, specimens for culture should be obtained for identification of the causative organism
so that appropriate therapy may be instituted.
Contraindications
Claforan is contraindicated in patients who have shown hypersensitivity to cefotaxime sodium, the cephalosporin
or the penicillin groups of antibiotics.
Warnings
Before therapy with Claforan is instituted, it must be carefully determined whether the patient has had previous
hypersensitivity reactions to cefotaxime, cephalosporins, penicillins or other drugs. Claforan should be given with
caution to patients with Type 1 hypersensitivity reactions to penicillin. Antibiotics, including Claforan should be
administered with caution to any patient who has demonstrated some form of allergy, particularly to drugs. If an
allergic reaction to Claforan occurs, the drug should be discontinued and the patient treated with the usual agents
(e.g. epinephrine, antihistamine, pressor-amines or corticosteroids).
Pseudom em branous colitis has been reported w ith the use of cephalosporins (and other broad spectrum
antibiotics); therefore, it is im portant to consider its diagnosis in patients who develop diarrhea during
the adm inistration of Claforan. This colitis can range from m ild to life-threatening in severity.
Treatment with broad spectrum antibiotics, such as Claforan, alters the normal flora of the colon and may permit
overgrowth of Clostridium difficile or other Clostridia, it has been established that a toxin produced by Clostridium
difficile is one primary cause of antibiotic-associated colitis.
Mild cases of colitis may respond to discontinuation of Claforan and replacement with a suitable specific antibiotic.
Moderate to severe cases should be managed with fluid, electrolyte and protein supplemntation as indicated.
When the colitis is not relieved by discontinuance of Claforan administration or when it is severe, an antibiotic
specifically effective in antibiotic-associated pseudomembranous colitis (e.g. vancomycin) or other suitable therapy
may be indicated. Other possible causes of colitis should also be considered (see Adverse Reactions).
Precautions
Claforan (cefotaxime sodium) should be prescribed with cauton in individuals with a history of lower gastro
intestinal disease, particularly colitis.
The safety of Claforan in pregnancy has not been established. Consequently, use of the drug in pregnant women
requires that the likely benefit from the drug be weighed against the possible risk to tne mother and fetus.
Use of Claforan in women of child-bearing potential requires that the anticipated benefits be weighed against the
possible risks.
Cefotaxime is excreted in human milk in low concentrations. Caution should be exercised when the drug is
administered to nursing mothers.
Prolonged use of Claforan may result in the overgrowth of nonsusceptible organisms. Constant evaluation of the
patient's condition is essential. If super-infection occurs, therapy should be discontinued and appropriate measures
taken.
Although Claforan rarely produces alterations in kidney function, evaluation of renal status is recommended,
especially in severely ill patients receiving high doses.
Patients with markedly impaired renal function should be placed on the special dosage schedule recommended
under Dosage and Administration, because normal dosage in these individuals is likely to produce excessive and
prolonged serum antibiotic concentrations.
Positive direct Coomb’s test is known to develop in individuals during treatment with the cephalosporin group of
antibiotics, including cefotaxime sodium
In laboratory tests a falso positive reaction to glucose may occur with reducing substances but not with the use
of specific glucose oxidase methods.
Adverse Reactions
The most frequent adverse reactions with their frequency of occurrence are:
H ypersensitivity (1.8%); Rash, pruritus, fever. Local (5%): Injection site inflammation with intravenous
administration Pam, induration and tenderness after intramuscular injection. Gastrointestinal (1.7%); Colitis,
diarrhea, nausea and vomiting. Symptoms of pseudomembranous colitis can appear during or after Claforan
treatment. Hemic and Lymphatic System ( < 1 % ). Mild, reversible leukopenia, granulocytopenia and thrombo
cytopenia have been reported. Some patients developed positive direct Coomb's test during treatment with
Claforan G enitourinary System ( < 1%): Moniliasis, vaginitis. Liver ( < 1%); Transient elevations in SGOT, SGPT,

serum LDH and serum alkaline phsphatase levels have been reported. Kidney ( < 1%). Increased serum creatinine
and BUN have occasionally been observed. Central Nervous System (0.2%): Headache.
Symptoms and Treatment of Overdosage
Since no case of overdosage has been reported to date with Claforan, no specific information on symptoms or
treatment is available. Treatment of overdosage should be symptomatic.
Dosage and Administration
Claforan (cefotaxime sodium) may be administered intramuscularly or intravenously after reconstitution (see Table
with recommended mode of reconstitution according to route of administration)
Adults
The dosage of Claforan should be determined by susceptibility of the causative organisms, severity of the infection
and condition of the patient.
Guidelines for Dosage of Claforan (cefotaxime sodium)
Daily Dose
Type of Infection

(g )

Frequency and Route

Uncomplicated Gonorrhea

1

Uncomplicated infections

2

1 g every 12 hours IM or IV

3-6

12g every 8 hours IM or IV

6-8

2g every 6-8 hours IV

Moderately severe to severe infections
Very severe infections (e.g. septicemia, CNS)
Life-threatening infections

up to 12

1 g IM (single dose)

2g every 4 hours IV

To prevent postoperative infection in contaminated or potentially contaminated surgery, recommended doses are
as follows.
(a) 1 g IM or IV administered 1/2 to 1-1/2 hours prior to the initial surgical incision to ensure that adequate
antibiotic levels are present in the serum and tissues at the start of surgery
(b) 1 g IM or IV administered 1-1/2 to 2 hours following the first dose; for lengthy operative procedures, additional
intraoperative doses may be administered, if necessary, at appropriate intervals (1-1/2 to 2 hours) during surgery
(c) 1 g IM or IV administered within 2 hours following completion of surgery
The total cumulative prophylactic dose should not exceed 6g in a 12 hour period
Caesarian Section Patients
The first dose of 1 g is administered IV as soon as the umbilical cord is clamped. The second and third doses
should be given as 1 g IM or IV at 6 and 12 hours after the first dose.
Neonates, Infants, and Children
The following dosage schedule is recommended:
Neonates:
0-1 week of age
50 mg / kg IV q 12 h
1-4 weeks of age
50 mg / kg IV q 8 h
Infants and children (1 month to 12 years): For body weights less than 50 kg, the recommended daily dose is
50 to 100 mg / kg IM or IV of body weight divided into 4 to 6 equal doses, or up to 180 mg / kg/day for severe
infections (including central nervous system infections).
For body weights 50 kg or more, the usual adult dosage should be used.
The maximum daily dosage should not exceed 12 grams.
Administration of Claforan should be continued for a minimum of 48 to 72 hours after the patient defervesces or
after evidence of bacterial eradication has been obtained; a minimum of 10 days of treatment is recommended for
infections caused by Group A beta-hemolytic streptococci in order to guard against the risk of rheumatic fever or
glomerulonephritis; frequent bacteriologic and clinical appraisal is necessary during therapy of chronic urinary
tract infections and may be required for several months after therapy has been completed; persistent infections may
require prolonged treatment. Doses less than those recommended should not be employed.
Dosage for Patients with Impaired Renal Function
In patients with estimated creatinine clearance of less than 20 mL / min / 1.73m? the dose of Claforan should be
halved (see Precautions).
If serum creatinine values alone are available, the following formula (based on sex, weight, and age of the patient)
may be used to convert these values into creatinine clearance.
Males;

Weight (kg) x (140 - age)

Females;

0.85 x above value

72 x serum creatinine
Administration
Intra m uscular: Claforan should be injected well within the body of a relatively large muscle such as the upper
outer quadrant of the buttock (i.e. gluteus maximus); aspiration is necessary to avoid inadvertent injection into a
blood vessel
Intravenous: The intravenous route is preferable for patients with bacteremia, bacterial spticemia, or other severe
or life-threatening infections, or for patients who may be poor risks because of lowered resistance resulting from
such debilitating conditions as malnutrition, trauma, surgery, diabetes, heart failure, or malignancy, particularly if
shock is present or impending.
For bolus administration a solution containing 1 or 2 g of Claforan can be injected over a period of 3 to 5 minutes.
Using an infusion system, it may also be given over a longer period of time through the tubing system by which
the patient may be receiving other intravenous solutions. Butterfly* or scalp vein type needles are preferred for this
type of infusion. However, during infusion of the solution containing Claforan, it is advisable to discontinue
temporarily the administration of other solutions at the same site.
ADD-Vantage* Vial
When administering Claforan using the ADD-Vantage* Drug Delivery system, Claforan powder is added directly to a
single-dose flexible plastic ADD-Vantage* diluent container. Claforan 1 g or 2 g may be reconstituted in 50 mL or
100 mL of 5% Dextrose Injection USP or 0.9% Sodium Chloride Injection USP
Stability
Solutions of Claforan reconstituted in 5% Dextrose Injection USP or 0.9% Sodium Chloride Injection USP in the
ADD-Vantage* flexible containers maintain satisfactory potency for 12 hours at room temperature.
Availability
Claforan (cefotaxime sodium) is supplied as a sterile, white to pale yellow powder, in vials containing 500 mg,
1.0 and 2.0 g of cefotaxime sodium and in ADD-Vantage* vials containing 1.0 and 2.0 g of cefotaxime sodium
(expressed as acid on a dry basis).
S to ra g e : Claforan in the dry state should be stored at room temperature protected from light and heat.
Product monograph available on request.
Reference
Jones R.N. et a l.; Antibiotic Prophylaxis of 1036 Patients Undergoing Elective Surgical Procedures.
The American Journal of Surgery, 1987; 153 341-346.
’ Reg’d TM of Abbott Laboratories.
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Heparin-Associated Thrombocytopenia
and Thrombosis: Optimal Therapy With
Ancrod
C.Wm. Cole, MD, FRCSC;* Lise M. Fournier, BScN, RVT;* Janis Bormanis, MD, FRCPCt
Heparin-associated thrombocytopenia and thrombosis (HATT) is an infrequent
occurrence but may have disastrous consequences. Continued therapy with heparin
must be avoided and anticoagulation achieved by alternative means. Among the few
alternatives to heparin in critically ill patients, the best is ancrod. Depletion of
fibrinogen with ancrod results in anticoagulation comparable to therapy with
heparin within 12 hours. In a small series, nine patients with HATT were treated
with ancrod; one underwent angiographic assessment, angioplasty and subsequent
vascular reconstruction. Ancrod therapy was not associated with bleeding
complications. It appears to provide optimal therapy for patients suspected of
having HATT.

La thrombocytopenie et la thrombose provoquees par l’heparine (TTPH) sont des
evenements rares, mais qui peuvent avoir des consequences desastreuses. La
poursuite du traitement a l’heparine doit etre evitee et l’anticoagulation obtenue par
d’autres moyens. Parmi le peu d’alternatives qui existent a l’heparine pour les
patients gravement malades, la meilleure est l’ancrod. La depletion du fibrinogene a
l’aide d’ancrod offre une anticoagulation comparable a celle de l’heparine en moins
de 12 heures. Un petit groupe de neuf patients souffrant de TTPH ont re?u un
traitement a l’ancrod; un d’entre-eux fut soumis a une angiographie et a une
angioplastie, et il subit par la suite une reconstruction vasculaire. II n’y eut aucune
complication hemorragique reliee a l’ancrod. Celui-ci semble offrir la meilleure
therapie pour les patients soup^onnes de souffrir de TTPH.

thrombocyto
H eparin-associated
penia and thrombosis (HATT)
is a rare complication of heparin
therapy, but one with dire conse
quences. In a recent review1 of
published cases the death rate was
estimated to be 29%, and the rate of

major morbidity, such as lower ex
tremity amputation, to be 21%.
These figures probably underesti
mate the incidence and risk. Be
cause of the life-threatening nature
of this complication, patients who
have thrombocytopenia while being
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treated with heparin must be con
sidered to be at risk for HATT and
be treated accordingly. All heparin
must be discontinued in such pa
tients, since exposure to even small
amounts is sufficient to perpetuate
the process. Unfortunately, there
are few alternatives to heparin in
the emergency situation. Coumadin
cannot be used in most critically ill
patients because it must be adminis
tered orally, and because its action
is delayed by 2 or 3 days in any
case. Antiplatelet agents, such as
acetylsalicylic acid (ASA) or dextran, have little to recommend them
as anticoagulants. The purpose of
this report is to describe the ratio
nale for treatment of patients with
HATT, using ancrod to deplete fi
brinogen, and to report the results
of treatment in nine such patients.

Mechanism of HATT
That thrombosis occurs in a pa
tient being treated with heparin is
paradoxical; it is coagulation in
stead of anticoagulation. If it is
going to develop, thrombocytopenia
is usually observed after several
days of heparin therapy, or upon
re-exposure after a brief interval.
Laboratory data support the prevail
ing theory that HATT is mediated
by a heparin-dependent immunoglobulin-G (IgG) or immunoglobulin-M (IgM) antibody that acts
against the heparin-platelet comCJS, VOL. 33, NO. 3, JU N E 1990
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plex, resulting in platelet activation
and aggregation.27 These observa
tions are consistent with an immune
mechanism, although some features
of the phenomenon are not clear.
For example, thrombosis occurs in
only a few patients with heparinassociated thrombocytopenia, and
does not always develop when the
patient is rechallenged. A possible
explanation may be that of a short
lived immune reaction.
Still, many of the elements that
make up the clinical picture of
HATT are well established. There is
a central role for platelets, which
aggregate abnormally and make up
the bulk of the resulting thrombus.8
Platelet-associated IgG can be mea
sured in most patients in whom
heparin-associated thrombocyto
penia is suspected, but because it is
also present in a variety of other
conditions that are characterized by
thrombocytopenia, it is not a useful
diagnostic test for HATT. The
mechanism of HATT appears to
involve an immune-mediated activa
tion of platelets, either directly, by
the appearance of an antibody
against the platelet-heparin com
plex, or indirectly, by a mechanism
causing endothelial injury.2 Ratio
nal therapy for patients with HATT
is directed towards inhibition of
pathologic platelet aggregation. For
example, Iloprost (ZK36374), a sta
ble analogue of prostacyclin,1011
has been used as a potent inhibitor
of platelet aggregation in patients
with HATT.12 Inhibition of platelet
aggregation by such agents does
not establish anticoagulation equal
to heparin, however, and they are at
best only a partial solution.

Rationale for Using Ancrod
Fibrinogen is indispensable in
platelet aggregation1314 and may be
a key element in adherence.15 The
initial binding of fibrinogen to
208
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platelets requires exposure of the
platelet membrane GPIIb—Ilia com
plex,16 which occurs in response to
adenosine diphosphate or to throm
bin, to which fibrinogen molecules
bind with high affinity.1718 Platelets
lacking these glycoproteins fail to
bind fibrinogen or aggregate.2 In
HATT, where pathologic platelet
aggregation and adherence are the
putative mechanisms, depletion of
fibrinogen would reduce the matrix
that links platelets during aggrega
tion or binds them to injured endo
thelial surfaces. Fibrinogen can be
safely depleted with ancrod. This
purified venom of the Malayan pit
viper (Agkistrodon rhodostoma)
acts enzymatically on the fibrinogen
molecule and cleaves off the fibrinopeptide A but not fibrinopeptide B, and it fragments the a-chain
of the fibrinogen-fibrin monomer.19
The result is a weak fibrin matrix
without cross-links that is rapidly
cleared by the native fibrinolytic
and reticuloendothelial systems. An
crod has no effect on other blood
coagulation factors20 and its clinical
use is not associated with a bleed
ing tendency. Indeed, surgical pro
cedures have been carried out suc
cessfully using ancrod.21

Patients and Methods
Nine patients suspected of having
HATT were treated with ancrod.
The diagnosis was made on the
basis of significant thrombocyto
penia and progressive thrombosis
while they were undergoing treat
ment with heparin. Heparin was
completely eliminated and, when
necessary, the patency of intra
arterial catheters was maintained by
infusing sodium citrate in saline,
instead of heparinized solutions.
Ancrod was administered intrave
nously in all cases, with an initial
infusion of 70 units over 12 hours,
followed by a maintenance dose of 3

to 4 units/h. This therapy was
monitored by regular determina
tions of the serum fibrinogen level
and prothrombin time. An attempt
was made to keep the fibrinogen
level between 0.2 and 0.4 g /L by
adjusting the ancrod dose. When
the fibrinogen level fell below 0.2
g/L , the prolonged prothrombin
time was used in making adjust
ments to the infusion rate.

Results
The relevant features of the nine
cases are outlined in Table I. Effec
tive anticoagulation was achieved
within 12 hours in all cases and no
bleeding complications were ob
served. In eight patients the throm
botic process was controlled with
ancrod, which was subsequently re
placed with Coumadin. One patient
died of causes unrelated to therapy
with ancrod. No patient required an
amputation.
In one case (no. 3, Table I) HATT
had been diagnosed when throm
bocytopenia and progressive throm
bosis developed while the patient
was being treated with heparin for
deep vein thrombosis, which had
occurred after coronary artery by
pass surgery. Symptoms of aortoiliac occlusive disease developed
while he was receiving long-term
Coumadin therapy. The Coumadin
was discontinued and ancrod substi
tuted. The patient underwent un
complicated transfemoral angiogra
phy and subsequent common iliac
balloon dilatation and femorofemoral bypass surgery, during which the
fibrinogen level was maintained at
less than 0.2 g/L . Coumadin was
restarted in the postoperative peri
od.

Discussion
When any patient being treated

ANCROD THERAPY FOR HATT

with heparin is found to have
thrombocytopenia and progressive
or new arterial or venous thrombo
sis, HATT should be suspected. At
present, the diagnosis of HATT is
based on clinical observation and
exclusion of other causes of throm
bocytopenia. Due to the high inci
dence of major morbidity, some
immediate therapeutic action is
necessary. Thrombolytic therapy
has been used successfully but this
should be followed by some alterna
tive form of anticoagulation. Other
therapies recommended for patients
who have HATT have included
agents that inhibit platelet cyclo
oxygenase, such as ASA, that in
crease cyclic AMP, like dipyrida
mole, or that are prostacyclin ana
logues, like Iloprost; but these
agents have had limited clinical ap
plications.1022
The specific advantages of ancrod
in patients with HATT lie in its
mechanism of action, which is com
pletely different from heparin. An
ticoagulation with ancrod is
achieved by fibrinogen depletion.
The drug does not degrade pre
formed thrombin or fibrin or the
coagulation factors. Fibrinogen is

T a b le 1.
P atien t
no.

1
2
3
4
5
6
7
8
9

removed from the pathologic proc
ess involved in HATT. Reducing
fibrinogen to low levels also reduces
blood viscosity, which may be of
added benefit in situations in which
intra-arterial thrombosis has caused
significant ischemia.23
Clinical experience with ancrod
worldwide is substantial, but be
cause it is not yet approved for use
in the United States, most physi
cians and surgeons in North Ameri
ca are unaware of its benefits. It is
available in Canada, however, and
has been used successfully in some
centres. Ancrod is an excellent sub
stitute for heparin because it pro
vides effective anticoagulation with
a low risk of bleeding or other
significant complication.24
Ancrod was obtained from Knoll Phar
maceuticals, Whippany, NJ.
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Relevant Features in Nine Patients Who Had Heparin-Associated Thrombocytopenia and Thrombosis (HATT)
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planned thoracotomy to investigate
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U se of h e p a rin
p re -H A T T

Lowest
p la te le t count, x 1 0 9/L

T

63.0

T

87.0

N/A

N/A

SC

17.0

Iliac angioplasty; femorofemoral bypass. Ancrod for
3 d pre- and intraoperatively and beginning
Coumadin again postoperatively. Discharged
Ancrod for 11 d then Coumadin. Discharged

T

56.0

Ancrod for 6 d then Coumadin. Died

SC

39.0

Ancrod for 9 d then Coumadin. Discharged

T
SC

54.0
101.0

Ancrod for 7 d then Coumadin. Discharged
Ancrod for 20 d then Coumadin. Discharged

SC

35.0

Ancrod for 5 d then Coumadin. Discharged

C om m ent

Streptokinase for 50 h followed by ancrod for 7 d
then Coumadin. Discharged
Ancrod for 17 d then Coumadin. Discharged

T = heparin given intravenously in therapeutic dose; SC = heparin given subcutaneously in prophylactic dose.
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BOOK REVIEWS
continued from page 188

Each topic is introduced by reprint
ing an article previously published by
prominent workers in the field; the
article is then discussed by one or more
groups with recognized expertise on
the topic and the section is completed
with an overview and annotated bibliog
raphy done by surgeons well known for
their understanding of the topic.
Although the book does not pretend
to be comprehensive, it covers a broad
spectrum of surgical urology. The chap
ters range from transplantation to va
sectomy and vas reversal. Most topics
are dealt with in a well-balanced and
thorough manner. The areas of conti
nent urinary diversion and the surgical
management of female urinary inconti
nence are particularly well discussed
and provide an excellent overview of
current techniques. The reading is easy
and creates a situation similar to being
in a journal club in which relevant
articles are discussed by knowledgeable
guests. The editorial comments and
“discussions” are sensible, focused and
informative. The choice of topics and
the leading articles introducing them is
generally appropriate.
Some weaknesses are evident: the
leading articles are 5 or more years old;
although this is compensated for by
updated commentaries and references,
some of the techniques have changed
substantially. This problem, fortunately,
210
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occurs infrequently. 1 felt that an inor
dinate amount of space was devoted to
some surgical techniques that would be
irrelevant to the expert and neophyte
alike: to the former because of a lack of
new developments and to the latter
because of too-sketchy information.
The strengths of this book, however,
overwhelm its weaknesses. It is a
worthwhile addition to a surgical library
and of major interest to senior trainees
and practising urologists.
A. Morales, MD, FRCSC
Department o f Urology,
Queen's University,
Kingston, Ont.

INFECTION IN THE ORTHOPAEDIC
PATIENT. Edited by Richard Coombs
and Robert H. Fitzgerald, Jr. 347 pp.
Illust. Butterworths, London. 1989.
$185 (US). ISBN 0-407-01316-4
This volume, under combined British
and American editorship, includes con
tributions from 75 different authors, 9
of whom are American; the others are
chiefly from the United Kingdom. The
book is divided into 12 parts and 58
sections, covering bacteriology, diagno
sis and assessment, prophylaxis, surgi

cal technique, antibiotics, specific infec
tions and psychological aspects of or
thopedic infections.
The text is well and copiously illus
trated, easy to read and well indexed.
As far as I can judge, it is up to date
(publication date of 1989 and receipt
for review in September 1989) and
some experimental work is included
(e.g., antibiotic-impregnated fibrin). I
found no difficulty in using the index to
locate references to antibiotic impreg
nated bone cement, Brodie's abscess or
Madura foot. Each section has its own
bibliography.
In the past, there have been many
criticisms of multiauthored texts be
cause of variations in style. In my
opinion this criticism is no longer im
portant because we have been inundat
ed with such texts, and medical writing
has become so standardized by the
professional wordsmith that individual
style is no longer a factor. I found no
difficulty in shifting from one section to
another in this text.
In contrast, this British-flavoured
and published text is refreshing in that
it contains two early sections, one on
musculoskeletal sepsis — the black
hole of orthopedics — and another
titled “Is infection still a problem?”, and
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(Sterile Cefotetan Disodium U.S.P.)

A highly effective cost efficient choice
for parenteral cephalosporin therapy
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• against E. coli
• against gram-negative anaerobic bacteria
• marked beta-lactamase stability

Gynecologic
• against susceptible strains of certain gram-negative bacteria
• against anaerobic bacteria such as Bacteroides species
(excluding B. distasonis, B. ovatus and B. thetaiotaomicron)
• marked beta-lactamase stability
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therapeutic blood levels over a 12-hour period.
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1st
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cefoxitin
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CEFOTAN 1IM /IV
(Sterile Cefotetan Disodium U.S.P.)

Treatment with broad-spectrum antibiotics may alter normal flora of the colon
and may permit overgrowth of Clostridia. Studies indicate a toxin produced
by Clostridium difficile is one primary cause of antibiotic-associated colitis.
Mild cases of colitis may respond to drug discontinuance alone.

A highly effective cost efficient
choice for parenteral
cephalosporin therapy
THERAPEUTIC CLASSIFICATION

Antibiotic

► >

ACTION
Cefotetan Disodium is a semisynthetic, beta-lactamase resistant (refer to
STABILITY TO BETA-LACTAMASES), cephalosporin (cephamycin) antibiotic.
In vitro studies indicate that the bactericidal action of cefotetan results from
an interference of bacterial cell wall synthesis by inhibiting the cross-linking
of peptidoglycan. Studies with 14C-labelled cefotetan have shown that on
reaching the target penicillin-binding proteins (PBPs) in the inner membrane,
the radiolabelled antibiotic binds principally to PBP 3 followed by PBP 1A
and 1B. Cefotetan, like other cephamycins, does not bind to PBP 2.
The plasma elimination half-life of cefotetan is 3 to 4.6 hours after either
intravenous or intramuscular administration. In normal patients, from 51 % to
81% of the administered dose is excreted unchanged by the kidney in 24
hours. The biliary tract is the other major route of elimination.
INDICATIONS AND CLINICAL USE
CEFOTAN (Cefotetan Disodium) is indicated for the treatment of the following
infections when caused by susceptible strains of the designated organisms:
Urinary tract infections caused by E. coli and Klebsiella species (including
K. pneumoniae), Proteus mirabilis and indole-positive Proteus.
Lower respiratory tract infections caused by Streptococcus pneumoniae
(formerly D. pneumoniae), Staphylococcus aureus (penicillinase and nonpenicillinase-producing), Haemophilus influenzae (including ampicillinresistant strains), Klebsiella species (including K. pneumoniae ) and E. coli.

\

Skin and skin structure infections caused by Staphylococcus aureus (penicil
linase and non-penicillinase-producing), Staphylococcus epidermidis, Strep
tococcus pyogenes, Streptococcus species (excluding Enterococci) and
E. coli.
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Gynecologic infections caused by Staphylococcus aureus (penicillinase and
non-penicillinase-producing), Staphylococcus epidermidis, Streptococcus
species (excluding Enterococci), E. coli, Proteus mirabilis, Neisseria gonorrhoeae, anaerobic gram-positive cocci and gram-negative bacilli, Bacteroides
species (excluding B. distasonis, B. ovatus and B. thetaiotaomicron).
Intra-abdominal infections caused by£. coli, anaerobic gram-negative bacilli,
Bacteroides species (excluding B. distasonis, B. ovatus and B. thetaiotaomicron).
Bone and joint infections caused by Staphylococcus aureus.
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Specimens for bacteriological examination should be obtained prior to therapy
in order to isolate and identify causative organisms and to determine their
susceptibilities to CEFOTAN. Therapy may be instituted before results of
susceptibility studies are known. However, once these results become available, the antibiotic treatment should be adjusted accordingly.
CONTRAINDICATION
CEFOTAN (Cefotetan Disodium) is contraindicated in patients with Type 1
hypersensitivity reactions (ie, hives, angioedema, bronchospasm or ana
phylactic shock) to the cephalosporin group of antibiotics.

WARNINGS
BEFORE THERAPY WITH CEFOTAN (Cefotetan Disodium) IS INSTITUTED,
F-xCAREFUL INQUIRY SHOULD BE MADE TO DETERMINE WHETHER THE
PATIENT HAS HAD PREVIOUS HYPERSENSITIVITY REACTIONS TO
t C E F O T E T A N DISODIUM, CEPHALOSPORINS, PENICILLINS OR OTHER
DRUGS. CEFOTAN SHOULD BE GIVEN CAUTIOUSLY TO PENICILLIN.
SENSITIVE PATIENTS. ANTIBIOTICS, INCLUDING CEFOTAN, SHOULD BE
ADMINISTERED WITH CAUTION TO ANY PATIENT WHO HAS DEMON
STRATED SOME FORM OF ALLERGY, PARTICULARLY TO DRUGS. IF AN
ALLERGIC REACTION TO CEFOTAN OCCURS, ADMINISTRATION OF
CEFOTAN SHOULD BE DISCONTINUED. SERIOUS ACUTE HYPERSEN
SITIVITY REACTIONS MAY REQUIRE EPINEPHRINE AND OTHER
EMERGENCY MEASURES.
PSEUDOMEMBRANOUS COLITIS HAS BEEN REPORTED WITH THE USE
OF CEPHALOSPORINS, INCLUDING CEFOTAN, (AND OTHER BROADSPECTRUM ANTIBIOTICS); THEREFORE, IT IS IMPORTANT TO CONSIDER
THIS DIAGNOSIS IN PATIENTS WHO DEVELOP DIARRHEA IN ASSOCIATION
WITH ANTIBIOTIC USE.

Moderate to severe cases should be managed with fluid, electrolyte and
protein supplementation as indicated. When the colitis is not relieved by drug
discontinuance or when it is severe, consideration should be given to the
administration of oral vancomycin for antibiotic-associated pseudomembranous
colitis produced by C. difficile. Other causes should also be considered.
PRECAUTIONS
General: Prolonged use of CEFOTAN (Cefotetan Disodium) may result in
overgrowth of non-susceptible organisms and organisms initially sensitive to
the drug. Careful observation of the patients is essential. If superinfection
does occur during therapy, appropriate measures should be taken.
CEFOTAN may be associated with a fall in prothrombin activity. Those at risk
include patients with renal or hepatic impairment, poor nutritional state, the
elderly, and patients with cancer. Prothrombin times should be monitored in
patients at risk and exogenous Vitamin K administered as indicated.
CEFOTAN should be used with caution in individuals with a history of gastro
intestinal disease, particularly colitis.
A disulfiram-like reaction characterized by flushing, sweating, headache and
tachycardia may occur when alcohol (beer, wine, etc.) is ingested within 72
hours after CEFOTAN administration. Patients should be cautioned about the
ingestion of alcoholic beverages following the administration of CEFOTAN.
Patients with impaired renal function; ie, creatinine clearance of 30 m l/m in or
less, should be placed on a special dosage schedule for CEFOTAN recom
mended under DOSAGE AND ADMINISTRATION.
Drug Interactions
Renal function should be carefully monitored, especially if high dosages of
the aminoglycosides are to be administered or if therapy is prolonged, because
of the potential nephrotoxicity and ototoxicity of aminoglycosidic antibiotics.
Although, to date, this has not been noted when CEFOTAN was given alone,
increased nephrotoxicity has been reported following concomitant adminis
tration of cephalosporins and aminoglycoside antibiotics. However, at the
recommended doses, enhancement of nephrotoxicity is unlikely to be a
problem with CEFOTAN.
Drug/Laboratory Test Interactions
A false positive reaction for glucose in urine may occur with Benedict’s or
Fehling’s solution.
High concentrations of cefotetan may interfere with measurement of serum
and urine creatinine levels by Jaffe reaction and produce false increases in
the levels of creatinine reported.
Use in Pregnancy
The safety of CEFOTAN in the treatment of infection during pregnancy has
not been established. The use of CEFOTAN in pregnant women requires that
the likely benefit from the drug be weighed against the possible risks to the
mother and fetus. Reproduction studies have been performed in rats and
monkeys at doses up to 20 times the human dose and have revealed no
evidence of impaired fertility or harm to the fetus due to cefotetan. There are,
however, no adequate and well-controlled studies in pregnant women. Because
animal reproductive studies are not always predictive of human response,
CEFOTAN should be used during pregnancy only if clearly needed.
Use in Nursing Mothers
Cefotetan is excreted in human milk in very low concentrations. Caution
should be exercised when CEFOTAN is administered to a nursing woman.
Pediatric Use
Safety and effectiveness in children have not been established.
ADVERSE REACTIONS
In clinical studies, the following adverse effects were considered related to
CEFOTAN (Cefotetan Disodium) therapy.
Gastrointestinal: Gastrointestinal symptoms occurred in 1.5% of patients,
the most frequent were diarrhea (1 in 80) and nausea (1 in 700).
Hematologic: Hematologic laboratory abnormalities occurred in 1.4% of
patients and included eosinophilia (1 in 200), positive direct Coom bs’ test
(1 in 250) and thrombocytosis (1 in 300). Transient thrombocytopenia and
leucopenia have been reported.
Hepatic: Hepatic enzyme elevations occurred in 1.2% of patients and in
cluded a rise in SGPT (1 in 150), SGOT (1 in 300), alkaline phosphatase
(1 in 700) and LDH (1 in 700).
Hypersensitivity: Hypersensitivity reactions were reported in 1.2% of
patients and included rash (1 in 150) and itching (1 in 700). During post
marketing experience with CEFOTAN, anaphylactic reactions have been
reported.

Local Effects: Local effects were reported in less than 1% of patients
and included phlebitis at the site of injection (1 in 300) and discomfort
(1 in 500).
SYMPTOMS AND TREATMENT OF OVERDOSAGE
To date, there have been no documented cases of overdosage with
CEFOTAN (Cefotetan Disodium). If overdosage should occur, it should be
treated symptomatically. CEFOTAN may be removed by dialysis.
DOSAGE AND ADMINISTRATION
DOSAGE: Adults: The usual adult dosage is 1 or 2 g of CEFOTAN (Cefotetan
Disodium) administered intravenously or intramuscularly every 12 hours for
5 to 10 days. Proper dosage and route of administration should be determined
by the condition of the patient, severity of the infection and susceptibility of the
causative organism. Therapy may be started while awaiting the results of
susceptibility testing.
The intravenous route is preferable for patients with bacteremia, bacterial
septicemia, or other severe or life-threatening infections, or for patients who
may be at risk particularly if shock is present or impending.
GENERAL GUIDELINES FOR CEFOTAN DOSAGE
Type of Infection
Daily Dose
Frequency and Route
Urinary Tract

1-4g

Other Sites

2-4g

500 mg every 12 hours IV or IM
1 or 2 g every 24 hours IV or IM
1 or 2 g every 12 hours IV or IM
1 or 2 g every 12 hours IV or IM

Severe

4g

2 g every 12 hours IV

Life Threatening

6 g tt

3 g every 12 hours IV

PHARMACEUTICAL INFORMATION
Chemistry
Trade Name:
CEFOTAN +
Proper Name:
Sterile Cefotetan Disodium U.S.P.
Chemical Name:
CEFOTAN is the disodium salt of [6R*(6<v, 7u)j-7-[[[4(2-amino-1 -carboxy-2-oxoethylidene)-1,3-dithietan-2yljcarbonyl] am ino]-7-methoxy-3-[[(1 -methyl-1 Htetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo
[4.2.0joct-2-ene-2-carboxylic acid.

Molecular Formula:
Molecular Weight:

Description
A white to pale yellow powder which is very soluble in water. The solution
varies from colorless to yellow depending on the concentration and contains
approximately 80 mg (3.5 mEq) of sodium per gram of cefotetan activity. The
pH of freshly reconstituted solutions is usually between 4.5 to 6.5.
RECONSTITUTION
For Intramuscular Use
Reconstitute with Sterile Water for Injection; Normal Saline, USP; 0.5%
Lidocaine HCL; or 1.0% Lidocaine HCL. Shake to dissolve and let stand until
clear.

t t Maximum daily dosage should not exceed 6 g.
IMPAIRED RENAL FUNCTION
When renal function is impaired, a reduced dosage schedule must be employed.
The following dosage guidelines may be used.
DOSAGE GUIDELINES FOR PATIENTS WITH IMPAIRED RENAL
FUNCTION
Creatinine Clearance
ml/min
Dose
Frequency
> 30
1 0 -3 0
<10

Usual Recommended Dose**
Usual Recommended Dose**
Usual Recommended Dose**

Vial Size

Alternatively, the dosing interval may remain constant at 12-hour intervals,
but the dose reduced to one-half the usual recommended dose for patients
with a creatinine clearance of 10 - 30 ml/min and one-quarter the usual recom
mended dose for patients with a creatinine clearance of less than 10 ml/min.
When only serum creatinine levels are available, creatinine clearance (ml/min)
may be calculated from the following formulae. The serum creatinine level
should represent a steady state of renal function.
Creatinine Clearance (ml/min):

Males:

Traditional Units
Weight (kg) x (140 - age)

S.l. Units
Weight (kg) x (140 - age)
0.8 x serum creatinine
(/tmol/L)

Females:

72 x serum creatinine
(mg/100 ml)
0.9 x male value

Cefotetan is dialyzable and it is recommended that for patients undergoing
intermittant hemodialysis, one-quarter of the usual recommended dose be
given every 24 hours on days between dialysis and one-half the usual recom
mended dosage on the day of dialysis.
Children
The safety and effectiveness in children has not been established.
ADMINISTRATION
Intravenous
For intermittent intravenous administration, a solution containing 1 g or 2 g of
CEFOTAN in Sterile Water for Injection can be injected over a period of three
to five minutes. Using an infusion system, it may also be given over a longer
period of time through the tubing system by which the patient may be
receiving other IV solutions.
Butterfly or scalp vein-type needles are preferred for this type of infusion.
However, during infusion of the solution containing CEFOTAN, it is advisable to
discontinue temporarily the administration of other solutions at the same site.
NOTE: Solutions of CEFOTAN must not be admixed with solutions containing
aminoglycosides. If CEFOTAN and aminoglycosides are to be administered
to the same patient, they must be administered separately and not as a mixed
injection.
Intramuscular
CEFOTAN should be injected well within the body of a relatively large muscle
such as the upper outer quadrant of the buttock (ie, gluteus maximus); aspiration
is necessary to avoid inadvertent injection into a blood vessel.

Amount of
Diluent To
Be Added
(ml)

Approximate
Withdrawable
Vol (ml)

Approximate
Average
Concentration
(mg/ml)

19

2

2.5

400

2g

3

4.0

500

For Intravenous Use
Reconstitute with Sterile Water for Injection, 0.9% Sodium Chloride Injection
or 5% Dextrose Injection. Shake to dissolve and let stand until clear.

Every 12 hours
Every 24 hours
Every 48 hours

** Dose determined by the type and severity of infection, and susceptibility of
the causative organism.

C i7H i5N7Na208S4
619.56

Vial Size

Amount of
Diluent To
Be Added
(ml)

Approximate
Withdrawable
Vol (ml)

Approximate
Average
Concentration
(mg/ml)

19

10

10.5

95

2g

10 - 20

11 - 21

182 - 95

A solution prepared with Sterile Water for Injection may be further diluted to
the desired volume with any of the “ Solutions for I.V. Infusion” listed below.
Solutions for I.V. Infusion
0.9% Sodium Chloride for Injection
5% Dextrose Injection
10% Dextrose Injection
Ringers Injection
Lactated Ringers Injection
5% Dextrose and 0.9% Sodium Chloride Injection
5% Dextrose and 0.225% Sodium Chloride Injection
5% Dextrose and Ringers Injection
5% Dextrose and Lactated Ringers Injection
10% Invert Sugar Injection
5% Sodium Bicarbonate Injection
Sodium Lactate Injection, 1/6 Molar
Isolyte-S Injection
Compatibility and Stability
CEFOTAN reconstituted as described above (Reconstitution) maintains
satisfactory potency for 24 hours at room temperature (25°C), or 72 hours
under refrigeration (5°C).
Any unused portions of the reconstituted solutions should be discarded.
CEFOTAN should not be physically mixed with other antimicrobial agents.
NOTE: Parenteral drug products should be inspected visually for particulate
matter and discoloration prior to administration, whenever solution and
container permit.
DOSAGE FORM
Availability
CEFOTAN (Cefotetan Disodium) is a dry, white to pale yellow powder supplied
in vials containing cefotetan disodium equivalent to 1 g and 2 g cefotetan
activity for intravenous and intramuscular administration. The 1 g dose
(No. 961) is available in 10 ml vials, and the 2 g dose (No. 962) is available in
20 ml vials. The vials should not be stored in excess of 25°C and should be
protected from light.
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Laser-Assisted Transluminal Angioplasty
of the Superficial Femoral and Popliteal
Arteries
A.J. Salvian, MD, FRCSC;* D.C. Morris, MD, FRCPC;t D.G. Connell, MD, FRCPCt
During an initial 1-year experience with percutaneous laser-assisted balloon
angioplasty at the Vancouver General Hospital, 9 of 61 patients considered suitable
for intervention because of arterial occlusive disease were selected for laser
treatment. The neodymium-YAG laser with a contact sapphire tip was chosen
because the probes and tips are reusable, thereby reducing the cost per patient. The
patients had either severe limiting claudication or pain at rest, involving the
superficial femoral or popliteal artery. One of the patients had lesions in both legs,
making a total of 10 lesions.
In 8 of the 10 lesions, treatment initially was successful. In the other two
instances, the laser perforated the arterial wall, but the patients suffered no ill
effects; repair by bypass surgery was uncomplicated. Another patient had distal
thrombosis at the time of angioplasty of the popliteal artery; this responded to
fibrinolytic therapy and subsequent balloon angioplasty of the peroneal artery.
The initial 80% success rate was reasonable, considering that all these patients
would otherwise have undergone bypass surgery. One patient had recurrent stenosis
5 months after the procedure. The other seven had good results with relief of
symptoms. However, follow-up has been short (mean 4.9 months), the longest being
only 11 months.

Au cours de la premiere annee d’utilisation de l’angioplastie percutanee par
ballonnet et laser a l’ Hopital General de Vancouver, 9 des 61 patients admissibles a
une intervention pour arteriopathie obliterante ont ete choisis pour etre soumis au
laser. Le laser YAG au neodymium, qui utilise un embout de saphire, fut choisi pour
ses sondes et embouts reutilisables qui permettent de reduire les couts par patient.
Les patients souffraient soit d’une claudication grave limitante, soit de douleur au
repos, avec atteinte de 1’artere femorale superficielle ou de la poplitee. Un des
patients avait des lesions aux deux jambes, portant le total des lesions a 10.
Pour 8 des 10 lesions, le traitement initial fut reussi. Dans les deux autres cas, il
y eut perforation de la paroi arterielle par le laser mais les patients n’en subirent
aucune consequence facheuse, le pontage chirurgical s’averant sans complication.
Un autre patient subit une thrombose distale au moment de l’angioplastie de l’artere
poplitee; cette thrombose ceda a un traitement par fibrinolyse et a une angioplastie
subsequente par ballonnet de l’artere peroniere.
Ce taux de reussite initial de 80% est acceptable, compte tenu du fait que tous ces
patients auraient subi, autrement, un pontage chirurgical. Subsequemment, un
patient a souffert, apres 5 mois, d’une restenose. Les sept autres patients jouissent
de bons resultats avec soulagement des symptomes. Toutefois, la surveillance des
suites therapeutiques est courte (moyenne de 4.9 mois), le suivi le plus long etant
de 11 mois.

aser recanalization o f arterial
occlusion has become more
prominent in the surgical and radi
ologic literature over the past 2
years. There is hope that total o c
clusions not amenable to percutane
ous balloon angioplasty can be
treated either primarily by laser or
recanalized by laser and subse
quently dilated using a conventional
Gruntzig-type balloon technique.
However, recent papers12 suggest
that results are not acceptable or
the recanalization is not durable,
except in certain areas and in cer
tain patients.
Is it worth supporting laser pro
grams, which involve a major capi
tal outlay for the purchase o f a
dedicated laser, plus the heavy on
going costs? We felt that a careful
study was needed to determine the
place o f this technique in its present
form for vascular surgery within
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the cost-sensitive Canadian system.
Patients with long occlusions of
the superficial femoral artery do not
do well with laser-assisted balloon
angioplasty, but those with short
occlusions and stenosis can usually
be treated by balloon angioplasty
alone.1' 5 To determine the efficacy
and practicability of laser-assisted
balloon angioplasty, therefore, we
studied a group of patients whose
symptoms were severe enough to
warrant bypass surgery, but who
were probably not candidates for
standard transluminal balloon dila
tation alone.

Patients and Methods
We considered for this study all
patients admitted to our hospital
between September 1988 and Sep
tember 1989 for possible surgical
intervention for occlusive arterial
disease. They had to have either
severe claudication with failure of
conservative therapy (a treadmill
walking distance of less than 100
m), or symptoms at rest or loss of
tissue. We looked for occlusions
that were less than 15 cm long in
the superficial femoral or popliteal
segment, which would be accessible
percutaneously, but we excluded
patients in whom balloon dilatation
alone would be possible. We also
excluded all patients with iliac and
tibial lesions, and all lesions involv
ing the origin of the superficial
femoral artery.
Nine of 61 patients met our as
sessment criteria, having, we
thought, a reasonable chance of
success over the long term. Six
patients had a total of seven occlu
sions of the superficial femoral ar
tery, and three had popliteal occlu
sions. Their average age was 66.6
years (range from 55 to 72 years).
One patient was diabetic and eight
were former smokers. The average
length of occlusion was 7.7 cm.
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Patients were evaluated with ref
erence to treadmill testing, anklebrachial pressures, and aortic and
peripheral arteriography. All cases
were reviewed by the principal in
vestigators, a vascular surgeon and
two vascular radiologists.
All patients were given an expla
nation of the experimental nature of
this procedure before they gave
their informed consent.
We used an SLT 60 W Nd:YAG
laser with a 2.2 mm fiberoptic light
guide and a 2.2 mm synthetic sap
phire probe (Surgical Laser Tech
nology, Surgimedic Products Inc.,
Downsview, Ont.). Power settings
for the laser were always started at
10 W for a 1 second burst. The
average energy required in treating
any one patient was about 300 J.
The first two patients were treat
ed in the operating room under spi
nal anesthesia and the other seven
in the radiology suite under local
anesthesia, with sedation adminis
tered intravenously. We found the
patients’ sensation of discomfort
when the arterial adventitia was
accidentally heated to be a useful
warning sign of impending perfora
tion and therefore preferred to use
local anesthesia.
All patients had percutaneous
catheterization of the superficial
femoral arteries, and an attempt
was made to cross the lesions with
a guide wire; in only one patient
was this possible.
Preoperatively (between 2 and 10
hours) patients were given 325 mg
of acetylsalicylic acid and 50 mg of
dipyridamole; intraoperatively an
ticoagulation was achieved with
3000 units of heparin; for 3 months
postoperatively the patients were
maintained on acetylsalicylic acid
and dipyridamole. In only one case
was postoperative anticoagulation
therapy necessary because of distal
emboli; a urokinase infusion was
given for 12 hours and heparin
continued for 48 hours.

Angiography was done where
possible, and noninvasive testing
was carried out postoperatively in
all patients, as well as duplex scan
ning of the arteries where possible.
No statistical analysis was possi
ble because of the small numbers,
and we present only our initial
experience with this technique.

Results
In two of the three patients with
popliteal lesions the vessels were
successfully recanalized using the
laser; in one a soft thrombus embolized distally and was dissolved with
urokinase. Six of the seven superfi
cial femoral artery lesions were suc
cessfully recanalized by the laser
and were dilated with initially excel
lent results, as evidenced by the
return of pulses and relief of symp
toms. One of these patients re
turned 5 months after the proce
dure with reocclusion of the super
ficial femoral artery below the level
of the laser angioplasty. Subse
quently, in-situ femoropopliteal by
pass grafting was done.
There were two cases in which
the laser perforated the arterial
wall. In one case the superficial
femoral artery was perforated distal
to the occlusion, after the artery
had been successfully recanalized.
In the other, perforation of the
popliteal artery occurred because
the occlusion was calcified. At the
time of perforation, the power of
the laser had been increased to 18
W at 2 second pulses from the
usual 10 W, 1 second settings.
Although there was a hematoma in
the popliteal fossa when bypass
surgery was carried out in both
cases, there were no other unto
ward side effects.
In one other patient distal emboli
formed after we crossed a popliteal
lesion with first a wire and then a
catheter. This thrombus was suc-
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cessfully lysed with urokinase.
In our series, the longest follow
up after successful angioplasty was
11 months (mean 4.9 months). All
patients in whom the treatment was
successful had an increase of at
least 0.2 in the ankle-brachial pres
sure index. Their average hospital
stay was 2 days. In the two unsuc
cessful cases, bypass surgery was
done, so their stays were increased
by 3 to 5 days.

Discussion
We found successful recanaliza
tion to be relatively easy in straight
occlusions without calcification.
The risk of perforation was higher
if there was a relatively tight bend
in the artery or if it was calcified.
All patients whose arteries were
successfully recanalized by laser
and then dilated were clinically and
objectively improved, as seen by
noninvasive testing.
The initial success of the proce
dure in 8 of 10 lesions in selected
patients is reasonable, considering
that all of these patients would
otherwise have had to undergo by
pass surgery. One of those in whom
the technique was initially success
ful had recurrent stenosis 5 months
later, but the others had good re
sults, with relief of symptoms. How
ever, follow-up is short (mean 4.9
months), the longest being only 11
months.
Although there were two perfora
tions of the arterial wall, neither
patient suffered ill effects from this,
and both later underwent uncompli
cated bypass surgery. Another pa
tient had distal thrombosis or embo
li, but the complication responded
well to fibrinolytic therapy and sub
sequent balloon angioplasty of the

peroneal artery. This patient was
subsequently asymptomatic, with
and increase of 0.4 in the anklebrachial pressure ratio.
Our patients suffered mainly
from severe (less than one block)
claudication or mild pain at rest.
They generally had single-level,
moderate-length occlusions, a con
dition for which laser treatment
tends to be successful. We believe
there is no reason to broaden our
present guidelines for intervention
to include patients we otherwise
would treat conservatively.
Tibial and distal popliteal occlu
sions may well be treatable by this
technique as experience accumu
lates.1 The technique may thus be
come applicable in the limb-salvage
situation. As larger laser probes and
“over the wire” tips become avail
able, it may be possible to improve
the results of percutaneous balloon
angioplasty in the superficial femo
ral and popliteal segments, or even
to treat lesions primarily without
balloon dilatation.
There are three broad catagories
of laser systems presently available.
• Excimer technology, is promis
ing, but is not yet a functional tool.
It requires a sophisticated optics
and delivery system. A dedicated
system costs about $250 000, plus
operating expenses.
•The Hot-tip system, with a
heated tungsten probe, has been
used successfully, but there can be
problems directing the device and
controlling temperature to prevent
perforation of the vessel. Also, the
tips are disposable, so operating
costs are high.
• Contact surgery using an
Nd:YAG laser directed down a fibe
roptic cable and focused through a
synthetic sapphire crystal is the
third system. Although the tip itself

stays cool, just 1 mm beyond it the
temperature can be as high as
400 °C, hot enough to vaporize
plaque. Each tip can be reused 5 to
10 times. The YAG laser is portable
and it can be used in other services.
These features reduce the expense
on a per patient basis.
Given the lower costs and greater
versatility of this system, we chose
it for our study, because we
thought it was more applicable to
the practice of vascular surgery in
Canada.
Although the number of our pa
tients is small, we feel we have
shown that recanalization by laser
is safe and relatively successful in
broadening the application of
Gruntzig balloon angioplasty. How
ever, this is still an experimental
procedure and not enough data are
available to compare either the
short- or long-term results with
those of conventional balloon dila
tation or of femoropopliteal bypass
surgery. This will be the yardstick
by which laser angioplasty will be
measured to find its place in the
treatment of vascular disease.
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Comparison of In-situ and Reversed
Saphenous Vein Grafts for Infrageniculate
Bypass
Michael A. Ricci, MD; Alan M. Graham, MD, FRCSC; James F. Symes, MD, FRCSC
Current controversy surrounding in-situ and reversed saphenous vein grafts
prompted a review of 161 procedures performed between 1982 and 1987. Analysis
was based on objective criteria recommended by the Society for Vascular
Surgery/International Society for Cardiovascular Surgery (SVS/ISCVS) Committee
on Reporting Standards.
There were 92 in-situ bypasses, 42 to the popliteal artery below the knee, and 50
to tibial vessels; of 69 reversed vein grafts, the comparable figures were 51 and 18.
Sixty-seven in-situ and 43 reversed grafts were done for foot salvage.
The overall primary patency rate for in-situ grafts was 81.1% at 30 days, 77.0% at
1 year, 74.7% at 3 years and 59.8% at 5 years; corresponding reversed vein patency
rates were 85.2%, 76.8%, 67.0% and 42.3%. Patency rates for foot salvage for in-situ
grafts were 81.7% at 1 month, 75.9% at 1 year and 72.6% at 3 years, and for
reversed vein grafts 78.6%, 70.3% and 66.5%. Secondary patency rates were 72.8% at
3 years for in-situ vein and 67.2% for reversed vein; the foot-salvage rate at 3 years
was 91.0% with in-situ vein and 78.9% with reversed vein.
The study demonstrated no statistically significant difference between in-situ and
reversed saphenous vein bypass for infrageniculate reconstruction, regardless of the
distal anastomotic site or severity of disease. Although a trend favouring the in-situ
technique was noted, particularly at the tibial level, longer follow-up and a
prospective randomized trial is needed to evaluate this.

La controverse actuelle qui entoure les techniques de greffe de la saphene (in situ
ou inversee), est l’origine de cette etude portant sur 161 interventions pratiquees
entre 1982 et 1987. L’analyse s’est appuyee sur les criteres objectifs recommandes
par le Comite des normes devaluation SVS/ISCVS.
II y eut 92 pontages in situ, 42 de l’artere poplitee, sous le genou, et 50 des
vaisseaux tibiaux. Sur 69 greffes inversees, les chiffres equivalents etaient de 51 et
18. Soixant-sept greffes in situ et 43 greffes inversees avaient ete pratiquees pour
sauvegarder le pied.
Les taux de permeabilite primaires pour les greffes in situ ont ete de 81,1% a 30
jours, de 77,0% a 1 an, de 74,7% a 3 ans et 59,8% a 5 ans; pour les greffes inversees,
les taux de permeabilite correspondants furent de 85,2%, 76,8%, 67,0% et 42,3%.
Dans les cas de greffe in situ pour sauvegarder le pied, les taux de permeabilite
furent de 81,7% a 1 mois, 75,9% a 1 an et 72,6% a 3 ans; pour les greffes inversees
les taux sont de 78,6%, 70,3% et 66,5%. Le taux de permeabilite secondaire a ete de
72,8% a 3 ans pour la greffe in situ et de 67,2% pour la greffe inversee; le taux de
sauvegarde du pied a 3 ans a ete de 91,0% pour la greffe in situ et de 78,9% pour la
greffe inversee.
Cette etude n’a montre aucune difference significative entre les techniques de
greffe in situ ou inversee de la veine saphene pour une reconstruction sous le
genou, quels que soient le lieu d’anastomose ou la gravite de l’arteropathie. Bien
qu’il existe une tendance favorisant la technique in situ, particulierement au niveau
tibial, une surveillance plus longue des resultats et une etude prospective
randomisee sont requises pour confirmer cette observation.
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he in-situ saphenous vein by
pass, popularized recently by
Leather and colleagues,1'3 has pro
duced excellent long-term patency
and foot-salvage rates. Recently,
Taylor and associates45 have report
ed achieving equivalent results with
the reversed vein technique using
current technical innovations and
paying meticulous attention to de
tail. In light of controversy over
which method is best, we reviewed
our experience at the Royal Victoria
Hospital with both techniques over
a recent 5-year period.

T

Patients and Methods
The records of 161 patients who
had undergone infrageniculate by
pass with autogenous saphenous
vein grafts between 1982 and 1987,
for whom complete follow-up was
available, were reviewed retrospec
tively. The in-situ bypass was first
used in 1984, while reversed vein
bypasses were used throughout the
period. The technique for in-situ
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SAPHENOUS VEIN FOR INFRAGENICULATE BYPASS

bypass was virtually identical to
that described by Leather and asso
ciates,3 and that for reversed vein
bypasses was similar to the one
described by Taylor and associates.5
Demographic data, the presence of
diabetes, the site of distal anasto
mosis and operative death rate were
documented. Each patient was clas
sified retrospectively according to
the objective criteria recently rec
ommended by the Society for Vas
cular Surgery/International Society
for Cardiovascular Surgery (SVS/
ISCVS) Ad Hoc Committee on Re
porting Standards.6 Categories 1, 2
and 3 represent patients generally
considered to have claudication;
categories 4 and 5 represent footsalvage situations.
Data recorded noninvasively in
the laboratory during regular fol
low-up visits at 3- to 6-month inter
vals were used to determine patency
and foot-salvage rates. Grafts were
considered patent if the segmental
pressure ankle-arm index was with
in 0.10 of the index immediately
preoperatively, if plethysmographic
tracings were substantially im
proved, if pulses were present in the
graft or at the pedal level on physi
cal examination, or they were seen
to be patent at reoperation, as rec
ommended.6

Primary patency was considered
to be uninterrupted patency from
the time of surgery (except for
arteriovenous fistula ligation after
in-situ saphenous vein grafting). If
patency was maintained or restored
by reoperation, this was considered
secondary patency.
Foot salvage was considered suc
cessful if, at most, transmetatarsal
amputation or other minor amputa
tions had to be performed.
Failures were reviewed retrospec
tively and, if possible, a reason for
failure determined for both types of
graft.
Life-table analysis was performed
according to the recommendations
of the Ad Hoc Committee on Re
porting Standards,6 as described by
Peto and colleagues.7-8 Only those
points at which the standard error7-8
is less than or equal to 10% are
reported (or are represented in the
life tables by heavy dashes.6 Com
parisons of life-table patency rates
were done by the log-rank test of
significance.6-8 Other statistical
comparisons between groups were
done by Fisher’s exact test. All
life-table and statistical calculations
were done on a personal computer
with the aid of commercially avail
able software (Lotus 1-2-3 (R), Systat/Survival (R), Epistat).

Table I. Patient Characteristics for Those Receiving In-situ Versus Reversed Saphenous Vein
Grafts
Saphenous vein grafts
Characteristic
Age (± SD), yr
Sex, no.
Male
Female
Diabetes present, no.
Previous bypass, no.
SVS/ISCVS classification, no.
Class 2-3
Class 4-5
Distal anastomosis site, no.
Popliteal artery, below knee
Tibial artery*

In-situ
(n = 92)

Reversed
(n = 69)

67 ± 9.6

64.8 ± 10.2

64
28
32
9

53
16
21
11

24
67

25
42

42
50

51
18

'The only significant difference between the two groups was that of the tibial artery being the site
of distal anastomosis, p = 0.003.

Results
Both groups were equally
matched with regard to age, sex,
presence of diabetes, incidence of
prior ipsilateral reconstruction and
SVS/ISCVS classification, al
though a significantly greater per
centage of in-situ bypasses were to
tibial vessels (Table I). There were
no deaths perioperatively in the
patients undergoing reversed saphe
nous vein bypass, but one patient
(1.1%) died after in-situ saphenous
vein grafting; the overall death rate
for the entire group of 161 patients
was 0.6%.
Overall primary patency of the
in-situ and reversed vein bypasses
was not significantly different (Fig.
1). At 30 days, the in-situ patency
rate was 81.1%, at 1 year 77.0%, at
3 years 74.7% and, at 5 years
59.8%. Patency rates of the re
versed vein at the corresponding
times were 85.2%, 76.8%, 67.0%
and 42.3%.
When anastomosis was to the
popliteal artery below the knee, no
significant difference was noted be
tween the two groups (Fig. 2, left);
at 3 years, in-situ patency was
82.1% and reversed vein patency
was 70.4%. Likewise, neither proce
dure was significantly better at the
tibial level (Fig. 2, right), although
the trend favoured the in-situ by
pass. At 1 year, in-situ patency to
tibial vessels was 72.3%, and at
both 3 and 5 years was 67.8%; the
reversed vein patency rates in this
group were 59.1% at each of these
times (although the standard error
at these points was 12%).
When patency was considered in
relation to the SVS/ISCVS classificiation (Fig. 3), the trend again
favoured the in-situ bypass, but no
significant difference was found
with either group (claudication or
foot salvage). Likewise, age, sex
and the presence of diabetes did not
affect patency rates.
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jThe secondary patency rate of
the in-situ bypasses was 72.8% at 3
years, not significantly different
from the 67.2% rate for reversed
vein after the same period (Fig. 4).
The reason for early graft failures
was attributable to technical errors
in 8 of 12 in-situ bypasses: vein
injury (3), veins that were too small
(2), retained valves (2) and problems

at the distal anastomosis (1). The
use of poor veins was the cause of
failure of two reversed vein grafts,
but the reason could not be deter
mined in the remaining 12 cases.
Foot-salvage rates were also not
significantly different for the two
techniques: at 3 years they were
91% (in situ) and 78.9% (reversed)
(Fig. 5).
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FIG. 1. Life-table showing overall pri
mary patency rates of in-situ (circles)
and reversed (squares) saphenous vein
bypass grafts. Heavy dashed line indi
cates standard error > 10%.

Controversy continues as to the
superiority of the in-situ bypass
over the reversed vein technique for
infrainguinal reconstruction in the
ischemic limb. It has been suggest
ed that the in-situ procedure has
superior hemodynamic characterist
ics,910 preserves endothelium11 and
avoids fibrosis at valve sites,12 re
sulting in better long-term patency
and foot salvage.13 Others4513-15

have questioned these claims, sug
gesting that the in-situ technique is
not innately superior to reversed
vein bypasses but simply reflects
current technical improvements and
innovations. Furthermore, the re
versed vein technique has the added
advantage of allowing reconstruc
tion when the ipsilateral saphenous
vein is absent or inadequate.14-16
In early reports of in-situ graft
ing, 3-year patency rates in excess
of 80% were compared with those
of previously published series of
reversed vein bypasses, in which the
patency rate was generally 50% or
less.1-2 More recently, Leather and
colleagues3 have summarized their
13-year experience with 1038 insitu bypasses. Operative mortality
was 6.7%. The primary patency rate
at 5 years was 59% and the second
ary patency rate was 76%. Graft
failures were usually the result of
technical problems, such as the use
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FIG. 2. Primary patency rates of in-situ (circles) and reversed (squares) saphenous
vein bypass grafts to (left) popliteal artery, below knee, and (right) tibial artery.
Heavy dashed line indicates standard error > 10%.
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FIG. 3. Primary patency rates of in-situ (circles) and reversed (squares) saphenous
vein bypass grafts in patients classified as SV/ISCVS classes 2 and 3 (left) and 4
and 5 (right). Heavy dashed line indicates standard error > 10%.
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FIG. 4. Overall secondary patency
rates of in-situ (circles) and reversed
(squares) saphenous vein bypass
grafts.
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FIG. 5. Foot-salvage rates with use of
in-situ (circles) and reversed (squares)
saphenous vein bypass grafts.

A

SAPHENOUS VEIN FOR INFRAGENICULATE BYPASS

of a vein of insufficient size, vein
injury or retained valves. Others
have reported comparable re
sults;1718 the results of this study,
regarding primary patency, are also
comparable.
Leather’s group3 used a follow
up program similar to the one we
used, with the later addition of
duplex sonography. They reported
that secondary patency rates gener
ally improved by 10% to 20% over
primary rates. The reasons for fail
ure in that series are similar to
ours. However, in our series, sec
ondary patency rates were not sig
nificantly improved. In general, we
experienced a significant early fail
ure rate because of technical prob
lems, followed by a relatively slower
decline in patency in subsequent
years, a pattern observed by oth
ers.19 It is quite possible that our
surveillance protocol was not suffi
ciently sensitive to detect impending
late graft failures. Duplex scanning
allows hemodynamic assessment of
the failing graft and may be superi
or to the use of segmental pres
sures and waveforms.18 This is cur
rently being evaluated in our labo
ratory.
In contrast, the reversed saphe
nous vein bypass displayed a gradu
al decline in patency rates with
time, as has also been described
previously.19 This is in contrast to
the findings of Taylor’s group5 who
demonstrated excellent results with
reversed saphenous vein: at 1 year
their primary patency rate was 90%,
at 3 and 5 years, it was 85%. The
limb salvage rate was 93% at 5
years. Our results are more in line
with those of others, who have
reported 3-year patency rates in the
range of 60% to 70%.19-21
Several studies have attempted to
compare the two techniques retro
spectively, but no difference has
been noted.14-2022 Similarly, our re
sults showed no significant differ
ence between in-situ and reversed

vein bypasses, whether considering
primary and secondary patency or
foot-salvage rates.
Likewise, in two prospective tri
als23-24 no difference was found be
tween the two techniques. In addi
tion, in our review there was no
significant difference between tech
niques when analysed according to
the SVS/ISCVS classification or
the site of distal anastomosis. The
trend at the tibial level, however,
clearly favoured the in-situ tech
nique. It is possible that this differ
ence did not attain significance be
cause of the smaller number of
bypasses to the tibial level with
reversed saphenous vein. Thus the
possibility of a type II error must be
acknowledged. This bias clearly rep
resented surgeon preference due to
a greater confidence in the in-situ
bypass at the tibial level during this
period.
In summary, from this retrospec
tive review of our recent experience
with 161 infrageniculate recon
structions, there appears to be no
significant difference between insitu and reversed saphenous vein
bypasses with regard to primary
patency, secondary patency or limbsalvage rates. Although a trend
favoured the in-situ bypass at the
tibial level, further study, including
longer follow-up and perhaps a pro
spective randomized evaluation, is
necessary to confirm this. Improved
protocols for surveillance, using
currently available duplex scanning
techniques to detect the failing
graft, may increase secondary pat
ency rates.
We have found the SVS/ISCVS
classification system based upon ob
jective criteria useful for standard
ized comparisons of infrainguinal
reconstructions in the ischemic
limb.
We thank Dr. Jack Williams for assis
tance in the statistical analysis, Ms.
Diane Major and Ms. France Singher

for assistance in data collection and
Mrs. Maria Grant for preparing the
manuscript.
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Studies performed in lactating rats have shown that
PEPCID® is secreted in breast milk. It is not known
whether this drug is secreted in human milk.
Nursing mothers should either stop this drug or
should stop nursing.
Pediatric Use

Safety and effectiveness in children have not been
established.
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Histamine H2 Receptor Antagonist
ACTIONS AND
CLINICAL PHARMACOLOGY
PEPCID® (famotidine) is a competitive inhibitor of
histamine H2-receptors. The prim ary clinically
important pharmacologic activity of PEPCID® is
inhibition of gastric juice secretion. PEPCID®
reduces the acid and pepsin content, as well as the
volume, of basal, nocturnal, and stimulated gastric
secretion.

INDICATIONS AND CLINICAL USE
PEPCID® (famotidine) is indicated in the treatment
of the following conditions where a controlled
reduction of gastric secretion is required for ulcer
healing:
1. Treatment of acute duodenal ulcer;
2. Prophylactic use in duodenal ulcer;
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3. Treatment of acute benign gastric ulcer;
4. Treatment of pathological hypersecretory
conditions (e.g., Zollinger-Ellison syndrome).
PEPCID® I.V. is indicated in some hospitalized
patients with pathological hypersecretory con
ditions or intractable ulcers, or as an alternative to
the oral dosage forms for short-term use in patients
who are unable to take oral medication.

CONTRAINDICATIONS
H y p e rs e n s itiv ity to any co m p o n e n t o f th is
medication.

PRECAUTIONS
Patients with Severe Renal Insufficiency

Dosing intervals may need to be prolonged in
p a tie n ts w ith advanced renal in s u ffic ie n c y
(creatinine clearance<10 mL/min.) to adjust for the
longer elimination half-life of fam otidine. (See
CLINICAL PHARMACOLOGY and DOSAGE AND
ADMINISTRATION.)

PEPCID® (famotidine) is usually well tolerated;
most adverse reactions have been mild and
transient. The adverse reactions listed below have
been reported during clinical trials in 2333 patients.
In those controlled clinical trials in which PEPCID®
was compared to placebo, the overall incidence of
adverse experiences in the group which received
PEPCID®, 40 mg at bedtime, was similar to the
placebo group. No antiandrogenic or other adverse
hormonal effects have been observed.
The following adverse reactions have been reported
at a rate of greater than 1% in patients on therapy
with PEPCID® in controlled clinical trials, and may
be causally related to the drug: headache (4.6%),
dizziness (1.2%), constipation (1.2%) and diarrhea
( 1. 6% ) .

Other reactions have been reported in clinical trials
but occurred under circumstances where a causal
relationship could not be established. However, in
these rarely reported events, that possibility cannot
be excluded. Therefore, these observations are
listed to serve as alerting information to physicians.
Gastrointestinal

8.0%

Nausea
Vomiting
Anorexia
Abdominal discomfort
Dry mouth

1.6%
0.9%
0.5%
0.3%
0.2%

Nervous System/Psychlatrlc

7.3%

Insomnia
Somnolence
Anxiety
Paresthesia
Depression
Libido decreased

0.6%
0.4%
0.3%
0.3%
0.2%
0.1%

Respiratory

Bronchospasm

4.4%

<0.1%

Body as a Whole

3.0%

Fatigue
Asthenia
Fever

0.6%
0.3%
0.2%

Musculoskeletal

1.7%

Musculoskeletal pain
Arthralgia

0.1%
0.1%

Drug Interactions

Skin

1.7%

Studies with famotidine in man, in animal models,
and in vitro have shown no significant interference
with the disposition of compounds metabolized by
the hepatic microsomal enzymes, e.g., cytochrome
P450 system. Compounds tested in man have
in c lu d e d w a rfa rin , th e o p h y llin e , p h e n yto in ,
diazepam, am inopyrine and antipyrine. Indo
cyanine green as an index of hepatic blood flow
and/or hepatic drug extraction has been tested and
no significant effects have been found.

Pruritus
Rash
Alopecia
Flushing
Acne
Dry skin

0.4%
0.3%
0.2%
0.2%
0.1%
0.1%

Use in Gastric Ulcer

Gastric malignancy should be excluded prior to
initiation of therapy of gastric ulcer with PEPCID®.
Symptomatic response of gastric ulcer to PEPCID®
therapy does not preclude the presence of gastric
malignancy.
Use In Pregnancy

Reproductive studies have been performed in rats
and rabbits at oral doses of up to 2000 and
500 mg/kg/day, respectively (approximately 2500
and 625 times the maximum recommended human
dose, respectively), and have revealed no evidence
of impaired fertility or harm to the fetus due to
PEPCID®. There are, however, no adequate or wellcontrolled studies in pregnant women.
Since the safe use of PEPCID® in pregnant women
has not been established, the benefits of treatment
with PEPCID® should be weighed against potential
risks.

Cardiovascular

1.0%

Palpitations

0.2%

Special Senses

0.9%

Taste disorder
Tinnitus
Orbital Edema

0.1%
0.1%
<0.1%

Urogenital

0.9%

The adverse reactions reported fo r PEPCID®
Tablets may also occur with PEPCID® I.V. In
addition, transient irritation at the injection site has
been observed with PEPCID® I.V.
Laboratory Abnormalities

Laboratory parameters may be affected during
treatment with PEPCID®, but the changes are
u su ally not considered serious. A m ong the
laboratory changes that were reported during
clinical trials were increases in AST, ALT, BUN, and
serum creatinine. These changes were rarely of
clinical significance.

Only three patients had to be discontinued from
therapy because of laboratory adverse experiences,
however laboratory abnormalities were present at
baseline.

The oral LD m of famotidine in male and female rats
and mice was >5000 mg/kg.

DOSAGE AND ADMINISTRATION
DUODENAL ULCER
Acute Therapy

Other effects

Dilution of PEPCID® I.V.
for Infusion

SYMPTOMS AND TREATMENT
OF OVERDOSAGE
There is no experience to date with deliberate
overdosage. Doses of up to 640 mg/day have been
employed in patients with pathological hyper
secretory conditions w ith no serious adverse
effects. In the event of overdosage, treatment
should be sym ptom atic and sup portive . Un
absorbed material should be removed from the
ga strointestina l tra c t, the pa tie n t should be
monitored, and supportive therapy should be
employed.

emptying and exocrine pancreatic function are not
affected by PEPCID®

RECO NSTITUTION
Parenteral Products

P E P C ID * I.V .
S o lution

V o l....a o f
C o m pa tib le
I.V . S o lution

Final
V o lu m e

Final
Co n ce n tra tio n

R a te o f
In fu s io n

2 mL

3m L

5m L

4 mg/mL

Not less than
2 minutes

2 mL

8 mL

10 mL

2m g/m L

Not less than
2 minutes

2 mL

100 mL

102 mL

0.196 mg/mL

15-30 minutes

PEPCID® I.V. Solutions are compatible with:
Water for Injection
0.9% Sodium Chloride Injection
5% Dextrose Injection
10% Dextrose Injection
Lactated Ringer’s Injection
Sodium Bicarbonate Injection 5%

The recommended adult oral dosage of PEPCID®
(famotidine) for acute duodenal ulcer is 40 mg once
a day at bedtime. Treatment should be given for
4-8 weeks, but the duration of treatment may be
shortened if healing can be documented. Healing
occurs within 4 weeks in most cases of duodenal
ulcer.

STABILITY AND STORAGE
RECOMMENDATIONS

Maintenance Therapy

Diluted PEPCID® I.V. Solutions should be used
within 24 hours due to the possibility of microbial
contamination during preparation.

For the prevention of recurrence of duodenal ulcer,
it is recommended that therapy with PEPCID® be
continued with a dose of 20 mg once a day at
bedtime, for a duration of up to 6-12 months
depending on the severity of the condition.
BENIGN GASTRIC ULCER
Acute Therapy

PEPCID® I.V. Solution

Store at 2 - 8°C. Protect from light. If solution
freezes, bring the solution to room temperature;
a llo w s u ffic ie n t tim e to s o lu b iliz e a ll th e
components.

NOTE: P are nteral d ru g p ro d u c ts s h o u ld be
i nspected visually for particulate matter and
d is co lo u ra tio n p rio r to ad m in istra tio n
whenever solution and container permit.

DOSAGE FORMS AND AVAILABILITY

The recommended adult oral dosage for acute
benign gastric ulcer is 40 mg once a day at bedtime.
Treatment should be given for 4 to 8 weeks, but the
duration of treatment may be shortened if healing
can be documented.

T a b le ts PEPCID® (fa m o tid in e ta b le ts ) are
D-shaped, film-coated tablets supplied as follows:

P A T H O L O G IC A L H Y P E R S E C R E T O R Y C O N 
D IT IO N S (S U C H AS Z O L L IN G E R -E L L IS O N
SYNDROME)

No. Ca 8103 - 40 mg light brownish orange,
coded 964. Available in bottles of 100 tablets.

The dosage o f PEPCID® in p a tie n ts w ith
pathological hypersecretory conditions varies with
the individual patient. The recommended adult oral
starting dose fo r pathological hypersecretory
conditions is 20 mg q6h. In some patients, a higher
starting dose may be required.
Doses should be adjusted to individual patient
needs and should continue as long as clinically
indicated. Doses up to 160 mg q6h have been
adm inistered to some p a tie n ts w ith severe
Zollinger-Ellison syndrome.
Intravenous Administration

In some hospitalized patients with pathological
hypersecretory conditions or intractable ulcers, or
in patients who are unable to take oral medication,
PEPCID® I V. may be administered. The recom
mended dosage is 20 mg every 12 hours.
Intravenous injection therapy should be changed to
oral treatment as soon as the acute situation is
under control.
Concomitant Use with Antacids

Antacids may be given concomitantly if needed.
Dosage Adjustment for Patients with Severe Renal
Insufficiency

In patients with advanced renal insufficiency, i.e.,
with a creatinine clearance less than 10 mL/min.,
the elimination half-life of PEPCID® may exceed
12 hours reaching approximately 24 hours in anuric
patients.
To avoid excess accumulation of the drug, the
dosing interval of PEPCID® may be prolonged to
36-48 hours as indicated by the patient's clinical
response.

PHARMACEUTICAL INFORMATION
COMPOSITION
Tablets

Each tablet for oral administration contains either
20 mg or 40 mg of famotidine.
Injection

Each mL of the solution for intravenous injection
contains 10 mg of famotidine and the following
in a c tiv e in g re d ie n ts : L -a s p a rtic acid 4 mg,
mannitol 20 mg, and Water for Injection, q.s., 1 mL.
The multidose injectio n also contains benzyl
alcohol 0.9% added as preservative.

N o. Ca 8102 - 20 mg b e ig e c o lo u re d ,
coded 963. Available in bottles of 100 tablets.

No. Ca 3539 - PEPCID® I.V., 10 mg per 1 mL, is a
clear, colourless solution and is available as a nonpreserved unit dose containing 2 mL of injectable
solution. Available in 10 x 2 mL vials.
No. Ca3541 - PEPCID® I.V., 10 mg per 1 mL, is a
clear, colourless solution and is available as a
preserved m u ltip le dose c o n ta in in g 4 mL of
injectable solution. Available in 4 mL vials.

HUMAN PHARMACOLOGY
In both normal volunteers and hypersecretors,
PEPCID® inhibited basal nocturnal and daytime
gastric secretion, as well as secretion stimulated by
a variety of stimuli, such as pentagastrin and food.
After oral administration, the onset of the antisecretory effect occurred within one hour; the
maximum effect was dose-dependent, occurring
within one to three hours. Duration of inhibition of
secretion was 10 to 12 hours. After intravenous
administration, the maximum effect was achieved
within 30 minutes. Single intravenous doses of 10
and 20 mg inhibited basal nocturnal secretion fo r a
period o f 10-12 hours. The 20 mg dose was
associated with the longest duration of action in
most subjects. Single oral doses of 20 and 40 mg
inhibited basal nocturnal acid secretion in all
subjects; mean gastric acid secretion was inhibited
by 86% and 94%, respectively, for a period of at least
10 hours. S im ilar doses given in the m orning
suppressed food-stimulated acid secretion in all
subjects, with mean suppression of 76% and 84%,
respectively, 3 to 5 hours after drug, and of 25% and
30%, re spectively, 8 to 10 hours a fte r drug;
however, in some subjects who received the 20 mg
dose, the antisecretory effect was dissipated earlier,
within 6-8 hours. There was no cumulative effect
with repeated doses. The basal nocturnal intragastric pH was raised by evening doses of 20 and
40 mg of PEPCID® to mean values of 5.0 and 6.4,
respectively. When PEPCID® was given in the
morning, the basal daytime interdigestive pH at 3
and 8 hours after 20 or 40 mg of PEPCID® was
raised to about 5.0.
Fasting and postprandial serum gastrin levels may
be s lig h tly elevated d u rin g periods o f drug
antisecretory effect, and with chronic therapy an
increase in gastric bacterial flora may occur. Gastric

Systemic pharmacologic effects of PEPCID® in the
CNS, cardiovascular, respiratory or endocrine
systems have not been found to date. Serum
prolactin levels do not rise after intravenous bolus
doses of 20 mg PEPCID® and no antiandrogenic
effects have been detected.
Pharmacokinetics

PEPCID® is incompletely absorbed. The bioavaila
bility of oral doses is 40-45%. Bioavailability may be
slightly increased by food, or slightly decreased by
acntacids; however, these effects are of no clinical
consequence. PEPCID® undergoes minimal firstpass metabolism. After oral doses, peak plasma
levels occur in 1-3 hours. Plasma levels after
multiple doses are sim ilar to those after single
doses. Fifteen to 20% of PEPCID® in plasma is
protein bound. PEPCID® has an elimination half-life
of 2 5-3.5 hours. PEPCID® is eliminated by renal
(65-70%) and metabolic (30-35%) routes. Renal
clearance is 250-450 mL/min., indicating some
tubular excretion.
Twenty-five to 30% of an oral dose and 65-70% of an
intravenous dose are recovered in the urine as
unchanged com poun d. The o n ly m e ta b o lite
identified in man is the S-oxide. There is a close
relationship between creatinine clearance values
and the elimination half-life of PEPCID®. In patients
w ith severe renal insufficiency, i.e., creatinine
clearance less than 10 mL/min., PEPCID® elim i
n a tio n h a lf- life m ay exceed 20 h o u rs and
adjustment of dosing intervals may be necessary
(see PRECAUTIONS, DOSAGE AND ADMINIS
TR A TIO N ). In e ld e rly patients, there are no
clinically significant age-related changes in the
pharmacokinetics of PEPCID®
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Management of Venous Stasis Ulcer:
Long-Term Follow-up
W.G. Jamieson, MD, FRCS, FRCSC, FACS; G. DeRose, MD, FRCSC, FACS; K.A. Harris, MD, FRCSC
In this study 112 patients (122 lower limbs) who had chronic venous stasis
ulceration refractory to conservative management were treated surgically. Subfascial
ligation was performed on 118 limbs and the long saphenous vein was removed in 4.
Complications consisted of postoperative thromboplebitis (2%), wound infection (2%)
and wound infection with ulcer necrosis (1.5%). These all responded to conservative
management. Follow-up (mean 7.9 years, median 11 years) showed a good or
excellent result in 82% of cases, with healing of the ulcer and no ulcer recurrence
despite significant noncompliance with support stockings.
This paper is a long-term follow-up study of a surgical procedure for chronic
venous stasis ulcers. The authors believe that the 82% good and excellent results
may indicate that surgical intervention for refractory venous ulcers is a worthwhile
procedure, providing potentially satisfactory long-term results.

Dans cette etude, 112 patients souffrant d’ulceres d’insuffisance veineuse chronique
(affectant 122 membres inferieurs), resistants au traitement conservateur, ont ete
traites par chirurgie. Une ligature sous-aponevrotique fut pratiquee sur 118 jambes
et un stripping de la saphene longue, sur les 4 autres. Les complications observees
comprennent des thrombophlebites postoperatoires (2%), des infections de plaies
(2%) et des infections de plaies avec necrose ulcereuse (1.5%). Toutes cederent a un
traitement conservateur. La surveillance des suites therapeutiques (d’une duree
moyenne de 7.9 ans et mediane de 11 ans) revele des resultats bons ou excellents
dans 82% des cas, avec cicatrisation de l’ulcere et absence de recidive malgre un
manque de fidelite notoire au port de bas de soutien.
Cet article fait le bilan a long terme de l’etude d’une intervention chirurgicale
pour les ulceres d’insuffisance veineuse chronique. Les auteurs croient qu’avec 82%
de bons ou d’excellents resultats une intervention chirurgicale dans les cas d’ulceres
veineux tenaces represente une approche interessante qui offre la possibilite de
resultats satisfaisants a long terme.

enous ulcers are common, de
bilitating and costly to both the
patient and the health-care system.
Long-term management is difficult
and recurrence is frequent. The
cause of venous ulcers is venous
hypertension in the subcutaneous
space due either to incompetent
perforating veins or to incompetent
valves in the long saphenous vein.

V

Management includes compression
therapy, sclerotherapy and surgery.
No study of refractory ulcers treat
ed by surgery with a follow-up of
more than 10 years has yet been
published.1 In this paper we discuss
the management and follow-up of
112 patients (122 lower limbs) with
refractory venous ulcers operated
on between 1966 and 1986. The
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mean follow-up was 7.9 years (me
dian 11 years).

Patients and Methods
The diagnosis of incompetent
perforating veins was made by his
tory, physical examination and as
cending phlebography (96 limbs).
All limbs were subjected to a
subfascial ligation of incompetent
perforators (88), long saphenous
vein stripping and tributary removal
(4), or combination of the two (30).
The type of incision depended on
the site of the ulcer; posteromedial
and posterolateral incisions were
used originally, but these were re
placed by the posterior seam ap
proach. All perforators were ligated
and divided between sutures.
Wounds were closed in one layer
with nonabsorbable sutures. Postoperatively the patient had complete
bed rest for 3 days with the limb
well elevated and was instructed to
move the foot in plantar and dorsiflexion.
After operation the 112 patients
were followed up by chart review
and telephone interview by a labora
tory assistant. Information on 31
limbs was unavailable because the
patients were lost to follow-up
(death — 13 limbs, inability to
locate — 15 or lost charts — 3).
The follow-up therefore was of 91
limbs, 75% of those operated on.
The factors considered were as
follows: recurrence of the ulcer,
relief of symptoms and compliance
in wearing support stockings postoperatively. The criterion for a good
result was no recurrent ulcer.

Results
Five limbs required reoperation
for recurrent venous ulcer. In all at

VENOUS STASIS ULCER

least one recurrent or missed in
competent perforating vein was
found and ligated between non
absorbable sutures. There was no
further recurrence; however, these
limbs were followed up for a maxi
mum of only 2 years.
In 71 limbs (82%) there was a
good result; the patients had no
recurrence, and had marked allevia
tion of symptoms of heaviness,
bursting and swelling of the calf. In
the other 16 (18%) limbs the result
was poor, because of recurrent re
fractory ulcers.
Compliance in wearing support
stockings in the postoperative
phase was poor and probably no
more than 20% to 25%.

Discussion
Venous stasis ulcer is a demand
ing, persistent problem for the pa
tient and physician because of its
chronicity due to underlying venous
hypertension. The cause of the ve
nous hypertension is well docu
mented.2 Incompetent perforating
veins release the hypertension in
the deep venous system into the
subcutaneous tissue. Incompetence
of the long saphenous valve in the
superficial system of veins, trans
mitting a high venous pressure to
the gaiter area is also implicated,
although this is a rare cause. We
have adopted the attitude that if the
subcutaneous venous hypertension
can be alleviated the ulcer has a
good chance of healing.
Patients are treated conservative
ly at first with attention to good
hygiene. Antibiotics are given if the
ulcer is infected, the limb is kept
elevated whenever possible and sup
port stockings, ranging from sup
port hose to elastic stockings to
pressure gradient stockings to vi
scopaste boot are prescribed. No
patient in this series was operated
on without at least 1 year of this
type of conservative therapy aimed

at healing a long-standing ulcer.
We believe that the diagnosis of
venous ulcer secondary to incompe
tent valves in the long saphenous
vein is not difficult since these
ulcers are always associated with
greatly dilated veins, and incompe
tent valves can be demonstrated on
clinical examination.
Our operative approach has been
to ligate and divide the incompetent
perforating veins and when neces
sary remove coexisting varicose
veins. In only four limbs was the
long saphenous alone removed and
in these cases there was a huge
dilatation of the long saphenous
vein and no incompetent perforators
as shown on venography. This con
dition seems to be very rare and
some authors suggest it does not
exist,3 but in these four cases there
was no ulcer recurrence.
We used aggressive subfascial li
gation. Originally we used post
eromedial and posterolateral inci
sions, but recently we have been
using the seam approach from pop
liteal fossa to the ankle joint. We
stress a bold approach, making the
incisions at right angles to the skin
to prevent undermining, and quick
ly entering the subfascial space.
The short saphenous vein is re
moved if it is varicose, taking care
to protect the sural nerve. The
subfascial exposure is developed
medially as far as the tibia, being
very sure, by blunt and sharp dis
section, not to overlook any perfo
rating veins. If there is pigmenta
tion laterally the lateral side is done
at the same time, taking the dissec
tion to the fibula.
The surgeon must be aggressive
in the region of the fascial insertion
into the tibia and fibula, because we
believe that if any incompetent per
forating veins are left intact, the
problem is not solved. In this paper,
we have reported a long-term fol
low-up and have shown an 82% rate
of freedom from ulcer recurrence.

We believe these figures are signifi
cant and accurate. Others4 have
reported a similar ulcer-free rate
(80%) but a shorter follow-up.
In some areas of the country
conservative therapy is the pre
ferred method of managing this
problem. With aggressive weight
reduction, exercise, leg elevation
and appropriate support stockings
including the Unna paste boot this
can be done. However, we think
that the effort expended, the long
term morbidity with the various
stockings and the repeat visits indi
cate another approach.
Sclerotherapy has been used in
many centres with excellent results
but it is our feeling that the ability
to inject these perforating veins is
very difficult. The legs are often
brawny, thick and ulcerated, and it
is extremely difficult to ascertain
the exact location of the perforating
veins.

Conclusion
Ninety-one limbs were operated
on for refractory venous ulcers with
a good result in 82%, the criterion
for a good result being no recurrent
ulcer. The median follow-up was 11
years. We believe that this result
suggests that an aggressive surgi
cal approach is a satisfactory alter
native in the management of refrac
tory venous ulcers.
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Comparison of Left Ventricular Function
and Myocardial Perfusion for Evaluating
Perioperative Cardiac Risk of Abdominal
Aortic Surgery
N.V. McPhail, MD, FRCSC;* T.D. Ruddy, MD, FRCPC;t J.E. Calvin, MD, FRCPC;t G.G. Barber, MD,
FRCSC;* C.Wm. Cole, MD, FRCSC;* R.A. Davies, MD, FRCPC;t K.Y. Gulenchyn, MD, FRCPC*
The measurement of left ventricular function by gated blood pool scanning and of
myocardial perfusion by dipyridamole thallium imaging were compared in a
prospective study of patients who had abdominal aortic aneurysm or aortoiliac
occlusive disease to determine which measurement was the better predictor of
postoperative cardiac complications. Sixty-six men and 19 women (mean age 67
years) underwent both tests before admission for surgery. Fifty-six had repair of an
abdominal aortic aneurysm, and 29 had reconstruction for aortoiliac occlusive
disease. In 17 patients the left ventricular ejection fraction was less than 50%.
Dipyridamole thallium imaging was positive, showing redistribution, in 45
patients. Postoperative cardiac complications occurred in 33 patients.
The sensitivity of dipyridamole thallium imaging (91%) was significantly (p <
0.01) greater than that observed with gated blood pool scanning (27%). However,
the specificity of gated blood pool scanning (85%) was similar to that of
dipyridamole thallium imaging (71%). Diagnostic accuracy was greatest with
dipyridamole thallium imaging (79% versus 62% [p < 0.02]).
Dipyridamole thallium imaging is superior to gated blood pool scanning for
perioperative evaluation of vascular surgical patients.

L’evaluation de la fonction ventriculaire gauche par scintigraphie controlee de la
masse sanguine et celle de la perfusion du myocarde par scintigraphie au
thallium-dipyridamole ont ete comparees dans une etude prospective chez des
patients souffrant d’un anevrisme de l’aorte abdominale ou d’une arteriopathie
aorto-iliaque, dans le but d’etablir quelle methode etait la meilleure pour predire les
complications cardiaques postoperatoires. Soixante-six hommes et 19 femmes (dont
l’age moyen etait de 67 ans) furent soumis aux deux examens avant la chirurgie.
Cinquante-six subirent la reparation d’un anevrisme de l’aorte abdominale et 29
eurent une reconstruction pour stenose aorto-iliaque. Chez 17 de ces patients, la
fraction d’ejection ventriculaire gauche etait inferieure a 50%.
La scintigraphie au thallium-dipyridamole fut positive, montrant une redistribu
tion chez 45 patients. Des complications cardiaques postoperatoires survinrent chez
33 patients.
La sensibilite de la scintigraphie au thallium-dipyridamole (91%) a ete significativement plus grande (p < 0.01) que celle observee avec la scintigraphie controlee de
la masse sanguine (27%). Neanmoins, la specificite de cette derniere (85%) a ete
similaire a celle de la scintigraphie au thallium-dipyridamole (71%). La precision
diagnostique fut meilleure avec la scintigraphie au thallium-dipyridamole (79%
contre 62% [p < 0.02]).
La scintigraphie au thallium-dipyridamole est superieure a la scintigraphie
controlee de la masse sanguine pour l’evaluation peroperatoire des patients qui
subissent une chirurgie vasculaire.
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C

areful preoperative cardiac as
sessment is most important in
patients who must undergo vascu
lar surgery, since cardiac complica
tions account for half of all the
postoperative deaths.1 The methods
used for this assessment include
clinical evaluation, electrocardio
graphic exercise stress testing,
gated blood pool scanning, dipyri
damole thallium imaging and coro
nary arteriography. Although coro
nary arteriography may be the most
definitive examination, its routine
use as a preoperative screening test2
has not been widely accepted, be
cause it is invasive and expensive
and provides anatomical rather than
functional information. Initially the
use of noninvasive tests may be
preferable to identify those patients
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who are at cardiac risk. Coronary
arteriography can then be carried
out selectively to plan preliminary
coronary artery repair when indicat
ed.
Indices of clinical risk, though
important, may be unreliable.3 The
use of exercise electrocardiographic
testing is severely limited by the
inability of many patients with vas
cular disease to perform at a level
sufficient to produce symptoms or
electrocardiographic changes.4-5
Dipyridamole thallium imaging is a
valuable preoperative screening test
in this group of patients because of
its high sensitivity.6' 8 The measure
ment of left ventricular ejection
fraction by gated blood pool scan
ning has proven helpful in deter
mining which patients are at high
risk for perioperative myocardial in
farction9 after aortic aneurysm re
pair.
The present study was undertak
en to compare the ability of dipyri
damole thallium imaging and gated
blood pool scanning to predict peri
operative cardiac complications in a
group of patients requiring abdomi
nal aortic surgery.

Method
Patients, seen by members of the
Division of Vascular Surgery at the
Ottawa Civic Hospital, who required
abdominal aortic aneurysm repair or
aortoiliac reconstruction for occlu
sive disease were enrolled in a pro
spective study protocol. Informed
consent was obtained. Each patient
was then seen by one of two cardi
ologists (J.E.C. or T.D.R.) for care
ful evaluation of their clinical status
and electrocardiographic findings.
Patients who had had an acute
myocardial infarction within 3
months, who had unstable angina
or valvular disease were excluded
from the study. The remaining pa
tients underwent dipyridamole thal

lium imaging and gated blood pool
scanning for measurement of left
ventricular ejection fraction prior to
admission for surgery. Patients who
had more than one area of delayed
reperfusion on dipyridamole thalli
um imaging or a left ventricular
ejection fraction of 20% or less
were also excluded.
Dipyridamole thallium imaging
was carried out as described previ
ously.8 Dipyridamole was infused
intravenously at a rate of 0.14
m g/kg-m in'1 for 5 minutes and
was followed 2 minutes later by 2
mCi of thallium-201. Myocardial
imaging was performed 5 and 180
minutes after thallium injection. Se
quential planar images were ob
tained on an imaging table in the
anterior, 45° and 70° left anterior
oblique positions for a pre-set time
of 7 minutes each. Electrocardio
graphic tracings and blood pressure
were monitored throughout the
test. The thallium images were re
viewed on a computer display and
interpreted by two independent ob
servers.
Gated blood pool scanning was
carried out as previously described9
The red blood cell pool of each
patient was labelled using the in
vivo method and 25 mCi of technetium-99m. Images were obtained
at rest in multiple views — anterior,
45° left anterior oblique and 30°
left posterior oblique. The left ven
tricular ejection fraction was calcu
lated from a background subtracted
time-activity curve generated using
a semiautomated threshold and sec
ond derivative edge detection algo
rithm.
Study patients were carefully
monitored intraoperatively and for
72 hours postoperatively. Cardiac
complications recorded were cardiac
death, acute myocardial infarction,
acute pulmonary edema, ventricular
tachycardia or fibrillation and se
vere intraoperative ischemia. A di
agnosis of acute myocardial infarc

tion was based on electrocardio
graphic evidence of new ST-segment elevation or T-wave inversion
with elevated levels of creatine ki
nase isoenzymes-MB fraction. A di
agnosis of acute pulmonary edema
was based on chest x-ray films and
clinical criteria with a mean pulmo
nary capillary wedge pressure great
er than 18 mm Hg.
Severe intraoperative ischemia
was diagnosed by electrocardio
graphic evidence of ST-segment de
pression in association with system
ic hypotension and an elevation of
the mean capillary wedge pressure
above 18 mm Hg.

Results
The final study population com
prised 85 patients (66 men, 19
women), and the average age was
67 years. Fifty-six patients had re
pair of an abdominal aortic aneu
rysm, and 29 had reconstruction for
aortoiliac occlusive disease.
Perioperative cardiac complica
tions were observed in 33 patients
(39%). These complications oc
curred following 21 (38%) of the 56
aortic aneurysm repairs and 12
(41%) of the 29 aortobifemoral
grafting procedures. There were 11
acute myocardial infarctions, 2 car
diac deaths, 26 episodes of acute
pulmonary edema, 3 of ventricular
arrhythmia and 2 of severe intraop
erative cardiac ischemia.
Thallium redistribution, indicat
ing an area of ischemic myocardi
um, was found in 45 (53%) patients.
Cardiac complications occurred in
30 (67%) of them. Only 3 (8%) of
the 40 patients without thallium
redistribution suffered cardiac com
plications. The sensitivity of dipyri
damole thallium scanning, defined
as the proportion of patients with
complications who had a positive
test, was 91%. The specificity, de
fined as the proportion of patients
CJS, VOL. 33, NO. 3, JUNE 1990
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without complications who had a
negative test, was 71%.
The left ventricular ejection frac
tion was less than 50% in 17 (20%)
of the patients in the study; cardiac
complications occurred in 9 (53%)
of these. Only 24 (35%) of the 68
patients with no ventricular dys
function suffered perioperative car
diac complications. The sensitivity
of the left ventricular ejection frac
tion was 27% and the specificity
85%.
The sensitivity of dipyridamole
thallium scanning was significantly
(p < 0.01, Student’s t-test) greater
than that of left ventricular ejection
fraction (Fig. 1). However, the spec
ificity of the two tests was not
significantly different.
Diagnostic accuracy combines
sensitivity and specificity and is cal
culated as true-positive results plus
true-negative results divided by the
total number of patients. The diag
nostic accuracy of thallium imaging
(79%) was significantly greater (p <
0.02) than that of gated blood pool
scanning (62%) (Fig. 1).

cized because of its high cost and
invasive complications.
Risk indices have been developed
by Goldman and colleagues12 and
modified by others, including
Detsky and associates.13 In our ex
perience,14 53 (15.9%) of a series of
353 patients requiring arterial re
pair had postoperative cardiac com
plications. The serious clinical risk
factors were symptom severity
(NYHA class III or greater), evi
dence of previous myocardial infarc
tion on a resting electrocardiogram,
nonspecific ST-segment electrocar
diographic changes and age older
than 70 years. Similar results were
reported by Johnston,15 who found
that 15.1% of patients from a mul
ticentre series of 666 nonruptured
aneurysms had postoperative cardi
ac problems, and that age, previous
electrocardiograhic evidence of
myocardial infarction and conges
tive failure were associated with
these events.
We have also reported the value
of exercise testing in the evaluation
of cardiac risk in vascular surgical

patients.48 Although the exercise
stress test is an excellent method of
excluding serious coronary artery
disease (specificity 89%), its sensi
tivity is low (23%), because up to
50% of patients with peripheral vas
cular disease cannot achieve a suffi
ciently high exercise level to pro
duce a positive test. This problem
of inconclusive electrocardiographic
test results has also been noted by
Cutler and colleagues5 and by
Leppo and associates.16 We believe
that exercise electrocardiographic
testing is not very helpful in preop
erative assessment of patients with
peripheral vascular disease.8
Dipyridamole thallium imaging is
a noninvasive test which can be
performed readily in most patients
with peripheral vascular disease. Its
value in these patients was first
reported by Boucher and associ
ates,6 who found that 8 of 16
patients with thallium redistribution
suffered postoperative cardiac com
plications compared with none of
32 patients without thallium redis
tribution. Leppo and associates,16 in

Discussion
The importance of perioperative
cardiac complications as a cause of
death and major morbidity after
arterial repair was noted by Hertzer,1 who followed up 273 patients
for as long as 11 years after lower
limb revascularization. He found
that acute myocardial infarction
was responsible for 52% of the early
and 55% of the late postoperative
deaths. He also reported2 an inci
dence of severe coronary artery dis
ease in 25% of 1000 patients who
presented with peripheral vascular
disease and had preoperative cardi
ac catheterization. It has been sug
gested that cardiac risk is decreased
by preliminary coronary artery re
construction.1011 However, coro
nary arteriography has been criti
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FIG. 1. Comparison of sensitivity, specificity and diagnostic accuracy of gated blood
pool scanning (stippled bars) and dipyridamole thallium-201 imaging (black bars)
for prediction of cardiac complications after aortic surgery. * = p < 0.02; ** = p <

0 .01 .
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a study of 89 patients, found that
thallium scanning was superior to
clinical risk factors and to exercise
stress testing. The presence of thal
lium redistribution was the most
important predictor of serious cardi
ac events. In a subsequent report by
Cutler and Leppo,7 60 patients with
normal thallium scan results had
aortic repair without myocardial in
farction or cardiac deaths, com
pared with an infarction rate of 21%
in 31 patients with one or more
areas of thallium redistribution. We
reported previously8 that dipyrida
mole thallium scanning had a sensi
tivity of 86% as a predictor of
cardiac complications after aortic
surgery and was clearly superior to
exercise stress testing.
The measurement of global and
regional ventricular function by
gated blood pool imaging was de
veloped by Strauss and colleagues
in 1971.9 The test is relatively noninvasive, is associated with mini
mal risk and radiation exposure, is
reproducible and can readily be re
peated. Like dipyridamole thallium
imaging, gated blood pool scanning
can be applied to almost all patients
with vascular disease. Left ventricu
lar ejection fraction has been shown
to correlate with both early and late
deaths after acute myocardial in
farction.17' 20
Pasternack and colleagues21 stud
ied 50 patients before they under
went abdominal aortic aneurysm re
pair and found that the risk of
postoperative myocardial infarction
and cardiac death correlated with
the left ventricular ejection fraction.
The cardiac death rate was zero
when the left ventricular ejection
fraction was greater than 55% and
20% when the ejection fraction was
less than 35%.
McCann and colleagues22 evaluat
ed the influence of left ventricular
ejection fraction on perioperative
death in 104 patients who had
repair of abdominal aortic aneu

rysms. They found that the periop
erative death rate was not signifi
cantly different in patients who had
an ejection fraction less than 35%
compared with those whose ejection
fraction was greater than 35%.
They concluded that patients
should not be denied aortic aneu
rysm repair solely on the basis of a
low left ventricular ejection frac
tion.
Our data showed (Fig. 1) that a
left ventricular ejection fraction less
than 50% was not a sensitive pre
dictor of perioperative cardiac com
plications. The presence of thallium
redistribution was significantly
more sensitive (91% versus 27%, p
< 0.01), with similar specificity.
The diagnostic accuracy of thallium
imaging was significantly greater
than that of gated blood pool scan
ning.
Postoperative cardiac complica
tions develop after vascular surgical
procedures because of severe coro
nary artery stenosis or left ventricu
lar dysfunction, or both. Dipyrida
mole thallium imaging detects sig
nificant coronary artery stenoses in
contrast to gated blood pool imag
ing which assesses left ventricular
function. Our data suggest that the
presence of coronary artery disease
is a more important factor than left
ventricular dysfunction in the devel
opment of postoperative cardiac
complications.
Optimal preoperative evaluation
of patients who require aortic sur
gery includes clinical assessment
and dipyridamole thallium imaging.
Patients who have a negative scan
are at low risk and can undergo
operation without further investiga
tion. Those with a positive dipyrida
mole thallium scan should undergo
coronary arteriography with the
goal of coronary revascularization if
the patient has angina or if the
perfusion defect is extensive, indi
cating multivessel disease.
In a patient who has a perfusion

abnormality limited to one segment,
the clinician must consider a num
ber of factors, including the urgen
cy of the aortic surgery, the likeli
hood of benefit from coronary angi
oplasty or repair over medical treat
ment, and the additional risk of
these procedures. Gated blood pool
scanning is useful to further stratify
risk in this group of patients.

Conclusions
Dipyridamole thallium imaging of
myocardial perfusion is superior to
gated blood pool scanning evalua
tion of left ventricular function for
predicting cardiac complications
after abdominal aortic surgery. It
should be the initial noninvasive
test used to screen these patients
preoperatively.
We acknowledge the technical assis
tance of Norma Bowman and Lynn
Vigus, RN, BScN.
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SESAP VI Critique
Item 121
Abdominal computed tomographic (CT) scans are helping to change the management of liver injuries. Small
intraparenchymal hematomas seen on CT scan in otherwise asymptomatic patients after blunt trauma may be
managed nonoperatively. Expanding intrahepatic hematomas are best treated by evacuation, direct ligation of
the bleeding vessels, and adequate drainage when found at operation. Subcapsular rupture may follow an injury
that appears to be slight, with an interval of several hours or days between the injury and the onset of
symptoms. Hepatic artery ligation is rarely indicated. Recent evidence suggests that packing the liver wound and
returning to the operating room three to four days later is a useful technique for an unstable patient whose
hemorrhage is otherwise uncontrollable.
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Chest-Wall Tumours
Kenneth G. Evans, MD, FRCSC;* Roberta R. Miller, MD, FRCPC;t Nestor L. Muller, MD, FRCPC;J Bill
Nelems, MD, FRCSC*
Between August 1984 and October 1988, 7 women and 16 men underwent
chest-wall resection. The 23 patients ranged in age from 17 to 79 years. Resection
was done for benign lesions in 9 patients, for recurrent chest-wall sarcoma in 4 and
for carcinoma involving the chest wall in 10. The number of ribs resected ranged
from none to six.
Prosthetic material was required for reconstruction in eight patients. There were
no operative deaths and no flail segments developed postoperatively. Three patients
have since died of metastatic disease, one has died of unrelated causes but with no
residual disease and the remainder were alive and well at follow-up intervals ranging
from 11 to 60 months. Aggressive resection, including a wide margin of healthy
tissue, provides the best chance for recurrence-free survival for patients with many
types of chest-wall tumour. Resection can be performed with low morbidity and
satisfactory cosmetic results.

Entre aout 1984 et octobre 1988, 7 femmes et 16 hommes ont subi une resection de
paroi thoracique. L’age des 23 patients s’etalait de 17 a 79 ans. La resection fut
pratiquee pour des lesions benignes dans 9 cas, pour une recidive d’un sarcome de
la paroi thoracique dans 4 cas et pour un carcinome envahissant la paroi thoracique
dans les 10 autres cas. Le nombre de cotes resequees a varie de zero a six.
Du materiel prosthetique a ete requis pour la reconstruction chez huit patients.
Aucun deces peroperatoire n’a ete enregistre et aucun volet thoracique n’est apparu
en postoperatoire. Trois patients sont decedes depuis, de metastases, un patient est
mort de causes non reliees mais sans signe de maladie residuelle, alors que les
autres sont toujours vivants et en bonne sante, de 11 a 60 mois apres Tintervention.
Une resection agressive comprenant une large bordure de tissu sain offre la
meilleure chance de survie sans recidive chez les patients souffrant de plusieurs
types de tumeurs de la paroi thoracique. Cette resection, qui peut etre pratiquee
avec une faible morbidity, donne des resultats esthetiques satisfaisants.

and reconstruction of
R esection
the chest wall is a continuing
challenge to the thoracic surgeon.
Indications for chest-wall resection
include primary benign tumours
and tumour-like lesions, primary
chest-wall sarcomas, neoplasms
metastatic to chest wall, direct ex
tension to chest wall by otherwise
operable bronchogenic carcinomas
(stage Ilia) and loss of chest-wall

integrity because of congenital
anomalies, traumatic injury, ra
dionecrosis or chronic infection.1-10
The two basic goals of chest-wall
resection are to treat the underlying
lesion adequately and to provide a
repair that is stable enough for
respiratory function, sturdy enough
to protect chest contents and cos
metically acceptable.
We present our experience with
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chest-wall resection and reconstruc
tion at the Vancouver General Hos
pital.

Patients and Methods
Between August 1984 and Octo
ber 1988, chest-wall tumours were
removed from 16 men and 7 women
who ranged in age from 17 to 79
years. Chest-wall resection, defined
as resection of bone and muscle,
was performed in 21 patients. Com
puted tomography (CT) of the chest
and bone scanning were carried out
preoperatively in all 23 patients. In
nine patients involvement of the
chest wall by bronchogenic carcino
ma was suspected; mediastinoscopy
and surveys for metastasis were
carried out, but preoperative chestwall biopsy was not done. Eight of
the remaining 14 patients had pre
operative biopsy of their chest-wall
lesion, as described below. All CT
scans were reviewed by one of us
(N.L.M.) and resected specimens
were reviewed by another (R.R.M.).

Results
Nine patients had resection for
benign lesions (Table I). Seven of
these were symptomatic. Two pa
tients had fibromatosis that was not
associated with rib destruction. Fol
lowing wide excision and Prolenemesh reconstruction, cosmetic and
functional results were excellent.
Five patients had radiologic evi
dence of bone destruction; three
were thought preoperatively to have
malignant disease, but needleCJS, VOL. 33, NO. 3, J U N E 1990
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aspiration biopsies were not diag
nostic (Table I). Four had local
excision only. One patient was
treated with wide excision when
intraoperative analysis of a frozen
section suggested a necrotic tu
mour; the interpretation was erro
neous. The two patients with
asymptomatic peripheral nerve
sheath tumour had excisional biop
sy only. No patient with a benign
lesion has experienced recurrence.
Four patients underwent resec
tion for recurrent chest-wall sarco
mas (Table I). All had radiologic
evidence of bone destruction and a
chest-wall mass on physical exami
nation. In two patients biopsy was
done before wide excision to con
firm the diagnosis. The three pa
tients with recurrent chondrosar
coma had undergone local excision,

4, 24 and 34 months previously.
The fourth patient had experienced
multiple recurrences of malignant
fibrous histiocytoma of the shoul
der which ultimately required en
bloc forequarter and apical chestwall resection. All patients required
reconstruction of the chest wall
with Prolene; all were free of recur
rence from 17 to 26 months after
operation.
Ten patients had carcinoma in
volving the chest wall (Table II).
Nine underwent pulmonary resec
tion for bronchogenic carcinoma
with en bloc removal of adjacent
ribs for suspected chest-wall inva
sion. Five lobectomies and four
pneumonectomies were performed.
Three patients had radiotherapy to
the chest wall preoperatively; none
had adjuvant therapy postoperative

ly. Intraoperatively in each case,
when no extrapleural plane of dis
section was found, two to five overlying ribs had to be removed. Al
though only two of these nine pa
tients had CT evidence of chest-wall
invasion preoperatively, at opera
tion tumour was found to involve
bone or soft tissue, or both, of the
chest wall in all but one. The tenth
patient had an isolated rib metasta
sis. Two of the 10 patients required
Prolene mesh reconstruction; the
defects in the other 8 were posterosuperior and protected by the
scapula. Three of these 10 patients
died of tumour, the other 7 were
alive and well at follow-up from 11
to 60 months after operation. There
were no operative deaths, no flail
segments and no wound complica
tions postoperatively.

Table 1. P a tie n ts W h o Had M e s e n c h y m a l C h e st-W a ll L e s io n s
Patient
no.
B e n ig n
1
2
3
4
5
6
7
8
9
M a lig n a n t
10
11
12
13

Sex

Age, yr

Symptoms

Biopsy type

M
F
F
M
F
M
F
M
M

29
35
33
65
40
17
52
32
33

M ass
M ass
N one
N one
Pain
Pain
Pain
Pain
Pain

IB
IB
N one
N one
FNA
N one
N one
FNA
FNA

M
F
M
M

62
69
67
72

M ass
M ass
M ass
M ass

FNA
N eedle
N one
N one

No. ribs
resected

Follow-up, mo

D e s m o id tu m o u r
D e s m o id tu m o u r
P e rip h e ra l ne rve sh e a th tu m o u r
P e rip h e ra l ne rve sh e a th tu m o u r
F ib ro u s d ys p la s ia
U n ic a m e ra l bone c y s t
E o s in o p h ilic g ra n u lo m a
T u b e rc u lo s is
T u b e rc u lo s is

6
2
0
0
1
1
1
4
1

17
46
50
14
28
21
50
50
15

R e c u rre n t
R e c u rre n t
R e c u rre n t
R e c u rre n t

3
3
5
4

21
20
26
17

No. ribs
resected

Follow-up, mo

4
3
2
2
5
3
3
3
4
3

2*
32*
38
36
16
11
11
20*
60
16

Diagnosis

ch o n d ro s a rc o m a
ch o n d ro s a rc o m a
c h o n d ro s a rc o m a
m a lig n a n t fib ro u s h is tio c y to m a

IB = in c is io n a l b io p s y , FN A = fin e -n e e d le a s p ira tio n b io p s y .

Table II. P a tie n ts W h o H ad C a rc in o m a s In v o lv in g th e C h e st W a ll
Patient
no.
14
15
16
17
18
19
20
21
22
23

Sex

Age, yr

Symptoms

Preoperative
radiotherapy

M
M
M
F
M
M
M
M
F
M

66
54
67
56
40
46
79
55
44
46

Pain
Pain
N one
Pain
N one
Pain
Pain
Pain
Pain
M ass

No
No
No
No
No
No
Y es
Y es
Y es
No

'D ie d o f d ise ase .
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Diagnosis
A d e n o c a rc in o m a , T 3 N 0
S q u a m o u s c a rc in o m a , T3N 1
S q u a m o u s c a rc in o m a , T3N 1
A d e n o c a rc in o m a , T 3 N 0
L a rg e c e ll c a rc in o m a , T 2 N 0
S q u a m o u s c a rc in o m a , T 3 N 2
S q u a m o u s c a rc in o m a , T 3 N 0
A d e n o c a rc in o m a , T 3 N 0
A d e n o c a rc in o m a , T 3 N 0
M e ta s ta tic m a lig n a n t m ix e d tu m o u r

CHEST-WALL TUMOURS

Discussion
The features of primary chestwall mesenchymal lesions are de
scribed in several series.1' 7 Overall,
approximately half of such lesions
are malignant. In those series, as in
ours, clinical features such as pain
or a palpable mass were unreliable
for distinguishing benign from ma
lignant processes. Relatively com
mon benign tumours include chon
dromas, osteochondromas and fi
brous dysplasia.1’27 Extensive fi
bromatosis of the chest wall is less
common6 and tuberculomas defying
pre-excisional diagnosis are unusu
al.2 Except in the instance of fi
bromatosis, local excision of benign
tumours is generally considered to
be adequate and is associated with a
low risk of recurrence.1'2,6
Malignant mesenchymal chestwall neoplasms are more difficult to
manage. Fibrosarcoma of soft tissue
and osteosarcoma and chondrosar
coma of bone23'56 are the most
common types in adults. The treat
ment of choice for fibrosarcoma and
osteosarcoma is radical excision
with adjuvant chemotherapy.2
These series clearly show that the
best chance for survival in patients
with such lesions is wide excision at
the time of presentation. Complete
initial excision of relatively well-dif
ferentiated osteo-, chondro- and fi
brosarcomas is associated with a
long-term survival of approximately
90%.4'6 However, late recurrence is
associated with a high risk of death.
In contrast, there are several
types of primary chest-wall malig
nant disease in which primary sur
gical resection is not indicated and
definitive treatment starts with che
motherapy or radiotherapy, or both.
These include lymphoma, Ewing’s
sarcoma, rhabdomyosarcoma and
solitary myeloma of bone.289
The dilemma facing the thoracic
surgeon is what approach to use in
a patient with an unknown diagno

sis so that the procedure is neither
unnecessarily radical nor so inade
quate as to risk recurrence. The
solution to this dilemma is contro
versial. Fine-needle aspiration
serves mainly to confirm a specific
diagnostic impression rather than
to establish a firm primary diagno
sis. Similarly, core needle biopsy
provides insufficient material for a
specific primary diagnosis.8 Al
though there are advocates of wide
excision for all lesions,7 most inves
tigators recommend excisional biop
sy followed by wide resection at a
later date, depending on the histo
logic diagnosis.1’26-8 For very large
lesions in which excisional biopsy is
not feasible, generous incisional bi
opsy is recommended.8
Clinical, diagnostic, surgical and
prognostic considerations for pa
tients with bronchogenic carcinoma
involving the chest wall differ from
those for patients with primary
mesenchymal chest-wall lesions. In
our series, seven of eight patients
who had chest-wall invasion had
pain, but none had a palpable mass.
This finding is in agreement with
the experience of others.1011 We
found that CT was insensitive for
assessing chest-wall invasion;12 two
series1011 reported radiologic evi
dence of bone or chest-wall invasion
in approximately 40% of cases in
which resection of the overlying
chest wall was required. Chest-wall
biopsy is not indicated in patients
with possible stage Ilia broncho
genic carcinoma.
Like Patterson and colleagues11
and unlike Grillo and asssociates10
we have not included in this series
cases of parietal pleural dissection
without sacrifice of bone and mus
cle. It is crucial that tumour not be
left behind at the resection margins
of pleural and chest wall in cases of
resected T3 bronchogenic carcino
ma. Grillo and colleagues10 in fact
recommend chest-wall resection
rather than extrapleural dissection

for T3 bronchogenic carcinoma be
cause in their series it provided the
best chance for long-term survival
and also better palliation; our ap
proach is less aggressive.
Intraoperatively, we decide to re
sect overlying chest wall on the
basis of whether or not an extra
pleural dissection plane can readily
be achieved. If there is any difficulty
in establishing such a plane, wide
excision of the adherent chest wall
is performed. In eight of our nine
cases of bronchogenic carcinoma,
the surgical impression of tumour
invasion of chest wall proved cor
rect; the other case was fibrous
adhesions negative for malignant
disease. The number of ribs sacri
ficed en bloc (two to five) in our
series was comparable to that of
others (one to five).11
The question of preoperative and
postoperative radiotherapy in such
patients is not resolved. Although
postoperative radiotherapy is used
by some surgeons,1011 we prefer to
apply radiotherapy, if appropriate,
to tissues that will later be resected
and to avoid the potential for post
operative radiation to damage the
residual lung tissue filling the in
volved hemithorax. The prognosis
for patients with bronchogenic car
cinoma involving the chest wall is
by no means hopeless. In the series
of Grillo and colleagues,10 for pa
tients undergoing chest-wall resec
tion, the 4-year survival rate was
16%. In the Toronto series,11 the
5-year survival rate was 38%. In a
Mayo Clinic series,6 in which the
median follow-up was 31.5 months,
54% of patients were survivors. In
our series, five of eight patients
with resected T3 bronchogenic car
cinoma were free of tumour al
though in only three of them was
the follow-up longer than 2 years.
Wide excision of the chest wall is
generally defined67 as complete re
moval of involved rib(s), portions of
the ribs immediately above and
CJS, VOL. 33, NO. 3, JUNE 1990
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below the area of involvement and
all adherent muscle, pleura and
lung. We strongly advise wide exci
sion for all malignant chest-wall
tumours. In our series, three of the
recurrent sarcomas resulted from
previous excisions that were inade
quate. Resection of the entire in
volved rib is recommended for pri
mary rib sarcomas.
Wide excision would often be
impossible were it not for methods
of chest-wall reconstruction.5-613' 17
Unless the bone defect is covered by
the scapula, resection of four or
more ribs usually requires bone
reconstruction to prevent flail seg
ments.14 Such reconstructions may
be achieved by a variety of prostheses. Marlex mesh is a single-stitch
knit polypropylene material6 that
can be used as a single layer,16 as a
double layer11 or as a “sandwich”
enclosing a solid layer of hardened
methyl methacrylate.5-15 Prolene
mesh is a double-stitch knit poly
propylene material6 that is more
rigid than Marlex and which we and
others6-13-17 prefer.
In the event that extensive overlying skin and subcutaneous tissue
must be sacrificed, soft-tissue repair
with myocutaneous or omental
flaps provide functionally accept
able results.14 Soft-tissue repair was
unnecessary for the 23 patients in
this series.
From a subjective standpoint, the
cosmetic results following wide ex
cision and reconstruction were sat
isfactory in this series. The func
tional results in terms of respiratory
mechanics and chest-wall stability
were also satisfactory.
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Everybody's now into activity
and healthy eating, doggone it!
We think you should be too!

Makeyourmove.

ORIGINAL ARTICLES

Abdominal Tuberculosis
Sabah Al-Hadeedi, MB, FRCSI; H.S. Walia, MB, MS, FRCS(Edin), FRCS;
Hilal M. Al-Sayer, MB, ChM, FRCS
Forty-two cases of abdominal tuberculosis seen between June 1984 and June 1988 at
Amiri Hospital in Kuwait were reviewed retrospectively. The clinical diagnosis was
correct in only 35%. Nine patients presented as an emergency, but in none was a
diagnosis of tuberculosis considered. Abdominal pain and tenderness were the
commonest clinical findings; “doughy abdomen” and a mass in right iliac fossa were
uncommon. Thus, symptoms were vague, signs nonspecific and investigations
nonpathognomonic. In spite of this, abdominal tuberculosis should be considered in
any patient who has obscure abdominal symptoms, weight loss and lethargy.
Laparoscopy and colonoscopy with biopsy for histologic and bacteriologic study led
to a definitive diagnosis in 66% of cases, obviating the need for exploratory
laparotomy in many. Histologic examination was the surest way to establish the
diagnosis.

Quarante-deux cas de tuberculose abdominale vus entre juin 1984 et juin 1988 a
l’hopital Amiri, au Koweit, ont fait l’objet d’une etude retrospective. Le bon
diagnostic clinique fut pose dans seulement 35% des cas. Neuf patients etaient des
cas d’urgence; pas une fois, le diagnostic de tuberculose fut entretenu. La sensibilite
et la douleur abdominales etaient les signes cliniques les plus frequents; la presence
d’une “abdomen pateux” et d’une masse dans la fosse iliaque droite etaient des
observations frequentes. Les symptomes etaient done vagues, les signes non
specifiques et les examens non pathognomoniques. Neanmoins, une tuberculose
abdominale devrait etre envisagee chez les patients qui se plaignent de symptomes
abdominaux obscurs, de perte de poids et de lethargie. Une laparoscopie et une
colonoscopie avec biopsie pour examens histologique et bacteriologique ont permis
d’arriver a un diagnostic definitif dans 66% des cas, ce qui a permis d’eviter, pour
plusieurs, une laparotomie exploratrice. L’examen histologique s’est avere le moyen
le plus fiable pour etablir le diagnostic.

t the turn of the century,
Walsh1 stated that it was im
possible to diagnose abdominal tu
berculosis with any degree of cer
tainty. Unfortunately, this remains
true, even in situations in which
abdominal tuberculosis is relatively
common. The number of cases of
abdominal tuberculosis has fallen

A

rapidly in developed countries, but
the disease continues to be a major
scourge in developing countries.
The symptoms are vague, signs
nonspecific and investigations are
nonpathognomonic, so many pa
tients require a diagnostic laparoto
my, even though tuberculosis is
rarely an emergency.2 Abdominal
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tuberculosis is often forgotten, es
pecially when pulmonary disease is
absent.3 Overemphasis on the pres
ence of an abdominal mass or
“doughy” abdomen, coupled with
the insidious nature of the disease,
reduces suspicion further.4 An accu
rate diagnosis of abdominal tuber
culosis is important because chemo
therapy alone has been proven sat
isfactory5 and a definitive diagnosis
would obviate an exploratory lapa
rotomy.
In this paper, we emphasize how
often abdominal tuberculosis is un
suspected, the pitfalls in diagnosis
and the use of emerging endoscopic
modalities.

Patients and Methods
The records of 42 patients (26
men, 16 women) who had abdomi
nal tuberculosis and were seen at
Amiri Hospital in Kuwait between
June 1984 and June 1988 were
studied retrospectively. They repre
sented 1.05% of all admissions to
the surgical department. Tuberculo
sis of the abdomen was diagnosed if
the following were present.
• Histologic evidence of caseating granulomas.
• Histologic demonstration of
acid fast bacilli (AFB) in the lesion
or lymph nodes.
• Growth of AFB on culture of
tissue or in ascitic fluid.
• Typical macroscopic appear
ance at operation with mesenteric
glands showing caseating granulo
mas or AFB.
CJS, VOL. 33, NO. 3, JU N E 1990
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• Typical picture with noncaseating granulomas but proven
tuberculosis elsewhere.
• Typical gross appearance of
bowel with positive response to che
motherapy without subsequent re
currence.
Specimens were examined for
bacteria using standard laboratory
techniques. The tubercular skin test
(Mantoux test, 1 in 1000) was inter
preted as positive if 10 mm or more
of induration was measured or if it
was recorded positive.
All patients underwent operation
or laparoscopy. Starting on postop
erative day 2, they received two or
three antitubercular drug regimens
consisting of streptomycin, rifampicin, isonicotinic acid hydrazide,
ethambutol or pyrazinamide, and
this was continued for 9 to 12
months.

Findings
Of the 42 patients, 16 were Ku
waitis, 16 were from the Indian
subcontinent, 3 were Egyptians and
the remaining 7 were from other
Arab countries. The average age
was 38.6 years (range from 22 to
70 years).
Nine patients presented with
acute abdominal symptoms and re
quired emergency surgery shortly
after admission. In none of these
was the diagnosis of abdominal tu
berculosis entertained (Table I).
Nine other patients underwent diag
nostic laparotomy and only in four
was tuberculosis suspected. In most
of the other cases either Crohn’s
disease, lymphoma or other intra
Table 1. Provisional Diagnosis in Patients
Who Had Emergency Surgery
Diagnosis
Perirenal abscess
Intestinal obstruction
Acute appendicitis
Peritonitis
Subphrenic abscess

234

No.
1
2
3
2
1
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abdominal malignant disease was
considered (Table II). In 12 patients
abdominal tuberculosis was diag
nosed unexpectedly when surgery
was performed for another indica
tion.
The duration of symptoms
ranged from 6 hours to 4 years
(mean 3.6 months). The majority of
patients (71%) had localized abdom
inal pain. Other common symptoms
(Table III) were vomiting, anorexia,
weight loss and pyrexia, followed in
frequency by night sweats, abdomi
nal distension and diarrhea. Tender
ness, with or without rigidity, was
the commonest sign, especially in
those who had acute symptoms.
Anemia and malnutrition were next.
An abdominal mass was found in
six cases; in four it occurred in the
right iliac fossa and in the other
two in the left hypochondrium and
right renal area.
The erythrocyte sedimentation
rate was elevated (more than 25
mm/h) in all patients except the 12
whose tuberculosis was found inci
dentally, in whom the rate was
normal (8 to 20 mm/h). In eight

patients the rate exceeded 100
m m /h. The hemoglobin level was
below 100 g /L in 17 patients, 6 of
whom had macrocytic anemia sec
ondary to vitamin B12 deficiency.
Surprisingly, all the patients who
had acute symptoms had leukocyto
sis (more than 11.0 X 109/L). The
Mantoux test was positive in only
30% of patients.
Thirty-nine of the 42 patients
had no evidence of pulmonary dis
ease on chest x-ray examination.
The others had a picture compatible
with healed lung lesions, pleural
effusion and mediastinal lymphnode enlargement, respectively. A
plain abdominal x-ray film, obtained
in 25 cases, showed nonspecific
changes such as small-bowel fluid
levels, with or without ascites, dif
fuse calcifications or localized ab
scess. Contrast studies, carried out
in 22 patients, included barium
meal in 10 patients, with followthrough in 5, and barium enema
examination in 7. The lesions iden
tified were as follows: esophageal
tuberculosis in one, duodenal stric
ture in one, small-bowel stricture in

Table II. Preoperative Diagnosis in Patients Who Had Elective Laparotomy
Crohn’s disease or tubercular stricture of duodenum
Right iliac fossa mass: tuberculosis or Crohn’s disease of colon
Lymphoma of the abdomen
Carcinoma of the head of the pancreas
Tuberculosis or carcinoma of the colon
Chronic appendicular abscess
Ileocecal tuberculosis
Stricture in the ascending colon, malignant disease or Crohn's disease
Cholangiocarcinoma
Table III. Presenting Clinical Features
Symptoms

No.

(%)

Signs

No.

(°/»)

Upper abdominal pain
Lower abdominal pain
Weight loss
Anorexia
Fever
Diarrhea
Vomiting
Distension
Night sweats
Constipation
Jaundice
Melena
Hematemesis (hemobilia)

17
13
22
19
14
8
24
10
10
3
3
3
1

(40)
(31)
(52)
(45)
(33)
(19)
(57)
(24)
(24)
(7)
(7)
(7)
(2)

Malnutrition
Anemia
Lymph nodes
Tender abdomen
“ Doughy” abdomen
Visible peristalsis
Ascites
Palpable liver
Rigidity
Mass: Right iliac fossa
Other
Pleural effusion
Hip flexion deformity

14
17
2
24
4
3
8
5
9
4
2
1
1

(33)
(40)
(5)
(57)
(10)
(7)
(19)
(12)
(21)
(10)
(5)
(2)
(2)
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two, ileocecal deformity in five and
proximal colonic deformities in
four. Ultrasonography and comput
ed tomography were done in 30
cases but did not add to the find
ings of conventional radiology, ex
cept in three patients. In one, an
abdominal mass was shown to
“melt” under antitubercular chemo
therapy. In the second, the two
investigations confirmed the origin
of a gluteal sinus from the retroper
itoneal lymph nodes and in the
third, they established the percuta
neous drainage in a case of psoas
abscess.
Twenty-four patients underwent
various endoscopic procedures. Six
had upper gastrointestinal endosco
py and biopsy which gave a diagno
sis in two (one lesion each in esoph
agus and duodenum). Seven of 11
colonoscopies were positive, but
surgery was avoided in only two
cases. Laparoscopy was the most
successful procedure, being positive
in all seven cases, and thus avoiding
surgery in all.
The accuracy of clinical diagnosis
was only 38%. In all patients, the
diagnosis was confirmed histologi
cally from peritoneal tubercles,
Table IV. Operative or Laparoscopic
Findings of Tissue Involvement in 42
Patients
Finding
Gastrointestinal involvement
Esophageal
Duodenal
Stomach
Small intestinal
Appendiceal
Ileocecal
C olonic/rectal
Perianal
Peritoneal or lymph-node
involvement
Peritoneal tubercles
Lymphadenopathy
Paradochal lymph nodes
Adhesive
Subphrenic
Other organ involvement
Pancreatic
Hepatic
Gallbladder
Omental

lymph nodes or resected specimens,
or by demonstration of AFB in
tissues or smears and cultures.
Table IV shows the tissues or or
gans involved in the tubercular
process.
All three patients who died had
associated serious disease. One had
leiomyosarcoma of the stomach
with a single secondary tumour in
the right lobe of the liver. Radical
gastrectomy and right hepatectomy
were performed. The liver was
found to be packed with caseating
granulomas. The patient had hemobilia from one of the tuberculomas
after disseminated intravascular co
agulation developed. The second
patient was operated on for cirrho
sis of the liver. A Sugiura proce
dure was performed. Liver biopsy
showed multiple caseating granulo
mas. Antitubercular treatment was
started, but a subphrenic abscess
developed and the patient died 8
weeks after operation. The third
patient had radical gastrectomy for
carcinoma of the stomach. The
stomach and enlarged lymph nodes
along the lesser curve contained
caseating granulomas. This patient
received antitubercular treatment in
addition to chemotherapy for carci
noma. She died 1.5 years later of
metastatic disease.

No.
1
1
1
5
2
5
4
3

10
17
2
3
1
1
9
1
2

Discussion
With socioeconomic progress,
the prevalence of tuberculosis has
declined in the West but remains a
common disease in developing
countries. The incidence of gas
trointestinal tuberculosis complicat
ing pulmonary disease has been
reported to range from 5%, possibly
due to antitubercular chemothera
py,6 to 70%.7-9 In contrast, abdomi
nal tuberculosis at our hospital is
almost never associated with pul
monary disease, and this has been
confirmed by others.210

Although it is generally believed
that abdominal tuberculosis is more
common in women than in men,
our ratio was 1:1.6. Kaufman and
Donovan11 and Khoury and associ
ates12 reported a similar predomi
nance. The mean age of our pa
tients (38.6 years) is similar to that
reported by Howell and Knapton13
and Wales and colleagues14 but is
considerably more than that report
ed by Addison15 and Walsh.1
Tuberculosis may infect the gas
trointestinal tract through blood,
lymphatics or by direct extension;
most infection results from swal
lowing infected sputum. But a
change in pattern with greater pre
dominance of nonpulmonary disease
has been reported by Schofield.16
The 42 cases of gastrointestinal
tuberculosis in this series included
few (only 5) cases of ileocecal in
volvement in contrast to earlier re
ports.141517 Disease higher up in the
ileum is considered common (but
not in our series), involvement of
jejunum and appendix uncommon,
and tuberculosis of colon, rectum
or upper gastrointestinal tract is
rare.14151819 Tubercular peritonitis
often follows blood-borne spread
from near or remote infection sites
or locally from the lymph nodes,
bowel or female reproductive or
gans. Concomitant lesions of bowel
and peritoneum were uncommon in
our study and that reported by
Gonnella and Hudson.20
The duration of symptoms of
abdominal tuberculosis before the
diagnosis is made range from 1 year
or less up to 3 years.21' 24 Although
symptoms are nonspecific, the dis
ease should be considered in any
patient who has obscure abdominal
symptoms with lethargy and weight
loss. Physical findings are also non
specific.1921 Although an abdominal
mass is cited historically as the
most common finding,71419 21 it was
noted in only six (14%) of our
cases. Twelve of our patients had
CJS, VOL. 33, NO. 3, JUNE 1990
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no complaints and the diagnosis
was made during unrelated surgery.
Most investigations were of little
help. The Mantoux test was positive
in only 30% of the patients, a rate
similar to that reported by Find
lay.25 Like Shukla and Hughes,10 we
observed a strong association be
tween a markedly positive test and
intra-abdominal tuberculosis. The
erythrocyte sedimentation rate was
elevated above 100 m m /h in about
19% of the cases and more than 25
m m /h in 70% of the patients but
was normal in the other 30%. Allen
and associates26 also noted a normal
rate in 25% of cases. The leukocyte
count was normal in all except
emergency cases. A further 40% of
our patients were anemic, and 33%
had m alnutrition and hypoproteinemia. Although a histologic
diagnosis was obtained in all pa
tients, only three had demonstrated
AFB and five were reported to have
positive cultures. This low yield has
also been reported by Prakash and
colleagues27 and Lambrianides and
associates.2
Homan and associates3 stated
that negative findings on the chest
x-ray film are sufficient to exclude
abdominal tuberculosis whereas
Sharma and colleagues24 and Shuk
la and Hughes,10 like us, recorded a
very small number of patients with
pulmonary disease. Similarly, radi
ologic appearances on contrast
studies of the gut are often sugges
tive, but seldom diagnostic, of tu
berculosis. The changes seen are
secondary to inflammatory masses,
thickening of bowel wall, ulceration
or fistulization of the gut.
In our series, ultrasonography
and computed tomography were not
especially helpful in making the
diagnosis of abdominal tuberculo
sis. This finding is in contrast to
that of Zirinsky and colleagues.28
Confirmation of the diagnosis re
mains the main problem in the
management of abdominal tubercu
236
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losis. There are no diagnostic clini
cal features, but awareness on the
part of the physician will lead to an
accurate clinical diagnosis in 38%
of cases, as in our study and that of
Hoon and colleagues.9 Das and
Shukla7 and others29 have quoted a
higher figure of 50%. Histologic
examination or culture of tissue are
the only tests that will clearly sepa
rate abdominal tuberculosis from
Crohn’s disease, carcinoma of colon
and small-bowel lymphoma.
Many authors believe that lapa
rotomy and biopsy are necessary
arbiters in the final diagnosis of
abdominal tuberculosis, thus the
rate of laparotomy in many studies
is high.2121619 Also, up to 50% of
patients may have acute manifesta
tions1719 necessitating emergency
surgery. But this course should not
be followed lightly, as a 20% death
rate was noted by Bhansali.19 In our
study, emergency surgery was car
ried out in 26% of cases, a figure
similar to that of others,2 and there
were no deaths in this group.
The role of endoscopy in diagnos
ing obscure abdominal conditions
was accepted reluctantly, but has
been used increasingly in surgical
practice. The importance of increas
ing diagnostic accuracy by obtain
ing multiple biopsies from suspect
ed lesions lies in avoiding a diag
nostic laparotomy. Laparoscopy and
colonoscopy coupled with histolog
ic and bacteriologic examinations
have emerged as the best diagnostic
approach. Udwadia is credited with
a personal series of 321 laparosco
pies, as a result of which 218
patients had their diagnosis con
firmed and tubercles were seen in
206.15 Wolfe and colleagues30 re
corded 8 positive biopsies out of 11;
we had 7 positive biopsies out of 7
on laparoscopy. The role of colo
noscopy in colonic tuberculosis was
established by Aoki and col
leagues.31 Hoshino and associates32
reviewed the literature and found a

50% yield for colonoscopic biopsies,
utilizing both culture and histologic
findings. We had positive results in
7 of 11 colonoscopies, similar to
Breiter and Hajjar’s33 8 positive
results out of 12. Thus, endoscopic
procedures were successful in 66%
of our cases (Table V) and surgery
was avoided in many.
The therapeutic approach to ab
dominal tuberculosis has undergone
much change during the last de
cade. Laparotomy and extensive re
section34 is being replaced by a
more medically oriented approach.
Our current policy is to recommend
a triple drug therapy for 9 to 12
months. With effective antitubercular therapy, the death rate has
decreased markedly.2,12

Conclusions
Abdominal tuberculosis in its di
verse forms still affects the local
and immigrant population in Ku
wait. Symptoms are vague, signs
nonspecific and investigations nonpathognomonic. Caseation or de
monstration of AFB remains the
hallmark of diagnosis. Accurate di
agnosis is important in avoiding
unnecessary laparotomy. Laparos
copy and colonoscopy are the diag
nostic modalities of choice in pa
tients with suspected abdominal tu
berculosis.

References
1. Walsh J: Diagnosis of intestinal tuber
culosis. Trans Natl Assoc Pres Tuberc
(London) 1909; 5: 2 1 7 -2 2 2

T a b le V. Endoscopic Procedures and Their

Success
P rocedure

Upper gastrointestinal
endoscopy
Colonoscopy
Laparoscopy

No.

6
11

7

P ositive

2
7
7

ABDOMINAL TUBERCULOSIS

2. Lambrianides AL, A ckroyd N, S horey
BA: Abdominal tuberculosis Br J Surg
1980; 67: 887-889
3. Homan WP, Grafe WR, Dineen P: A
44-year experience with tuberculous en
terocolitis. World J Surg 1977; 2: 245250
4. S ingh MM, B hargava AN, Jain KP:
Tuberculous peritonitis: an evaluation of
pathogenetic mechanisms, diagnostic
procedures and therapeutic measures. N
Engl J Med 1969; 281: 1091-1094
5. Schulze K, W arner HA, Murray D:
Intestinal tuberculosis. Am J Med 1977;
63:735-745
6. Mitchell RS, B ristol LJ: Intestinal tu
berculosis: an analysis of 346 cases
diagnosed by routine intestinal radiogra
phy on 5,529 admissions for pulmonary
tuberculosis, 1924-29. Trans Am Clin
Climatol Assoc 1954; 65: 32-48
7. Das P, S hukla HS: Clinical diagnosis of
abdominal tuberculosis. Br J Surg 1976;
63:941-946
8. Mandal BK, Schofield PF: Abdominal
tuberculosis in Britain. Practitioner
1976; 216: 683-689
9. Hoon JR, Dockerty MB, P emberton
J de J: Collective review: ileocecal tuber
culosis including comparison of this
disease with nonspecific regional entero
colitis and noncaseous tuberculated en
terocolitis. Int Abstr Surg 1950; 60:
417-440
10. S hukla HS, Hughes LE: Abdominal tu
berculosis in the 1970s: a continuing
problem. Br J Surg 1978; 65: 403-405
11. Kaufman HD, Donovan I: Tuberculous
disease of the abdomen. J R Coil Surg
Edinb 1974; 19: 377-380
12. K houry GA, Payne CR, Harvey DR:
Tuberculosis of the peritoneal cavity. Br
J Surg 1978; 65: 808-811
13. Howell JS, K napton PJ: Ileo-caecal
tuberculosis. Gut 1964; 5: 524-529
14. W ales JM, Mumtaz H, MacLeod WM:
Gastointestinal tuberculosis. Br J Dis
Chest 1976; 70: 39-57
15. A ddison NV: Abdominal tuberculosis - a
disease revived. Ann R Coll Surg Engl
1983; 65: 105-111
16. Schofield PF: Abdominal tuberculosis.
Gut 1985; 26: 1275-1278
17. P almer KR, Patil DH, Basran GS, et al:
Abdominal tuberculosis in urban Britain
- a common disease. Ibid: 1296-1305
18. S herman S, R ohwedder JJ, R avikrishnan KP, et al: Tuberculous enteritis and
peritonitis. Report of 36 general hospi
tal cases. Arch Intern Med 1980; 140:
506-508
19. B hansali SK: Abdominal tuberculosis.
Experiences with 300 cases. Am J Gas
troenterol 1977; 67: 324-337
20. Gonnella JS, Hudson EK: Clinical pat
terns of tuberculous peritonitis. Arch
Intern Med 1966; 117: 164-169

21. Wic KL, C hitkara NL, Gupta SP et al:
Ileocecal tuberculosis with particular
reference to isolation of Mycobacterium
tuberculosis. With a note on its relation
to regional ileitis (Crohn’s disease). Am
Rev Respir Dis 1961; 84: 169-178
22. B hansali SK, D esai AN: Abdominal tu
berculosis: clinical analysis of 135 cases.
Ind J Surg 1968; 97: 169-178
23. Levine H: Needle biopsy diagnosis of
tuberculous peritonitis. Am Rev Resp
Dis 1968; 97: 889-894
24. S harma GC, Kala PC, Bhargava U:
Obstructive tubercular lesions of the
large gut. Am J Proctol 1972; 23: 2 1 8 227

25. Findlay JM: Medical management of
gastrointestinal tuberculosis (editorial).
J R S o c Med 1982; 75: 583-584
26. A llen AR, Harmon RW, Klacsan LJ, et
al: Accuracy of the confirmatory diagno
sis of tuberculosis. Am J Med 1957; 22:
904-914
27. P rakash A, S harma LK, Koshal AL, et
al: Ileocaecal tuberculosis. Aust N Z J
Surg 1975; 45: 371-375

28. Z irinsky K, A uh YH, K neeland JB, et
al: Computed tomography, sonography,
and MR imaging of abdominal tubercu
losis. J Comput Assist Tomogr 1985; 9:
961-963
29. Abdominal tuberculosis in Britian (edito
rial) Br Med J 1977; 1: 1557
30. W olfe JH, B ehn AR, Jackson BT: Tu
berculous peritonitis and role of diag
nostic laparoscopy. Lancet 1979; 1:
852-853
31. A oki G, Nagasako K, N akal Y, et al:
The fibrocolonoscopic diagnosis of in
testinal tuberculosis. Endoscopy 1975;
7: 113-121
32. H oshino M, S hibata M, Goto K, et al: a
clinical study of tuberculous colitis. Gas
troenterol Jpn 1979; 14: 299-305
33. B reiter JR, Hajjar JJ: Segmental tuber
culosis of the colon diagnosed by colonscopy. Am J Gastroenterol 1981; 76:
369-373
34. A nand SS: Hypertrophic ileo-caecal tu
berculosis in India with a record of 50
hemicolectomies. Ann R Coll Surg Engl
1956; 19: 205-222

NOTICE OF CHANGE OF ADDRESS/
AVIS DE CHANGEMENT D’ADRESSE
To ensure that you continue to receive the Canadian Journal o f Surgery
without interruption, please fill in this form before you move.
Avant de demenager, assurez-vous de recevoir sans interruption le Journal
canadien de chirurgie en completant le formulaire suivant.
Please print / en lettres moulees, svp
Name / n o m .........................................................................................................
Royal College Fellow number / numero d’identite ...........................................
Old address / ancienne adresse...........................................................................

New address / nouvelle adresse

Postal code / code postal....................................................................................
D ate.......................................................................................................................
Royal College Fellows please mail to: Royal College of Physicians and
Surgeons of Canada, 74 Stanley Ave., Ottawa, Ont. KIM 1P4.
Membres du College royal, veuillez expedier a: College royal des medecins et
chirurgiens du Canada, 74 Stanley Ave., Ottawa, Ont. KIM 1P4.
Subscribers please mail to: Information Systems, Canadian Medical Associa
tion, PO Box 8650, Ottawa, Ont. K1G 0G8.
Abonnes, veuillez expedier a: Systeme de diffusion d’informations, l’Association medicale canadienne, CP 8650, Ottawa, Ont. K1G 0G8.

CJS, VOL. 33, NO. 3, JUNE 1990

237

PRESCRIBING INFORMATION
Rocephin * IV-IM
Sterile Ceftriaxone Sodium
F or Injection
Therapeutic Classification
Antibiotic
INDICATIONS AND CLINICAL USES The treatment of the following infections when caused by susceptible
strains of the designated micro-organisms: Lower respiratory tract infections caused by E. coli, H. influenzae,
K. pneumoniae and species, Staph, aureus, Strep, pneumoniae and species (excluding enterococci). Urinary
tra ct infections (com plicated and uncom plicated) caused by E. coli, Klebsiella species, P. mirabilis and
P. vulgaris. B acterial septicemia caused by E. coli, H. influenzae, K. pneumoniae, Staph, aureus and Strep,
pneumoniae (excluding enterococci). Skin and skin structure infections caused by K. pneumoniae and
species, P. mirabilis, Staph, aureus, Staph, epidermidis and Streptococcus species (excluding enterococci).
Bone and jo in t in fe c tio n s caused by Staph, aureus, Strep, pneumoniae and Streptococcus species (excluding
enterococci). M e n in g itis caused by H. influenzae, N. meningitidis, and Strep, pneumoniae. 'Rocephin' should
not be used for the treatment of meningitis caused by L. monocytogenes. U ncom plicated gonorrhea
(cervical/urethral and rectal) caused by N. gonorrhoeae (penicillinase and nonpenicillinase producing
strains). P ro p h yla xis: The preoperative administration of a single 1 g dose of ‘Rocephin’ (sterile ceftriaxone
sodium) may reduce the incidence of postoperative infections in patients undergoing vaginal or abdominal
hysterectomy. If signs of post surgical infection should appear, specimens for culture should be obtained for
identification of the causative organism(s)sothattheappropriatetherapy may beinstituted. CONTRAINDICATIONS
'Rocephin' (sterile ceftriaxone sodium) is contraindicated in patients with known allergy to ceftriaxone, other
cephalosporins or penicillins. WARNINGS Before therapy with ‘Rocephin1 (sterile ceftriaxone sodium) is
instituted, careful inquiry should be made concerning previous hypersensitivity reactions to ceftriaxone, other
cephalosporins, penicillins or other allergens. 'Rocephin' should only be administered with caution to any patient
who has demonstrated any form of allergy particularly to drugs. Serious, and occasionally fatal hypersensitiv
ity (anaphylactoid) reactions have been reported in patients receiving cephalosporins. The reactions are more
likely to occur in persons with a history of sensitivity to multiple allergens. ‘Rocephin’ should be administered
with caution to patients with type I hypersensitivity reaction to penicillin. If an allergic reaction occurs, the ad
ministration of ‘Rocephin’ should be discontinued and appropriate therapy instituted. Pseudomembranous
colitis has been reported with the use of ‘Rocephin’, (and with broad-spectrum and other antibiotics). Therefore,
it is important to consider its diagnosis in patients administered ‘Rocephin’ who develop diarrhea. Treatment
with broad-spectrum antibiotics, including 'Rocephin', alters the normal flora of the colon and may permit
overgrowth of Clostridia. Studies indicate that a toxin produced by Clostridium difficile is one primary cause of
antibiotic-associated colitis. Mild cases of colitis may respond to drug discontinuation alone. Moderate to severe
cases should be managed with fluid, electrolyte, and protein supplementation as indicated. When the colitis is
not relieved by discontinuation of ‘Rocephin’ administration or when it is severe, consideration should be given
to the administration of vancomycin or other suitable therapy. Other possible causes of the colitis should also
be considered. ‘Rocephin’ therapy should be discontinued in patients who develop signs or symptoms sugges
tive of gallbladder disease and conservative management considered. The effect of pre-existing gallbladder
disease is not known. In a few patients administered ‘Rocephin’, shadows suggesting “sludge" have been
detected by sonograms of the gallbladder in those who remained asymptomatic and in those who became
symptomatic. This condition appeared to be reversible on discontinuation of ‘Rocephin’ therapy. In a few
symptomatic patients receiving 4 g of ‘Rocephin’ who underwent cholecystectomy, "sludge" containing traces
of ceftriaxone was recovered from surgical specimens. Concretions consisting of the precipitated calcium salt
of ceftriaxone have been found in the gallbladder bile of dogs and baboons treated with high doses of
ceftriaxone. PRECAUTIONS General Hypoprothrombinemia and alterations in prothrombin time have oc
curred rarely in patients treated with ‘Rocephin’ (sterile ceftriaxone sodium) (see ADVERSE REACTIONS).
Patients with impaired vitamin K synthesis or low vitamin K stores (e.g. chronic hepatic disease and malnutri
tion) may require monitoring of hematology and coagulation parameters during ‘Rocephin’ treatment. Vitamin
K administration (10 mg weekly) may be necessary if the prothrombin time is prolonged before or during
treatment. Prolonged treatment with 'Rocephin' may result in overgrowth of non-susceptible organisms and
organisms initially sensitive to the drug. If superinfection occurs, appropriate measures should be taken. ‘Ro
cephin' should be administered with caution to individuals with a history of gastrointestinal disease, particularly
colitis. Renal and Hepatic Im pairm ent Although transient elevations of BUN and serum creatinine have been
observed in clinical studies, there is no other evidence that 'Rocephin', when administered alone, is nephrotoxic.
In severe renal impairment (creatinine clearance of less than 10 mL/min), periodic monitoring of serum
ceftriaxone concentrations is recommended. The maximum daily dose should not exceed 2 g. In severe renal
impairment associated with clinically significant hepatic impairment, close monitoring of serum ceftriaxone
concentrations, at regular intervals, is recommended. If there is evidence of accumulation, dosage should be
decreased accordingly. Interactions Interactions between ‘Rocephin’ and other drugs have not been fully
evaluated. Pregnancy The safety of ‘Rocephin’ in the treatment of infections during pregnancy has not been
established. ‘Rocephin’ should only be used during pregnancy if the likely benefit outweighs the potential risk
to the fetus and/or the mother. Ceftriaxone has been detected in the umbilical cord blood, amniotic fluid and
placenta. N u rsin g Mothers Ceftriaxone is excreted in human milk at low concentrations. The clinical signifi
cance of this is unknown; therefore, caution should be exercised when ‘Rocephin’ is administered to a nursing
mother. N eonates The safety of ‘Rocephin’ in neonates (birth to one month of age) has not been established.
In vitro studies have shown that ceftriaxone can displace bilirubin from serum albumin. Caution should be
exercised when considering 'Rocephin' treatment for hyperbilirubinemic neonates especially if premature.
Elderly P atie nts The elimination of ceftriaxone may be reduced in elderly patients possibly due to impairment
of both renal and hepatic function. D rug-Laboratory Test Interactions Ceftriaxone may interfere with urine
glucose determinations utilizing the copper-reduction test (CLINITEST), but not utilizing the glucose-oxidase
test (DIASTIX or TES-TAPE) ADVERSE REACTIONS During clinical trials with ‘Rocephin’ (sterile ceftriaxone
sodium) the following adverse reactions have been observed: C linical Adverse Experiences: D erm atologi
cal: Rash (1.3% ); exanthema, allergic dermatitis and pruritis (0.1 -1.0%). Hem atological: Anemia (0.1 -1.0%);
auto-immune hemolytic anemia and serum sickness (<0.1%). Hepatic: Jaundice, reports (in asymtomatic and
symptomatic patients) of ultrasonographic shadows suggesting precipitations in the gallbladder and reports of
gallbladder sludge (<0.1%). U rogenital: Moniliasis and vaginitis (0.1 -1.0% ). G astrointestinal: Diarrhea
(3.3%); nausea, vomiting, dysgeusia and gastric pain (0.1-1.0%); abdominal pain, colitis, flatulence, dyspepsia,
pseudomembranous colitis and stomatitis (<0.1%). Neurological: Dizziness and headache (0.1 - 1 .0%);ataxia
and paresthesia (<0.1 %). M iscellaneous: Fever, chills, diaphoresis, malaise, burning tongue, flushing, edema
and anaphylactic shock (0.1-1.0% ); bronchospasm, palpitations and epistaxis (<0.1%). Local Reactions at
Injection Site: Pain (9.4%), induration and tenderness (1 -2%); phlebitic reactions (0.1 -1.0%); thrombophlebi
tis (<0.1%). Laboratory Abnorm alities: H em atologic: Eosinophilia (4.6%), thrombocytosis (5.1%), leu
kopenia (2.0%); neutropenia, lymphophenia, thrombocytopenia, increase or decrease in hematocrit, prolonga
tion of prothrombin time and decrease in hemoglobin (0.1 -1.0% ); leukocytosis, lymphocytosis, monocytosis,
basophilia and decrease in prothrombin time (<0.1%). Hepatic: Increase in AST (SGOT) (4.0%)b, ALT (SGPT)
(4.8%)b, increase in alkaline phosphatase (1.0%); increase in bilirubin (0.1 -1.0% ). Urinary: Increase in BUN
(1.1%)c; increase in creatinine, erythrocyturia, proteinuria and presence of casts in urine (0.1 -1.0% ); glycosuria
(<0.1 % ).b Incidence is more frequent in patients less than one year old.c Incidence is more frequent in patients
less than one year old and over 50 years old. SYMPTOMS AND TREATMENT OF OVERDOSAGE
Ultrasonographic shadows suggesting precipitations in the kidneys accompanied by calcium ceftriaxone
precipitate in the urine was observed in one patient dosed with ‘Rocephin’ (sterile ceftriaxone sodium) at 10 g/
day (2.5 times the maximum recommended dose). No other case of overdosage has been reported to date with
'Rocephin'. No specific information on symptoms or treatment is available. Excessive serum concentration of
ceftriaxone cannot be reduced by hemodialysis or peritoneal dialysis. Treatment should be symptomatic.
DOSAGE AND ADMINISTRATION ‘Rocephin’ (sterile ceftriaxone sodium) may be administered intravenously
or intramuscularly after reconstitution. Dosage and route of administration should be determined by the severity
of infection, susceptibility of the causative organisms, and condition of the patient. The intravenous route is
preferable for patients with septicemia or other severe or life-threatening infections. With the exception of
gonorrhea, which is treated with a single dose, the administration of ‘Rocephin’ should be continued for a
minimum of 48 to 72 hours after the patient defervesces or after evidence of bacterial eradication has been
obtained, usually 4 to 14 days. In bone and joint infections the average duration of treatment during clinical trials

was 6 weeks, with a range of 1 to 13 weeks, depending on the severity of the infection. When treating infections
caused by beta-hemolytic Streptococcus, it is recommended that therapy be continued for at least 10 days. The
average duration of therapy for infections associated with beta-hemolytic Streptococcus during clinical trials
was 2 weeks, with a range of 1 to 5 weeks, depending on the site and severity of the infection. Prophylaxis
(Vaginal o r Abdom inal Hysterectomy) For preoperative use as prophylaxis before vaginal or abdominal
hysterectomy, a single dose of 1 g administered 1/2 to 2 hours before surgery is recommended. Impairment
of Renal and/or Hepatic Function In patients with mild to moderate renal impairment, changes in the dosage
regimen are not required, provided liver fu n c tio n is intact. In cases of preterminal renal failure (creatinine
clearance less than 10 mL/min), periodic monitoring of serum ceftriaxone concentrations is recommended. The
daily dosage should be limited to 2 g or less. In patients with liver damage, there is no need for the dosage to
be reduced provided renal function is intact. In cases of coexistent renal and clinically significant hepatic
insufficiency, close monitoring of serum ceftriaxone concentrations, at regular intervals, is recommended. If
there is evidence of accumulation, dosage should be decreased accordingly. ADMINISTRATION Intram us
cular: The reconstituted solution of ‘Rocephin’ should be administered by deep intragluteal injection. It is
recommended that not more than 1 g be injected at a single site. Pain on intramuscular injection is usually mild
and less frequent when ‘Rocephin’ is administered in sterile 1% Lidocaine solution. Intravenous (bolus)
Injection: The reconstituted solution should be administered over approximately 5 minutes. Short Intrave
nous Infusion: The further diluted intravenous solution should be given over a period of 10 to 15 minutes in
infants and children and 20 to 30 minutes in adults. NOTE: ‘Rocephin’ solution should not be physically mixed
with aminoglycoside antibiotics nor administered at the same site because of possible chemical incompatibility.
PHARMACEUTICAL INFORMATION
Reconstitution
For Intram uscular Use
Reconstitute ‘Rocephin’ powder with the appropriate diluent:
• Sterile Water for Injection
• Bacteriostatic Water for Injection
• 0.9% Sodium Chloride Injection
• 1% Lidocaine Solution
• 5% Dextrose Injection
Reconstitute as follows:
R eco nstitution Table (IM)
Approxim ate
available
volum e mL

Volum e to be
added to vial mL

Vial Size

Approximate
average
concentration g/mL

0.25 g

0.9

1

0.5 g

1.8

2

0.25

1.0 g

3.6

4

0.25

2.0 g

7.2

8

0.25

0.25

Shake well until dissolved.
NOTE: SOLUTIONS PREPARED FOR INTRAMUSCULAR USE OR ANY SOLUTION CONTAINING
LIDOCAINE OR BACTERIOSTATIC WATER FOR INJECTION SHOULD NEVER BE ADMINISTERED
INTRAVENOUSLY.
For Intravenous Use
Reconstitute only with Sterile Water for Injection.
Reconstitute as follows:
R econstitution Table (IV)

Vial
Size

Volum e to be
added to vial
mL

Approxim ate
available
volum e
mL

Approximate
average
concentration
g/mL

0.25 g

2.4

2.5

0.1

0.5 g

4.8

5.0

0.1

1.0 g

9.6

10.0

0.1

2.0 g

19.2

20.0

0.1

Shake well until dissolved. The prepared solution may be further diluted to the desired volume with any of the
“Solutions for IV Infusion" listed below.
S olutions for IV Infusion
0.9% Sodium Chloride Injection, 5% Dextrose Injection, Dextrose and Sodium Chloride Injection.
Pharmacy Bulk Package R econstitution fo r Preparation of Intravenous Infusion Solutions
The closure of the pharmacy bulk vial shall be penetrated only one time after reconstitution, using a suitable
sterile transfer device or dispensing set which allows measured dispensing for the contents.
R econstitution Table fo r Bulk Pharmacy Package
Vial
size

Volume to be
added to vial
mL

Approxim ate
available volum e
mL

Approximate
average concentration
g/mL

10 g

95

100.0

0.1

>}iiar\e wen uim

Infusion”. Any unused solution remaining within a period of 8 hours should be discarded.
S tability of Solutions - Storage
For complete stability and storage information, consult the Product Monograph,
Incom patibility:
'Rocephin' should not be physically mixed with other antimicrobial agents.
‘Rocephin’ should not be added to blood products, protein hydrolysates or amino acids.
‘Rocephin’ should not be added to solutions containing calcium.
DOSAGE FORM
Availability: Rocephin’ is available in vials containing dry substance equivalent to 0.25 g, 0.5 g, 1 g or 2 g of
ceftriaxone and as a pharmacy bulk vial containing the equivalent of 10 g ceftriaxone (not for direct
administration). The availability o f the Pharmacy bulk vialis restricted to hospitals with a recognized intravenous
admixture program.
Storage: Rocephin’ sterile powder should be stored at a controlled room temperature (between 15° and 30°C)
and protected from light.
References: 1. Hell K: Chemotherapy 1989;35:228-235.2. ‘Rocephin’ Product Monograph.
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Post-traumatic Microvascular
Reconstruction: Toronto’s 500th
Reattachment
David P. Ewart, BSc;* Ronald M. Zuker, MD, FRCSC, FACS
The authors describe a case of a severe crush injury in a 28-year-old man, whose left
hand was caught in a punch press. Several carpal bones and all structures at the
wrist except the extensor tendons were destroyed. The hand was totally denervated
and devascularized. This case represents the 500th reattachment performed by the
University of Toronto microvascular team. The authors review the operative
technique and discuss the functional results 9 months after operation followed by a
rigorous program of rehabilitative therapy.

devastating injury to the hand,
which demonstrates the postopera
tive results that can be obtained by
current surgical techniques and
postoperative therapy.

Case Report
Les auteurs decrivent un cas de fracture grave par ecrasement chez un homme de 28
ans dont la main gauche fut happee par une presse a emporte-piece. Plusieurs os
carpiens et toutes les structures du poignet, a l’exception des tendons extenseurs,
avaient ete detruits. La main avait perdu toute innervation et etait totalement
devascularisee. C’etait le 500eme cas de reimplantation pratiquee par l’equipe de
microchirurgie vasculaire de l’Universite de Toronto. Les auteurs passent en revue
la technique operatoire et commentent les resultats fonctionnels 9 mois apres
l’operation qui fut suivie d’un rigoureux programme de readaptation.

he first reported successful re
plantation was of the arm of a
12-year-old boy. The procedure was
performed in 1962 by Malt and
McKhann.1 The first reported re
plantation in Toronto was that of a
single digit, and was performed in
1973 by R.T. Manktelow (personal
communication). Since then, microsurgical and reconstructive tech
niques have advanced considerably,
allowing for the salvage of a variety
of amputated extremities. To date,
over 500 such replantations and
revascularizations have been per

T

formed in Toronto. Toronto’s mi
crovascular team now consists of
Drs. Ralph Manktelow, Ronald Zuk
er, James Mahoney, Nancy McKee,
Vaughan Bowen and Howard
Clarke and is cooperatively based at
St. Michael’s Hospital, Toronto
General Hospital and The Hospital
for Sick Children.
Replantation of the hand remains
one of the most important areas of
reconstructive surgery. A poor
functional result may be worse for
the patient than a complete amputa
tion. We present the case of a

From the Department o f Surgery, University o f Toronto, Toronto, Ont.
*Medical student, University o f Toronto
Accepted for publication Apr. 6, 1989
Reprint requests to: Dr. R.M. Zuker, Rm. 1524, Department o f Plastic Surgery, The Hospital for
Sick Children, 555 University Ave., Toronto, Ont. M5G 1X8

A 28-year-old left-handed ma
chinist sustained a major crush in
jury to his left hand while working
with a punch press. On arrival at
the emergency department of the
local hospital, the injury was found
to involve the wrist and proximal
palm. Multiple fragments of alumi
num, which was in use on the
press, were embedded in the palm,
dorsum and wrist. The wound wa?
also heavily contaminated with
grease. The hand was totally devas
cularized and remained attached to
the forearm only by the remaining
extensor tendons. He was stabi
lized, resuscitated and transferred
to Toronto General Hospital for
assessment by the microvascular
team for possible replantation.
On his arrival he was taken to
the operating room. Any decision to
attempt revascularization and sal
vage was deferred until the injury
could be properly evaluated. The
patient was intubated and given a
general anesthetic. A Foley catheter
and right radial artery catheter were
introduced. An inflatable tourniquet
was applied to the left upper arm
and inflated to 250 mm Hg. ExtenCJS, VOL. 33, NO. 3, JUNE 1990
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sive irrigation and debridement
were carried out; the fragments of
aluminum required mechanical re
moval. Assessment of the wound
revealed that all the carpal bones,
excluding portions of the scaphoid
and hamate, were destroyed. All the
flexor tendons and the median and
ulnar neurovascular bundles had
been transected. The thenar muscu
lature had been completely de
stroyed. There was also a partial
degloving over the dorsum of the
hand. The few structures that re
mained intact were the extensor
pollicis longus and extensor com
munis tendons, and a small dorsal
vein in the snuff-box region. Preop
erative x-ray films also showed frac
tures of all four metacarpals (Fig.
1). It was decided to attempt sal
vage. Proximal and distal vessel,
nerve and tendon ends were identi
fied and labelled.
Bony fixation was achieved by
first trimming the remaining carpal
bones and bases of the last four
metacarpals, to provide a surface

for wrist fusion. Longitudinal K
wires were then used to fix the first
four metacarpals to the distal radi
us. The first metacarpal required
two K wires to prevent rotational
instability. A bone graft, from the
debrided carpal bones, was placed
around the fusion area (Fig. 2).
Revascularization of the hand
began with anastomosis of the
ulnar artery, using the operating
microscope and 10-0 nylon inter
rupted sutures. This provided good
circulation to the three ulnar digits
but was insufficient to perfuse the
thumb and index finger properly.
The radial artery was therefore
anastomosed to a distal arterial
branch in the volar first web space,
again with 10-0 nylon sutures. As
well, the ulnar digital artery to the
thumb was anastomosed to the ar
terial palmar arch, originating from
the ulnar artery, at the mid-palm.
Adequate perfusion of all digits was
thereby obtained.
The single remaining vein in the
snuff-box area did not provide ade-

FIG. 1. Extensive carpal damage and
metacarpal fractures. Multiple alumi
num fragments are embedded in soft
tissues.

FIG. 2. Bony fixation has been ob
tained. K-wires were used to secure
first four metacarpals to radial head.
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quate drainage and there was evi
dence of venous hypertension. Vein
stumps in the ulnar area of the
wrist were anastomosed using a
small vein graft from the forearm.
Tendon repairs were facilitated by
a Mason-Alien type stitch, which
had been placed in the tendon ends
at the time of identification and
labelling. The four profundus ten
dons were connected first, followed
by the superficialis, flexor pollicis
longus and extensor digiti minimi.
Both motor and sensory branches
of the median nerve in the hand
were anastomosed primarily to the
median nerve stump in the forearm,
using the operating microscope,
with 9-0 and 10-0 nylon sutures.
Motor and sensory branches of the
ulnar nerve were likewise anas
tomosed to the proximal ulnar
nerve stump.
A large skin defect in the dorsum
of the hand was covered with a
distally based skin flap that had
been degloved to the level of the
metacarpophalangeal joints, but
there remained a skin defect over
the wrist and forearm. An interosse
ous muscle fasciotomy was per
formed under the flap.
To obtain soft-tissue coverage, all
skin edges were first debrided.
Using 4-0 nylon interrupted su
tures, the skin was closed primarily
on the volar surface of the hand.
The remaining skin defect over the
wrist and forearm was covered with
a split-thickness meshed skin graft,
taken from the patient’s right
thigh. A running horizontal mat
tress suture of 4-0 chromic catgut
was used to sew the graft in place.
Drains were placed in the volar
wrist and dorsal first web space.
Dressings, a volar supporting slab
and a protective tulip-type plaster
splint were applied.
The patient was transferred to
the recovery room where 2 units of
packed red cells were given and
mechanical ventilation was contin-

POST-TRAUMATIC MICROVASCULAR RECONSTRUCTION

Five days postoperatively, the
tulip splint was removed and a new
splint fashioned by the occupational
therapists was applied. Vascularity
of the hand remained intact. The
skin showed good healing. There
was no wound dehiscence or infec
tion. Physiotherapy was initiated to
mobilize the fingers and thumb.
Protected exercises and range-ofmotion exercises were also started
and were done several times daily.
Six weeks postoperatively, the
patient was given a bivalved wrist
cock-up splint to support the wrist
fusion during active finger-flexion
exercises. At this stage, he was
being treated by the physiothera
pists twice a week and performing
various exercises at home. His moti
vation continued to be very high,
despite some reported pain during
the exercises.

At this time all but one of the
K wires were removed. The final
K wire at the base of the first
metacarpal was removed 4 weeks
later, at which time an anti-claw
splint, to maintain the hand in a
functional position, and dynamic
extension splint were applied. Ul
trasonography was used to loosen
some scarring around the tendons.
Over the next few months, the
patient continued with therapy and
was periodically assessed by physio
therapy, occupational therapy and
surgical staff.
At approximately 9 months the
patient had achieved excellent func
tional results. Constant and moving
touch were intact to the tips of all
but the little finger, which was
intact to the proximal interphalangeal joint. Although sensation was
insufficient to provide two-point dis
crimination, localization to constant
touch stimulus was very good. Full
active flexion of the fingers was
evident (Fig. 3). Thumb flexion was
good but limited by the fusion of
the metacarpal to the radius. De
spite this limitation, the patient was
able to achieve a useful modified

key pinch (Fig. 4). We believed
function would further improve
with continued therapy. Grip
strength of his left hand was ap
proximately 20% of that of the
right. He had virtually full active
extension of all his fingers except
the long finger (Fig. 5). The wrist
was fused, stable and pain free. The
patient reported using his hand a
great deal in daily life to perform
such tasks as opening doors as well
as carrying various objects.

FIG. 3. Full active flexion of fingers is
demonstrated 9 months postoperative
ly.

FIG. 4. Modified key pinch was ob
tained and was useful in patient’s daily
life.

FIG. 5. There was full active extension
of all fingers except long finger 9
months postoperatively.

ued. Antibiotics were administered.
Total tourniquet time was 125 min
utes. Total operative time was 21.5
hours. The patient was extubated
the next day.
Postoperative Follow-up

Discussion
Considerable progress has been
made in the field of limb salvage
since 1962. While it is evident that
full recovery cannot yet be
achieved, useful function can be
restored. This case demonstrates
the results that can now be ob
tained through current surgical
techniques. In the past, a devastat
ing injury such as this would have
left the patient with an amputation
stump and prosthetic device. It is
important to point out that even
though the functional recovery ob-

CJS, VOL. 33, NO. 3, JUNE 1990

241

EWART & ZUKER

tained is not complete, it is infinite
ly preferable to an amputation.
The functional outcome depends
a great deal on the follow-up thera
py. Perhaps more important is the
patient’s motivation to comply with
such therapy. Expertise from reha
bilitative therapists constitutes an

integral component of the overall
management of these patients.
In celebrating its 500th reattach
ment, Toronto’s microvascular team
can look back on a history of
significant advancement in the field
and look forward to further im
provement in the years to come.

We acknowledge the contribution made
to this case by Drs. N. Hutchinson, J.
Semple, E. Swanson and B. Kenny.

ough discussion on the bacteriology of
various types of peritonitis. Wound re
pair is discussed under the heading of
healing of the peritoneum and considers
role of peritoneal closure. The impact of
drains and foreign bodies in the perito
neal cavity is discussed at a basic
science level. Lymphatic drainage, the
role of the diaphragmatic lymphatics in
clearing the peritoneal cavity and lym
phatic impairment in ascites are clearly
dealt with. The first chapters also de
scribe the role of prostaglandins in the
peritoneal cavity; this chapter is too
detailed for the average abdominal sur
geon.
The majority of the next 12 chapters
deal with the role of the peritoneum in
dialysis, which has no relevance for the
average abdominal surgeon, although I
found these chapters well written. They
describe the rationale, various tech
niques and complications of peritoneal
dialysis. Of importance to the surgeon,
particularly the urologist associated
with a dialysis unit, are several chapters
dealing with the techniques of peritone
al access. These include implantable
reservoirs and pumps as well as the
long-term use of catheters. Insertion
techniques and complications are dis
cussed thoroughly with excellent dia
grams. Within the second 12 chapters,
there is a detailed discussion of intraperitoneal insulin administration and
its potential role in the future. The role
of intraperitoneal chemotherapy is dis
cussed and will interest the oncologic
surgeon.
The final seven chapters include a

superb chapter on peritoneovenous
shunting. It is succinct and well written
and covers the techniques, indications
and complications and how to deal with
them. There is a thorough discussion of
diagnostic peritoneal lavage which is
excellent. The role of therapeutic la
vage, particularly in pancreatitis is well
discussed. Two chapters on laparoscopy
are included. These are quite basic but
describe the technique and its role in
abdominal as well as pelvic disease.
Laparoscopic surgical techniques are
discussed briefly.
The layout of the book is good with
many relatively short chapters, allowing
the reader to find a particular area of
interest easily. Although many of the
authors are European, the text is very
readable. Diagrams are appropriately
used and are clear.
Considered as a whole, this book will
be useful to the surgeon as well as the
nephrologist, but will be of particular
value to the surgical intensivist who
needs a working knowledge of dialysis.
It would certainly be of value to a
urologist affiliated with a dialysis unit.
As a reference book, it belongs in the
library of any institution that has a
dialysis unit. Its scope, however, is
beyond what is required by the average
general surgeon. Its list price of $225
US may deter many potential buyers.

Reference
1. M alt RA, M cK hann CF: Replantation of
severed arms. JAMA 1964; 189: 716-722

BOOK REVIEWS
continued from page 210

concludes with a section entitled “Un
conscious guilt in the treatment of
infected patients”.
Finally, there remains the question of
price. The orthopedic resident studying
for fellowship examinations may find
this book rather expensive and the
practising orthopedic surgeon may pre
fer to rely on a quick discussion with
colleagues in bacteriology and infec
tious diseases. But for a concise and
current presentation of the broad field
of orthopedic infection, this text will be
a welcome addition to medical libraries.
Kenneth S. Morton, MD, FRCSC, FACS
Department of Orthopedics,
University o f British Columbia,
910 West 10th Avenue,
Vancouver, BC

THE PERITONEUM AND PERITO
NEAL ACCESS. Edited by S. Bengmark. 376 pp. Illust. Butterworths,
Stoneham, Mass. 1989. $225 (US).
ISBN 0-7236-0767-2
This authoritative work on many facets
of the peritoneum comprises 31 chap
ters by different authors and deals with
scientific knowledge of the peritoneum
as well as the role of the peritoneum in
clinical medicine.
The first 12 chapters deal with anat
omy, ultrastructure and cellular biolo
gy, as well as the physiology of perito
neal fluid movements. The chapter on
peritoneal microbiology is really a thor
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Effet de la cyclosporine sur la fonction
renale apres transplantation cardiaque:
peut-on diminuer la toxicite?
Michel Carrier, MD, FRCSC; Guy B. Pelletier, MD, FRCPC; Yves Leclerc, MD, FRCSC;
Yves R. Castonguay, MD; B. Charles Solymoss, MD, PhD; L. Conrad Pelletier, MD, FACS, FRCSC
Entre 1983 et 1988, 50 patients ont subi une transplantation cardiaque a l’lnstitut
de Cardiologie de Montreal. Au cours de cette periode, quatre protocoles d’immunosuppression ont ete employes, chacun incluant la cyclosporine. L’association
cyclosporine-prednisone a ete utilisee chez les premiers 24 patients (groupe 1). Une
therapie triple composee de cyclosporine, prednisone et azathioprine a ete donnee a
la periode perioperatoire chez 13 patients (groupe 2). L’utilisation prophylactique
du serum anti-lymphocytaire de lapin et l’ administration tardive, au 4eme jour
postoperatoire, de la cyclosporine pour prevenir l’insuffisance renale precoce liee a
cette derniere, fut choisie chez 13 autres patients (groupe 3). Devant la deterioration
importante de la fonction renale du premier groupe, la creatinine passant a 255 ±
51 mmol/L et la clearance de la creatinine a 35 ± 2 ml/min 4 ans apres la
transplantation, 1’immunosuppression chez 15 d’entre eux a ete modifiee pour une
therapie triple par addition d’azathioprine et diminution des niveaux seriques de
cyclosporine (groupe 4). Douze (80%) de ces derniers patients ont presente une
amelioration significative de la fonction renale, 3 a 18 mois apres l’introduction de
ces changements. Aucun patient des groupes 2 et 3 n’a presente d’insuffisance
renale tardivement et les patients du groupe 3 ont tous conserve une fonction renale
normale meme a la periode postoperatoire immediate.
En conclusion, d’importantes modifications au protocole d’immunosuppression
ont permis de reduire la toxicite renale precoce et tardive due a la cyclosporine,
apres transplantation cardiaque.

Between 1983 and 1988, 50 patients underwent cardiac transplantation at the
Institut de Cardiologie de Montreal. During this period, four immunosuppression
protocols were used, each including cyclosporine. A combination of cyclosporine and
prednisone was used in the first 24 patients (group 1). Triple combination
immunosuppression (cyclosporine, prednisone and azathioprine) was given
perioperatively in 13 patients (group 2). The prophylactic use of rabbit
antithymocyte globulin and late administration (4 days postoperatively) of
cyclosporine to prevent early renal failure associated with cyclosporine therapy was
chosen in 13 other patients (group 3). Owing to serious deterioration of renal
function in 15 of the 24 group 1 patients, the serum creatinine levels reaching 255
± 51 mmol/L and the creatinine clearance 34 ± 2 ml/min between 6 months and 4
years after transplantation, immunosuppression was modified to triple-combination
therapy by the addition of azathioprine and a reduction of the serum levels of
cyclosporine (group 4). Twelve of the 15 patients showed a substantial improvement
in renal function from 3 to 18 months after these changes were introduced. No
patient in groups 2 and 3 had late renal insufficiency, and in all group 3 patients
renal function remained normal as in the immediate postoperative period.
In conclusion, important modifications in protocol permitted a reduction of early
and late renal failure due to cyclosporine after cardiac transplantation.

a transplantation cardiaque est
devenue une approche therapeutique valable dans le traitement
des patients atteints de maladies
cardiaques en phase terminale. Les
recents succes de cette approche
sont principalement lies a l’utilisation de la cyclosporine comme
agent immunosuppresseur.1-3
Toutefois, cette medication est entachee d’effets secondaires importants dont, particulierement, l’hypertension arterielle et 1’insuffisance
renale.4 L’atteinte de la fonction
renale se presente essentiellement
sous forme d’une oligoanurie au
cours de la periode postoperatoire
ou d’une deterioration progressive
de la fonction renale apres quelques
mois ou quelques annees.
Dans notre milieu, l’association
de cyclosporine et de prednisone fut
utilisee en immunosuppression au
cours de la phase initiale de notre
experience clinique. Etant donne
l’apparition d’une toxicite renale
non negligeable chez ces patients,
nous avons modifie notre approche.
Les effets de ces changements de

L
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regime immunosuppresseur sur la
fonction renale font l’objet de cette
etude.

Materiel clinique
De 1983 a 1988, 50 patients ont
subi une transplantation cardiaque
a l’lnstitut de Cardiologie de Mon
treal. Ces patients ont ete selectionnes selon les criteres habituels.5
Aucun d’entre eux ne presentait
d’atteinte renale preoperatoire importante.
Ce groupe de patients comprend
5 femmes et 45 hommes dont l’age
moyen est de 43 ± 1 ans. Les
cardiomyopathies ischemiques (32),
idiopathiques (13) et rhumatismales
(5) furent responsables de la defaillance ayant conduit a la transplan
tation cardiaque. Le diagnostic du
rejet fut etabli par biopsie endomyocardique selon la classification de
Billingham.6

Quatre protocoles d’immunosuppression ont ete utilises (tableau I).
De 1983 a 1986 (groupe 1), 24
patients ont re?u l’association cy
closporine et prednisone. En 1987
(groupe 2), une therapie triple composee de cyclosporine, prednisone
et azathioprine a ete donnee a partir
de la periode preoperatoire chez 13
patients. En 1988 (groupe 3), l’utilisation prophylactique du serum anti-lymphocytaire de lapin (RATG) a
permis de retarder l’administration
de la cyclosporine au 4eme jour
postoperatoire chez 13 patients. Finalement, un protocole de conver
sion a la therapie triple (groupe 4) a
ete applique a 15 patients du pre
mier groupe, suite a une deteriora
tion de leur fonction renale entre 6
mois et 4 ans apres la transplanta
tion. Ce dernier protocole implique
l’administration, a doses progressi
ves, d’azathioprine jusqu’a l’obtention d’une baisse du nombre des
globules blancs entre 5000 et 8000

T a b le a u 1. P ro to c o le s d ’ im m u n o s u p p re s s io n

G ro u p e

N o. de
p a tie n ts

1

24

2

13

3

13

4

15*

P rotocole
C y c lo s p o rin e (C S A ) e t p re d n is o n e .
C SA d o se d 'a tta q u e p re o p e ra to ire 10 m g /k g p a r v o ie orale,
d o s e s s u iv a n te s s e lo n les n iv e a u x se riq u e s m a in te n u s a u to u r de
1 5 0 n g /m l.
P re d n is o n e 1 m g /k g a 0 .2 m g /k g 1 m o is a p re s tra n s p la n ta tio n .
C y c lo s p o rin e , p re d n is o n e et a z a th io p rin s .
C SA do se d 'a tta q u e p re o p e ra to ire 6 m g /k g par v o ie orale, d o se s
s u iv a n te s s e lo n le s n ive au x s e riq u e s m a in te n u s a u to u r de 1 0 0
n g /m l.
P re d n is o n e 1 m g /k g a 0 .2 m g /k g 1 m o is a p re s tra n s p la n ta tio n .
A z a th io p rin e d o s e d 'a tta q u e p re o p e ra to ire 4 m g /k g par vo ie o rale
e t d o s e s s u iv a n te s v is a n t a m a in te n ir le n o m b re d e s g lo b u le s
b la n c s e n tre s 5 0 0 0 e t 8 0 0 0 /m m .
R A T G t, c y c lo s p o rin e , p re d n is o n e e t a za th io p rin e .
C SA d e b u te e au 4 e m e jo u r p o s to p e ra to ire .
RATG 1 2 5 m g / j par vo ie IV p o u r 3 j.
C SA n iv e a u x se riq u e s m a in te n u s a u to u r de 5 0 a 100 n g /m l.
P re d n is o n e 1 m g /k g a 0 .2 m g /k g 1 m o is a p re s tra n s p la n ta tio n .
A z a th io p rin e d o s e d 'a tta q u e p re o p e ra to ire 4 m g /k g par v o ie o rale
e t d o s e s s u iv a n te s v is a n t a m a in te n ir le n o m b re d e s g lo b u le s
b la n c s e n tre 5 0 0 0 e t 8 0 0 0 /m m .
C o n v e rs io n a la th e ra p is trip le .
A z a th io p rin e 2 5 m g / j e t d o s e a ju s te e p o u r m a in te n ir le n o m b re
d e s g lo b u le s b la n c s entre 5 0 0 0 e t 8 0 0 0 /m m .
R e d u c tio n p ro g re s s iv e du n iv e a u de c y c lo s p o rin e en tre 5 0 e t 100
n g /m l.

* A u s s i partie du g ro u p e 1
t S e r u m a n ti-ly m p h o c y ta ire de la p in .
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cellules/mm, la diminution des niveaux seriques de cyclosporine
entre 50 et 100 ng/m l et la maintien de la prednisone orale a la dose
quotidienne d’entretien de 0.2
mg/kg.
Le dosage serique de la cyclospo
rine a ete effectue par radio-immuno dosage. Les niveaux de creatini
ne ont ete mesures quotidiennement
pendant l’hospitalisation a la suite
de la transplantation et a chaque
visite en clinique externe. Une collecte urinaire de 24 heures pour
mesurer la clearance de la creatini
ne a ete faite a chaque annee apres
transplantation.
Les resultats sont exprimes en
moyennes ± ecart-type. La differen
ce entre deux moyennes fut evaluee
par le test de t, alors que la differen
ce entre plusieurs moyennes le fut
par analyse de variance (ANOVA).
La survie est exprimee selon la
methode actuarielle et la difference
entre deux courbes de survie fut
etudiee a l’aide du test de MantelCox. Le niveau de signification statistique fut etabli a 95%.
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FIG. 1. Fonction renale evaluee par la
creatinine du groupe 1 (CSA et predni
sone) (n = 24).

FIG. 2. Fonction renale evaluee par la
clearance de la creatinine du groupe 1
(CSA et prednisone) (n = 19).
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Resultats
Au cours de l’experience initiale,
chez le premier groupe de 24 pa
tients sous cyclosporine et predni
sone, nous avons observe une
deterioration lente et progressive de
la fonction renale telle que re
presentee par les niveaux de creati
nine et de clearance de la creatinine
(figs. 1 et 2). Les parametres de
fonction renale se deteriorent alors
que les niveaux seriques de cyclos
porine sont maintenus en moyenne
a 152 ± 10 ng/m l. Lors de la
premiere annee, la creatinine est
passee de 99 ± 7 mmol/L, 1 mois
apres la transplantation, a 157 ± 7
mmol/L apres 12 mois. Cette
deterioration se poursuit par la
suite de faqon progressive jusqu’a 4
ans apres la transplantation alors
que la creatinine atteint 255 ± 5 1

* p<0.05

Groupe 1
(CSA ♦ Prednisone)

mmol/L et la clearance de la creati
nine 35 ± 2 ml/min.
Dans le deuxieme groupe (13
patients), avec therapie triple en
perioperatoire, la fonction renale
demeure normale 1 an apres la
transplantation, avec une creatinine
de 120 ± 8 mmol/L et une legere
diminution de la clearance de la
creatinine a 79 ± 8 ml/min. L’evolution de la fonction renale differe
du premier groupe chez qui la crea
tinine etait de 157 ± 7 mmol/L et
la clearance de 57 ± 6 ml/min a la
meme periode postoperatoire (figs.
3 et 4). Toutefois, revolution posto
peratoire immediate fut aussi diffici
le pour le deuxieme groupe, tous
les patients presentant une eleva
tion transitoire de la creatinine et
quatre d’entre eux ayant developpe
une oligoanurie transitoire.
Chez les patients du troisieme
groupe (13 patients), traites par
RATG suivi de cyclosporine au
4eme jour, il n’y eut aucun episode
d’oligoanurie pendant la phase pos
toperatoire precoce, ni elevation de
la creatinine. La creatinine etait en

Groupe 2
(CSA ♦ Prednisone ♦ AZA)

FIG. 3. Fonction renale evaluee par les
niveaux de creatinine du groupe 1
(CSA et prednisone, n = 18) et groupe
2 (CSA, prednisone et azathioprine
[AZA], n = 10) 1 an apres la trans
plantation.
FIG. 5. Effets de la conversion a la
therapie triple sur la creatinine chez
12 patients.

p<0.05

Groupe 1
(CSA ♦ Prednisone)

Groupe 2
(CSA ♦ AZA ♦ Prednisone)

FIG. 4. Fonction renale evaluee par la
clearance de la creatinine du groupe 1
(CSA et prednisone, n = 15) et groupe
2 (CSA, prednisone et azathioprine, n
= 10) 1 an apres la transplantation.

FIG. 6. Effets de la conversion a la
therapie triple sur la clearance de la
creatinine chez 12 patients.

moyenne de 117 ± 11 mmol/L a la
fin de la premiere semaine et elle est
demeuree normale, avec une
moyenne de 97 ± 2 mmol/L, 1 an
apres la transplantation.
Enfin, le groupe 4, constitue de
15 des 24 premiers patients, dont le
traitement immunosuppresseur a
ete modifie par l’addition d’azathioprine pour diminuer la cyclosporine,
a montre une amelioration sensible
de la fonction renale apres modifica
tion du traitement. Les niveaux
seriques de cyclosporine furent diminues de faqon significative de
146 ± 13 a 100 ± 12 ng/m l (p <
0.05), la creatinine a diminue de
199 ± 23 a 160 ± 18 mmol/L et la
clearance est passee de 46 ± 6 a 75
± 15 ml/min, de 3 a 18 mois apres
le debut de la therapie triple chez
ces malades. L’amelioration de la
fonction renale fut observee chez
12 (80%) de ces 15 patients, avec
une diminution significative de la
creatinine et une augmentation de
la clearance de la creatinine (figs. 5
et 6). Dans ces cas, il y avait
correlation significative entre les ni
veaux seriques de cyclosporine et
ceux de la creatinine (r = 0.66). Par
contre, trois patients n’ont pas
demontre une amelioration de la
fonction renale, dont Tune evolua
vers une insuffisance renale chronique qui a necessite des hemodialy
ses et une greffe renale.
L’azathioprine a du etre interrompue chez deux patients qui ont
presente une anemie et une infec
tion virale resistante au traitement.
Parmi ces 15 patients, aucun episo
de de rejet n’a ete detecte au cours
de la periode de changement. Un
patient a developpe un sarcome de
Kaposi, dont le diagnostic a ete
etabli 30 mois apres la transplanta
tion alors qu’il etait sous therapie
triple.
De plus, ces changements au pro
tocole d’immunosuppression n’ont
pas eu que des effets sur la fonction
renale. En effet, la survie actuarielle
CJS, VOL. 33, NO. 3, JUNE 1990
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fut de 92 ± 6% 1 an apres la
transplantation pour le groupe recevant la therapie triple (groupes 2 et
3) comparativement a 83 ± 7%
pour les patients sous cyclosporine
et prednisone (groupe 1) (fig. 7).
Enfin, la therapie triple a aussi
diminue de fa?on significative l’incidence des episodes de rejet sans
augmenter celle des episodes infectieux (tableau II).

Discussion
L’insuffisance renale, l’infection
et le rejet, represented les compli
cations les plus frequentes apres
transplantation cardiaque depuis
l’utilisation de la cyclosporine
comme un agent immunosuppresseur.7’8
L’insuffisance renale progressive
survenant quelques mois ou quelques annees apres la transplantation
a ete attribute a une atteinte tubulo-glomerulaire, comme le demontrent les lesions histologiques importantes d’atrophie tubulaire, de
fibrose interstitielle et de glomerulosclerose.9 Malgre les effets toxiques de la cyclosporine sur les
tubules renaux et les lesions histo
logiques, nous avons constate une
reversibilite partielle de l’insuffisan
ce renale avec la diminution des
niveaux seriques de cyclosporine de
6 mois a 4 ans apres la transplanta
tion, diminution rendue possible par
l’addition de l’azathioprine. De plus,
lorsque la therapie triple est debutee d’emblee a la periode perioperatoire, cette triple association impliquant de faibles niveaux de cyclos
porine, permet d’eviter le risque
d’insuffisance renale precoce et de
maintenir une fonction renale normale 1 an apres la transplanta
tion.10' 13
Une incidence elevee de rejet et
une mortality non negligeable furent rapportees a la suite de l’arret
de la cyclosporine et de son remplacement par une immunosuppression
246
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conventionnelle composee d’azathioprine et de prednisone seulement.14' 16 Le protocole de conver
sion a la therapie triple tel qu’utilise
dans l’etude presente n’a pas provoque d’effet secondaire important en
ce qui a trait au rejet et a l’infec
tion, et il a entraine une ameliora
tion significative de la fonction
renale pour 80% des patients. De
plus, ces changements au traitement immunosuppresseur ont ete
effectues progressivement en clinique externe, sans necessiter d’hospitalisation.
L’atteinte precoce de la fonction
renale, se presentant sous forme
d’une oligoanurie postoperatoire,
semble reliee a un effet hemodynamique aigu de la cyclosporine qui

produit une diminution du flot sanguin cortical. L’administration tar
dive, progressive et a faible dose de
la cyclosporine au 4eme jour posto
peratoire apres stabilisation hemodynamique a permis d’eliminer entierement ce probleme et la morbidite qui lui est associee. Ceci a ete
rendu possible par l’utilisation prophylactique du RATG au cours des
jours postoperatoires 1 a 3.1718
Ce protocole, en plus de proteger
la fonction renale precocement
apres la chirurgie, a aussi permis le
maintien d’une fonction renale normale tout au long de la premiere
annee apres transplantation.19
Toutefois, en plus de la fonction
renale, il est aussi important d’evaluer attentivement l’effet des chan-

FIG. 7. Effets de l’administration de la therapie triple sur la survie actuarielle
(groupe 1, n = 24; groupes 2 et 3, n = 26).

Tableau II. Incidence des episodes de rejet et d'infection selon les quatre protocoles
Groupe
1 - CSA - prednisone
2 - CSA - prednisone azathioprine
3 - CSA - prednisone azathioprine - RATG
4 - Apres la conversion tardive

No. de
patients

Rejet
(no.
d’episodes/patient)

Infection

24

1.3 ± 1

1.7 ± 4

13

0.8 ± 1 t

0.3 ± 1

13
15*

0.3 ± 1 t
0

0.3 ± 1
0

*Les 15 patients font aussi partie du groupe 1.
tp < 0.05.

CYCLOSPORINE ET FONCTION RENALE

gements de la medication sur l’ensemble des resultats cliniques. L’utilisation de l’azathioprine et du
RATG ont entralne une diminution
de l’incidence de rejet sans causer
d’augmentation des episodes infectieux. De plus, la survie actuarielle
s ’est trouvee legerement amelioree
avec la therapie triple bien que les
changements ne soient pas significatifs.
En conclusion, l’utilisation de la
cyclosporine a permis le developpement de la transplantation d’organe
comme therapeutique courante. La
greffe cardiaque est ainsi devenue
une procedure bien acceptee et
mieux etablie. Notre experience
demontre que tout en conservant
les qualites immunosuppressives de
la cyclosporine, les effets toxiques
renaux peuvent etre evites par une
modification de l’approche immuno
suppressive visant a maintenir la
cyclosporine a des niveaux seriques
plus faibles, grace a l’utilisation
d’une therapie triple composee de
cyclosporine, azathioprine et pred
nisone. Pour ce qui est de l’atteinte
renale deja etablie, il semble qu’elle
soit du moins en partie reversible
par le changement de regime immunosuppresseur, meme plusieurs annees apres la transplantation et ce,
sans augmentation du risque de
rejet, si la modification therapeuti
que est effectuee graduellement
pour assurer le maintien constant
d’un niveau d’immunosuppression
adequat.
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GENERAL SURGEON
P ER M AN EN T AND/OR LOCUM
A general surgeon is required, either as a
summer locum and/or permanently, to
join a busy community practice in PEI. The
present medical centre has twenty doc
tors, split evenly between GPs and spe
cialists. The practice requires three gener
al surgeons; as of July 1, 1990 it will have
only tw o . Experience in orthopedics and
urology would be an asset, but not a
necessity. LMCC and FRCSC required for
licensure.
Applications to:
W .L. Walker, M D, FRCSC
Summerside Medical Center
Summerside, PEI
C 1N 3N 9
_s
_________ Tel: (902) 4 3 6 -9 2 8 3
bau 14

GENERAL SURGERY PRACTICE: BC - Lu
crative practice in the lower mainland. Excel
lent on-call schedule. Superb recreational area
on doorstep. Full complement of specialists
present. Reply in confidence to: Box 982,
CJS.
-S90-17

GENERAL SURGEON: ON - A general sur
geon is required for a 542-bed community
hospital in a rapidly growing city on the
outskirts of metropolitan Toronto. Please
send curriculum vitae and enquiries to: Dr. T.
Varga, Chief of Surgery, c/o Program Ad
ministration Office, Peel Memorial Hospi
tal, 20 Lynch St., Brampton, ON L6W 2Z8.
-S90-15

CHIEF OF SURGERY
Central Hospital is expanding its community services to
keep pace with evolving needs of its exciting, culturally
diverse, downtown community. To meet these needs the
Hospital has appointed a new Medical Director and is
currently seeking to recruit an imaginative, energetic, Chief
of Surgery. As Chief of Surgery in an accredited 176-bed
community hospital, located in the core of Downtown
Toronto, you will provide leadership in further developing
existing practice guidelines and quality assurance programs
to meet the surgical needs of the community in the 1990’s,
and to ensure the effective utilization of in-patient and day
surgical facilities as required to fulfill the demands of the
primary health care physicians in their new Department.
The successful applicant will head a sizeable Department
including general surgery and the specialties of
orthopaedics, urology, plastic surgery, ophthalmology and
otolaryngology. Preference will be given to applicants with
recent academic and/or administrative backgrounds.

—S90-21

HOSPITALJ

333 Sherbourne Street, Toronto, Ontario M5A 2S5

The Best Care in Any Language
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CLINICAL FELLOW IN
NEUROSURGERY
Applications are invited for the position of clinical fellow in
neurosurgery, Memorial University of Newfoundland. The post
becomes vacant July 1,1990 and is for a period of 1 year (renewable).
The Provincial Neurosurgeiy Unit is based at the Health Sciences
Centre. Previous e xp e rie n c e in ne u ro su rge ry is required.
Salary — $46 488.
In accordance with Canadian immigration requirements, priority will
be given to Canadian citizens and permanent residents.
For further information contact:

Send Curriculum Vitae to the
Medical Director.

yC E N TR A L I

THORACIC SURGEON: AB - Applications
are invited for an active staff position at the
University of Alberta Hospitals in the Division
of Cardiovascular and Thoracic Surgery of the
Department of Surgery. Candidates must
have the fellowship of the Royal College of
Physicians and Surgeons of Canada in cardio
vascular and thoracic surgery or certification
of special competence in thoracic surgery.
The position will carry an appropriate clinical
rank in the Faculty of Medicine for the Univer
sity of Alberta and candidates must be willing
to participate in the teaching programs of the
faculty and support academic activity. They
must also be eligible for registration with the
College of Physicians and Surgeons of Alber
ta. In accordance with Canadian immigration
requirements, this advertisement is directed
to Canadian citizens and permanent residents
of Canada. Please submit a current curriculum
vitae and the names of three referees by June
30, 1990 to: Dr. Bryce Weir, Chairman.
Department of Surgery, Faculty of Medi
cine, University of Alberta, 2D2 Walter C.
Mackenzie Health Sciences Centre, 8 440
- 112 St. Edmonton, AB T6G 2B7. The
University of Alberta is committed to the
principle of equity in employment.

Dr. F.B. Maroun, Acting Chairman
Discipline of Surgery
Memorial University
Health Sciences Centre
St. John’s, NF
A1B 3V6

—S90-24

HEAD, DIVISION OF GENERAL SURGERY
ST. MICHAEL’S HOSPITAL
St. Michael’s Hospital, a 700-bed active treatment
teaching hospital, fully affiliated with the University of
Toronto, invites applications for the position of Head,
Division of General Surgery.
Located in downtown Toronto, the hospital is in close
proximity to the University of Toronto and other major
teaching and research activities.
Essential requirements for the position include a clear
commitment to patient care, demonstrated clinical and
managerial expertise and proven leadership in teaching
and research.
Applicant must have certification by the Royal College of
Physicians and Surgeons of Canada or equivalent.
The successful candidate will be jointly appointed to the
Department of Surgery in the Faculty of Medicine at the
University of Toronto.
In accordance with Canadian immigration requirements,
this advertisement is directed to Canadian citizens and
permanent residents.
Please apply with curriculum vitae by June 30, 1990 to:
Dr. J.C. P latt, MD
V ice P re sid e n t, M edical A ffa irs
St. M ich a e l’s H ospital
30 B o n d S tre e t
T o ro n to , O n ta rio
M5B 1W8

_ S9o-18

Tel: (416) 864-5041

Iscarr& w H iT E

TEXAS A&M UNIVERSITY
College o f Medicine
TEMPLE CAMPUS

The Department o f Neurologic Surgery o f the Scott
and White Institutions and Texas A&M University
College o f Medicine is seeking applications for
senior staff physician faculty in the Sections o f
Pain/Stereotaxic Surgery or Neurosurgical Oncology.
Residency or post residency experience and a
defined interest in either subspecialty area together
with a broad capability and interest in general
neurosurgical disorders is desired. Basic and clinical
research opportunities are available commensurate
with previous experience. Medical student and
resident teaching/daily responsibilities are required.
The main campus is located in central Texas, north
o f Austin in the approximate center o f the Dallas/ Ft.
Worth, San Antonio, Houston triangle and benefits
from easy access to other surrounding universities
(Southwestern University, Georgetown; University o f
Mary Hardin-Baylor, Belton; Baylor University,
Waco.)
For further information, please send curriculum
vitae and references to:
M itc h e ll S m ig ic l, M .D .
C h a irm a n , N e u ro lo g ic S u rg e ry
S cott a n d W h ite , Texas A & M U n iv e rs ity
C o lle g e o f M e d ic in e
2401 S o u th 31st S tre e t
T e m p le , TX 7 6 5 0 8

LEADERSHIP
IN SURGICAL
ONCOLOGY
The Ontario Cancer Institute incorporating
the Princess Margaret Hospital is
Canadas largest centre for cancer
treatment, research and education, and
the major tertiary care cancer centre in the
Province of Ontario. The care, vision and
professional collaboration of this staff
have earned OCI/PMH an international
reputation for excellence.
In
collaboration
with
the
Faculty
Departments of Surgery, Otolaryngology,
Ophthalmology and Obstetrics and
Gynaecology of the University of Toronto,
the OCI/PMH wishes to appoint a Head
and create a program in Surgical
Oncology to function in parallel with the
Departments of Medical and Radiation
Oncology.
This program, with its
academic base at OCI/PMH, would be
part of a broad initiative in multidisciplinary
cancer patient care enacted through the
OCI/PMH and participating hospitals
affiliated with the University of Toronto.
Responsibilities of the appointee will
include planning and priority setting within
the
Surgical
Oncology
program,
development and maintenance of a
research program in collaboration with the
Department of Research, supervision of
the educational program in undergraduate
and post-graduate Surgical Oncology,
administrative
responsibility
for the
Surgical Oncology program and liaison
with other organizations such as
government, universities and industry.
The incumbent will havea major
opportunity to help shape oncology
programs for the new Princess Margaret
Hospital prior to and following its
relocation in 1993 to its University Avenue
site.
Professional
qualifications
and
accomplishments appropriate to this
important
leadership
position
will
encompass substantial achievement in
the
clinical,
administrative,
and
research/teaching
domains.
The
appointment will be at the Associate or full
Professor level within the appropriate
faculty department of the University of
Toronto.
Canadian citizens will be given priority
consideration. Surgeons attracted by this
im portant and challenging opportunity
should submit a current curriculum vitae
with their letter of application to Mr. W.R.
Livingston,
Chairman,
Search
Committee for Head o f Surgical
Oncology, The Princess Margaret
Hospital, 500 Sherbourne St., Toronto,
Ontario, M4X 1K9 by June 31,1990.

—S90-06
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The Calgary
General Hospital i *

General Surgeon
This vital young community of 35,000 seeks a general surgeon.
Office space available with another surgeon in a very rewarding
and lucrative practice with excellent referral base. Enjoy state
of the art technology, a full range of diagnostic and procedural
services including CT scan, and six O.R. theatres offering flexi
ble schedules and minimal waiting time. Our 300-bed hospital
is fully accredited, with planned expansion of the 150 beds cur
rently open. The city offers superb recreational, cultural, and
educational facilities. Don't miss this exceptional opportunity!

Contact:
The President
Fort McMurray Regional Hospital
7 Hospital Street
Fort McMurray, Alberta T9H 1P2
Phone (403) 791-6161

Bow Valley Centre
Peter Lougheed Centre

General Surgeon
The Calgary General Hospital invites
applications for a position in General
Surgery. The successful applicant will be
expected to have specialized training and
interest in thoracic or peripheral vascular
surgery and to participate in undergraduate
and post-graduate teaching and research.
The candidate should be a Fellow of the
Royal College of Physicians and Surgeons
of Canada and be eligible for licensure by
the College of Physicians and Surgeons of
Alberta.
The Calgary General Hospital is a 940-bed
te a c h in g h o sp ita l a ffilia te d w ith the
University of Calgary.

Fort McMurray
Regional
Hospital

In a c c o r d a n c e w i t h i m m i g r a t i o n
requirements, preference will be given to
C a n a d i a n c i t i z e n s and p e r m a n e n t
residents.
Reply, including curriculum vitae and the
names of three referees, to:

CLEAN AIR ENVIRONMENT
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Director, Department of Surgery
The Calgary General Hospital - Bow Valley Centre
841 Centre Avenue E. Calgary, Alberta T2E 0A1

INTENSIVIST/GENERAL
SURGEON
NOVA SCOTIA
Dalhousie University, Department of
Surgery Hospital invites applications
from individuals with an FRCSC in
g e n e ra l s u rg e ry and fo rm a l
postgraduate training in critical care
along w ith a proven research
background for a position prime
based at the V icto ria General
Hospital. Duties will include an active
involvement in basic and/or clinical
research and undergraduate and
p o s tg ra d u a te e d u c a tio n . The
successful applicant will assume
co-directorship of a surgical intensive
care unit and will be a member of the
h o s p ita l based tra u m a team .
Dalhousie University has a policy of
affirmative action in hiring qualified
women academ ic s ta ff and in
a c c o r d a n c e w ith C a n a d ia n
im m igration requirem ents, this
a d v e rtis e m e n t is d ire c te d to
Canadian citizens and permanent
residents. All interested persons
should send their resume to:
Dr. A .J. B o d u rth a , Head,
D e p a rtm e n t o f S u rg e ry ,
V ic to ria G e n era l H o sp ita l,
S uite 8-032
1278 T o w e r R oad
H a lifa x, N ova S co tia
B3H 2Y9
— S90-23

N A N A IM O REGIONAL
GENERAL HOSPfTAL

Requires An

Orthopaedic
Surgeon
The Nanaimo Regional General
Hospital is searching for an
orthopaedic surgeon to join four
others on the medical staff. Our 436
bed regional referral hospital
provides com m unity hospital
services for an im m ediate
population of 85,000 and secondary
referral services for a population of
250,000.
Nanaimo is a scenic harbour city
with e xceptional recreational
opportunities on the east coast of
Vancouver Island. We are looking
for a surgeon who is interested in
establishing a busy, general
orthopaedic practice in this very
desirable location.
Interested orthopaedic surgeons
should forward a curriculum vitae
and the names of three references
to Dr. B. Johnstone, Medical
Coordinator, Nanaimo Regional
General Hospital, 1200 Dufferln
C re s c e n t,
N a n a im o ,
B.C.
V9S 2B7.

The

NT

Burning

Question

Does Your Injectable H2 Antagonist Provide Prompt, Persistent Gastric pH Control?

The on set o f a n tisecreto ry e ffe ct o f PEPCID ® 20 m g I. V. w as n o ted as ea r ly as o n e h ou r a fter
a dm in istration in a study of hypersecretor individuals.1 Mean gastric pH values were maintained above
4.0 for up to 12 hours. The convenient ql2h dosage of PEPCID® I.V. may mean significant cost savings
and a reduction in time needed to prepare medication. So for prompt, persistent pH control: PEPCID®.
For many patients with pathological hypersecretory conditions or intractable
ulcers, or for short term use in patients unable to take oral medication.
__
/ q!2h
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MERCK
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CANADA

PAAB

For Complete Prescribing Information Please See Page 220
©Trademark Merck & Co., Inc./Merck Frosst Canada Inc., R.U.
PCD-90-CDN-3103-JA

Pepcid
M(famotidineinjection)
Answers the burning question

The best tip
for deep cavity surgery
VITAL VUE keeps control at your finger tips with superior
illumination, irrigation and suction...all in one compact unit.
•Superior visibility in dark cavities • Helps visualize elusive bleeders • May reduce the risk
of cross contamination • Minimizes inconvenience and delay of overhead light adjustments
• Reduces surgeon fatigue • Compact - easy to set up, easy to use, easy to store

VITAL'VUE
Irrigation, Suction and Illumination System
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©Registered UserCyanamid Canada Inc.
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Cyanamid Canada Inc. 88 McNabb Street, Markham Ontario L3R 6E6

